<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Psychosocial interventions for conversion and dissociative disorders in adults - Ganslev, CA - 2020 | Cochrane Library</title> <meta content="Psychosocial interventions for conversion and dissociative disorders in adults - Ganslev, CA - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005331.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Psychosocial interventions for conversion and dissociative disorders in adults - Ganslev, CA - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005331.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD005331.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Psychosocial interventions for conversion and dissociative disorders in adults" name="citation_title"/> <meta content="Christina A Ganslev" name="citation_author"/> <meta content="cadg@regionsjaelland.dk" name="citation_author_email"/> <meta content="Ole Jakob Storebø" name="citation_author"/> <meta content="Henriette E Callesen" name="citation_author"/> <meta content="Psychiatry of Region Zealand" name="citation_author_institution"/> <meta content="Rachel Ruddy" name="citation_author"/> <meta content="Ulf Søgaard" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="7" name="citation_issue"/> <meta content="10.1002/14651858.CD005331.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/07/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005331.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005331.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005331.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti-Anxiety Agents [therapeutic use]; Conversion Disorder [*therapy]; Diazepam [therapeutic use]; Hypnosis; Psychotherapy [methods]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD005331.pub3&amp;doi=10.1002/14651858.CD005331.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="8ranHhTh";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD005331\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD005331\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","ru","ko","ms","ja","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD005331.pub3",title:"Psychosocial interventions for conversion and dissociative disorders in adults",firstPublishedDate:"Jul 17, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Common Mental Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005331.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005331.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD005331.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD005331.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005331.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD005331.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD005331.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD005331.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD005331.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD005331.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11328 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD005331.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-sec-0234"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-sec-0022"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-sec-0023"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-sec-0054"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-sec-0207"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/appendices#CD005331-sec-0239"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/table_n/CD005331StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/table_n/CD005331StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Psychosocial interventions for conversion and dissociative disorders in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information#CD005331-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Christina A Ganslev</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information#CD005331-cr-0005">Ole Jakob Storebø</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information#CD005331-cr-0006">Henriette E Callesen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information#CD005331-cr-0007">Rachel Ruddy</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information#CD005331-cr-0008">Ulf Søgaard</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information/en#CD005331-sec-0244">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 July 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD005331.pub3">https://doi.org/10.1002/14651858.CD005331.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD005331-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005331-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD005331-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005331-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005331-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005331-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005331-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD005331-abs-0001" lang="en"> <section id="CD005331-sec-0001"> <h3 class="title" id="CD005331-sec-0001">Background</h3> <p>Conversion and dissociative disorders are conditions where people experience unusual neurological symptoms or changes in awareness or identity. However, symptoms and clinical signs cannot be explained by a neurological disease or other medical condition. Instead, a psychological stressor or trauma is often present. The symptoms are real and can cause significant distress or problems with functioning in everyday life for the people experiencing them. </p> </section> <section id="CD005331-sec-0002"> <h3 class="title" id="CD005331-sec-0002">Objectives</h3> <p>To assess the beneficial and harmful effects of psychosocial interventions of conversion and dissociative disorders in adults. </p> </section> <section id="CD005331-sec-0003"> <h3 class="title" id="CD005331-sec-0003">Search methods</h3> <p>We conducted database searches between 16 July and 16 August 2019. We searched Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, and eight other databases, together with reference checking, citation searching and contact with study authors to identify additional studies.  </p> </section> <section id="CD005331-sec-0004"> <h3 class="title" id="CD005331-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials that compared psychosocial interventions for conversion and dissociative disorders with standard care, wait list or other interventions (pharmaceutical, somatic or psychosocial).  </p> </section> <section id="CD005331-sec-0005"> <h3 class="title" id="CD005331-sec-0005">Data collection and analysis</h3> <p>We selected, quality assessed and extracted data from the identified studies. Two review authors independently performed all tasks. We used standard Cochrane methodology. For continuous data, we calculated mean differences (MD) and standardised mean differences (SMD) with 95% confidence interval (CI). For dichotomous outcomes, we calculated risk ratio (RR) with 95% CI. We assessed and downgraded the evidence according to the GRADE system for risk of bias, imprecision, indirectness, inconsistency and publication bias. </p> </section> <section id="CD005331-sec-0006"> <h3 class="title" id="CD005331-sec-0006">Main results</h3> <p>We included 17 studies (16 with parallel‐group designs and one with a cross‐over design), with 894 participants aged 18 to 80 years (female:male ratio 3:1).  </p> <p>The data were separated into 12 comparisons based on the different interventions and comparators. Studies were pooled into the same comparison when identical interventions and comparisons were evaluated. The certainty of the evidence was downgraded as a consequence of potential risk of bias, as many of the studies had unclear or inadequate allocation concealment. Further downgrading was performed due to imprecision, few participants and inconsistency. </p> <p>There were 12 comparisons for the primary outcome of reduction in physical signs.</p> <p><b>Inpatient paradoxical intention therapy compared with outpatient diazepam:</b> inpatient paradoxical intention therapy did not reduce conversive symptoms compared with outpatient diazepam at the end of treatment (RR 1.44, 95% CI 0.91 to 2.28; 1 study, 30 participants; P = 0.12; very low‐quality evidence). </p> <p><b>Inpatient treatment programme plus hypnosis compared with inpatient treatment programme:</b> inpatient treatment programme plus hypnosis did not reduce severity of impairment compared with inpatient treatment programme at the end of treatment (MD –0.49 (negative value better), 95% CI –1.28 to 0.30; 1 study, 45 participants; P = 0.23; very low‐quality evidence). </p> <p><b>Outpatient hypnosis compared with wait list:</b> outpatient hypnosis might reduce severity of impairment compared with wait list at the end of treatment (MD 2.10 (higher value better), 95% CI 1.34 to 2.86; 1 study, 49 participants; P &lt; 0.00001; low‐quality evidence). </p> <p><b>Behavioural therapy plus routine clinical care compared with routine clinical care:</b> behavioural therapy plus routine clinical care might reduce the number of weekly seizures compared with routine clinical care alone at the end of treatment (MD –21.40 (negative value better), 95% CI –27.88 to –14.92; 1 study, 18 participants; P &lt; 0.00001; very low‐quality evidence). </p> <p><b>Cognitive behavioural therapy (CBT) compared with standard medical care:</b> CBT did not reduce monthly seizure frequency compared to standard medical care at end of treatment (RR 1.56, 95% CI 0.39 to 6.19; 1 study, 16 participants; P = 0.53; very low‐quality evidence). CBT did not reduce physical signs compared to standard medical care at the end of treatment (MD –4.75 (negative value better), 95% CI –18.73 to 9.23; 1 study, 61 participants; P = 0.51; low‐quality evidence). CBT did not reduce seizure freedom compared to standard medical care at end of treatment (RR 2.33, 95% CI 0.30 to 17.88; 1 trial, 16 participants; P = 0.41; very low‐quality evidence). </p> <p><b>Psychoeducational follow‐up programmes compared with treatment as usual (TAU):</b> no study measured reduction in physical signs at end of treatment. </p> <p><b>Specialised CBT‐based physiotherapy inpatient programme compared with wait list:</b> no study measured reduction in physical signs at end of treatment. </p> <p><b>Specialised CBT‐based physiotherapy outpatient intervention compared with TAU:</b> no study measured reduction in physical signs at end of treatment. </p> <p><b>Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) compared with standard care:</b> brief psychotherapeutic interventions did not reduce conversion symptoms compared to standard care at end of treatment (RR 0.12, 95% CI 0.01 to 2.00; 1 study, 19 participants; P = 0.14; very low‐quality evidence). </p> <p><b>CBT plus adjunctive physical activity (APA) compared with CBT alone:</b> CBT plus APA did not reduce overall physical impacts compared to CBT alone at end of treatment (MD 5.60 (negative value better), 95% CI –15.48 to 26.68; 1 study, 21 participants; P = 0.60; very low‐quality evidence). </p> <p><b>Hypnosis compared to diazepam:</b> hypnosis did not reduce symptoms compared to diazepam at end of treatment (RR 0.69, 95% CI 0.39 to 1.24; 1 study, 40 participants; P = 0.22; very low‐quality evidence). </p> <p><b>Outpatient motivational interviewing (MI) and mindfulness‐based psychotherapy compared with psychotherapy alone:</b> psychotherapy preceded by MI might decrease seizure frequency compared with psychotherapy alone at end of treatment (MD 41.40 (negative value better), 95% CI 4.92 to 77.88; 1 study, 54 participants; P = 0.03; very low‐quality evidence). </p> <p>The effect on the secondary outcomes was reported in 16/17  studies. None of the studies reported results on adverse effects. In the studies reporting on level of functioning and quality of life at end of treatment the effects ranged from small to no effect. </p> </section> <section id="CD005331-sec-0007"> <h3 class="title" id="CD005331-sec-0007">Authors' conclusions</h3> <p>The results of the meta‐analysis and reporting of single studies suggest there is lack of evidence regarding the effects of any psychosocial intervention on conversion and dissociative disorders in adults. It is not possible to draw any conclusions about potential benefits or harms from the included studies. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD005331-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD005331-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD005331-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD005331-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD005331-abs-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD005331-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD005331-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD005331-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD005331-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD005331-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD005331-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD005331-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD005331-abs-0002" lang="en"> <h3>Therapeutic and social interventions for conversion and dissociative disorders</h3> <p>The aim of this review is to provide a better understanding of what is an effective and useful intervention (treatment) for people with conversion disorders and dissociative disorders. The interventions we look at are non‐medical. Instead they concern therapy or social interventions.<br/> <br/><b>Background</b> </p> <p>Conversion and dissociative disorders are conditions where people experience unusual neurological symptoms (relating to the nerves and nervous system) or changes in awareness or identity. Neurological disease or other medical conditions cannot explain these clinical signs; often a psychological (affecting or arising in the mind) stressor or trauma is present. The symptoms are real and can cause distress or problems with functioning in everyday life for the people experiencing them. </p> <p>This review seeks to help these patients, as well as the clinicians, policy makers and healthcare services working with these disorders. </p> <p><b>Review question</b> </p> <p>What is the evidence for psychosocial (relating to social factors and individual thought and behaviour) intervention of conversion and dissociative disorders? </p> <p><b>Search date</b> </p> <p>We searched medical databases between 16 July and 16 August 2019.</p> <p><b>Results of search</b> </p> <p>We read 3048 summaries of articles, resulting in 17 studies that met our criteria for the conditions, the groups of people, the interventions and the types of studies that are the focus of this review. </p> <p>The 17 studies had 894 participants, and each study was relatively small. </p> <p>More studies are under way, and we will include them in updates of this review.</p> <p><b>Study characteristics</b> </p> <p>The studies took place in nine different countries worldwide, with adults aged 18 to 80 years, who had a diagnosis of conversion or dissociative disorder for any length of time. Some studies were conducted in either psychiatric or neurological settings. Some included people already in hospital, some included people attending outpatient clinics.  </p> <p>The interventions were all psychosocial, meaning that they focused on psychological or social interventions such as therapy, hypnosis or simply teaching people about their illness. The number of sessions varied. </p> <p>The included studies all compared the intervention to a control group to see if the interventions made any difference. The control groups received a different psychosocial intervention, medication or the care that people would normally get if they had the same condition but were not part of a research study. </p> <p>The primary outcome we looked for was a reduction in physical signs.</p> <p><b>Key results</b> </p> <p>We investigated the effect of different types of psychosocial interventions, ranging from hypnosis to behavioural therapy. None of the studies were conducted to a high enough standard to be able to say anything conclusive about the evidence of the results. </p> <p>There was a reduction in physical signs at the end of treatment for three interventions.</p> <p>Hypnosis reduced the severity of impairment compared to people on a wait list for treatment; behavioural therapy, given on top of routine care to inpatients, reduced the number of weekly seizures (fits) and symptom severity compared with people receiving routine care alone; and psychotherapy preceded by motivational interviewing (a talking therapy that attempts to move an person away from a state of indecision or uncertainty to positivity) compared with psychotherapy alone reduced seizure frequency. </p> <p><b>Quality of the evidence</b> </p> <p>Most of the included studies had methodological flaws and the quality of evidence used to assess the effectiveness of the different treatments was judged as low or very low. Due to this low‐quality evidence, we cannot say how reliable the results are. </p> <p><b>Conclusion</b> </p> <p>The results of the meta‐analysis and reporting of single studies suggest that there is lack of evidence regarding the effects of any psychosocial intervention of conversion and dissociative disorders in adults. Therefore, it is not possible to draw any conclusions about potential benefits or harms from the included studies. </p> <p>However, the review shows that research in this area is possible.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD005331-sec-0234" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD005331-sec-0234"></div> <h3 class="title" id="CD005331-sec-0235">Implications for practice</h3> <section id="CD005331-sec-0235"> <p>The interventions of this review represent a broad spectrum of psychosocial interventions, covering behavioural therapy, cognitive behavioural therapy, hypnosis, psychodynamic therapy, specialised physiotherapy, paradoxical intervention and psychoeducation. </p> <p>However, there was no high‐quality, unequivocal evidence to support one psychosocial intervention over others or other comparisons for conversion or dissociative disorders in adults. Most studies had a high risk of bias and the results were of very low‐ to low‐certainty evidence due to imprecision, few participants and inconsistency. </p> <p>In relation to implications for practice, we must await ongoing and new studies that may bring forward valid evidence of treatment effect for these conditions, which also includes both patient and clinician involvements. </p> <p>Until then, evidence‐based practice must be based on critically appraised topics on available literature or national guidelines (external evidence), background information or expert opinions (internal evidence), and patient preferences and values. </p> </section> <h3 class="title" id="CD005331-sec-0236">Implications for research</h3> <section id="CD005331-sec-0236"> <p>This review highlights the need for long‐term, high‐quality studies with low risk of bias and with sufficient numbers of participants investigating the benefits and harms of psychological interventions for people with conversation disorders and dissociative disorders. If the CONSORT recommendations were followed in reporting future studies, including prepublished protocols to combat the problem of publication bias, we would be more aware of the effects of psychosocial interventions for conversion disorder (<a href="./references#CD005331-bbs2-0251" title="MoherD , SchulzKF , AltmanD . The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA2001;285:1987-91.">Moher 2001</a>). Important data from several of the included studies were lost due to poor reporting. </p> <p>Researchers may wish to investigate further the interventions included in this review in the ways suggested or to explore other psychosocial interventions for these disorders. Whatever intervention is studied it is important to have an appropriate control group that is receiving a comparable intervention. Some way of compensating for the additional time spent with people by allocation to a psychosocial intervention, particularly an inpatient one, may be desirable. </p> <p>Further studies of psychosocial interventions for conversion and dissociative disorders should include clinically meaningful outcomes such as: clinically significant changes in physical functioning, mental state, relapse, admission to hospital, engagement with services, quality of life, leaving the study early, satisfaction with care, social functioning, adverse effects and economic outcomes (cost‐effectiveness and cost‐benefit). It will also be important to create studies that explicitly include greater patient involvement from early design to final research in order to integrate end‐user perspectives more. </p> <p>Some studies are based on people with severe and complicated conditions with high comorbidity, severe psychopathology and need for long‐term treatment. Here, in particular for ethical reasons, it may be difficult to operate with control groups. A recommendation for these participants is to prepare a high standard non‐randomised design that allows optimal reviews and evaluation with ROBINS‐I in assessing the risk of bias (<a href="./references#CD005331-bbs2-0269" title="SterneJA , HernánMA , ReevesBC , SavovićJ , BerkmanND , ViswanathanM , et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ2016;355:i4919.">Sterne 2016</a>). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD005331-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD005331-sec-0008"></div> <div class="table" id="CD005331-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Paradoxical intention therapy compared with diazepam</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Paradoxical intention therapy compared with diazepam for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatient and inpatient </p> <p><b>Intervention:</b> paradoxical intention therapy </p> <p><b>Comparison:</b> diazepam over 45 days </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Diazepam</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Paradoxical intention therapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>(number of patients without any conversive attacks in last 2 weeks)</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.44</b> (0.91 to 2.28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>30<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Paradoxical intention therapy may have no effect on physical signs at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>600 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>864 per 1000</b><br/>(54 less to 768 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to imprecision (wide confidence intervals; based on one study with few patients).<br/><sup>b</sup>Downgraded one level due to high risk of bias. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Hypnosis plus treatment as usual compared with treatment as usual</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Hypnosis + treatment as usual compared with treatment as usual for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> inpatient </p> <p><b>Intervention:</b> hypnosis + TAU </p> <p><b>Comparison:</b> TAU </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TAU</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Hypnosis + TAU</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs (Severity of impairment)</b> </p> <p>Measured by the VRMC scale (higher is better)</p> <p>Range: 1–7</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 5.9</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.49 lower</b> </p> <p>(1.28 lower to 0.30 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypnosis + TAU may have no effect on physical signs at end of treatment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>TAU:</b> treatment as usual; <b>VRMC:</b> The Video Rating Scale for Motor Conversion Symptoms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (wide confidence intervals; based on 1 study with few patients). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Hypnosis compared with wait list</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hypnosis compared with wait list for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatient </p> <p><b>Intervention:</b> hypnosis </p> <p><b>Comparison:</b> wait list </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait list</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Hypnosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs (Severity of impairment)</b> </p> <p>Measured by the VRMC scale (higher is better)</p> <p>Range: 1–7</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 3.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.10 higher</b> </p> <p>(1.34 higher to 2.86 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypnosis may have little effect on reduction in physical signs at end of treatment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>VRMC:</b> Video Rating Scale for Motor Conversion Symptoms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded one level due to imprecision (based on 1 study with few patients). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Behavioural therapy plus treatment as usual compared with treatment as usual</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Behavioural therapy + TAU compared with TAU for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> inpatient </p> <p><b>Intervention:</b> behavioural therapy + TAU </p> <p><b>Comparison:</b> TAU </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TAU</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Behavioural therapy + TAU</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Number of weekly seizures, as assessed by daily self‐reported treatment diary</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 27.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 21.40 lower</b> </p> <p>(27.88 lower to 14.92 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Very low</b><sup>a,b</sup> </p> <p>⊕⊝⊝⊝</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Behavioural therapy + TAU may have little effect on reduction in physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p><b>(symptom severity)</b> </p> <p>Measured by Clinical Global Impression scale (lower is better)</p> <p>Range: 1–7</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 4.48</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.90 lower</b> </p> <p>(3.41 lower to 2.39 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Very low</b><sup>a,b</sup> </p> <p>⊕⊝⊝⊝</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Behavioural therapy + TAU may have little effect on reduction in physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> Confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to high risk of bias.<br/><sup>b</sup>Downgraded one level due to imprecision (data based on 1 study with few participants). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Cognitive behavioural therapy as compared with standard medical care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cognitive behavioural therapy compared with standard medical care for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings: </b>outpatient </p> <p><b>Intervention:</b> cognitive behavioural therapy </p> <p><b>Comparison:</b> standard medical care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard medical care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Cognitive behavioural therapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Reduction in monthly seizure frequency as assessed by a daily self‐reported seizure diary </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.56</b> (0.39 to 6.19) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>16<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on reducing physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>286 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>446 per 1000</b><br/>(174 less to 1484 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Monthly seizure frequency as assessed by a daily self‐reported seizure diary (lower is better) </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 6.75</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD –4.75 lower</b> </p> <p>(18.73 lower to 9.23 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on reducing physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical sign</b> </p> <p>Seizure freedom as assessed by a daily self‐reported seizure diary</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 2.33</b> (0.30 to 17.88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>16<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on reducing physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b><br/>(100 less to 2414 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> <p>As measured by the GAF (range 0–100) scale and the WSAS scale (0–40) (lower is better)</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.44 higher</b> </p> <p>(1.69 lower to 2.57 higher)</p> <p>I<sup>2</sup> = 91% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on level of functioning at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>As assessed by QOLIE31 (higher is better)</p> <p>Range: 15–97</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the control group was 9.7</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 11.20 higher</b> </p> <p>(7.98 lower to 30.38 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on quality of life at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>GAF</b> : global assessment of functioning; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>QOLIE31</b> : quality of life in epilepsy inventory; <b>RR:</b> Risk Ratio; <b>SMD:</b> standardised mean difference; <b>WSAS:</b> work and social adjustment scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (wide confidence intervals; 1 study with few participants).<br/><sup>c</sup>Downgraded one level due to imprecision (wide confidence intervals).<br/><sup>d</sup>Downgraded one level due to inconsistency (I<sup>2</sup> = 91%). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Psychoeducational follow‐up programme compared with treatment as usual</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Systematic follow‐up programme compared with TAU for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings: </b>outpatient </p> <p><b>Intervention:</b> systematic follow‐up programme </p> <p><b>Comparison:</b> TAU </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TAU</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Systematic follow‐up programme</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> <p>As assessed by WSAS scale (lower is better)</p> <p>Range: 0–40</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean level of functioning in the control group was 25.52</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 7.12 lower</b> </p> <p>(12.47 lower to 1.77 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychoeducational follow‐up programme may have little effect on level of functioning at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>TAU:</b> treatment as usual; <b>WSAS:</b> Work and Social Adjustment Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to high risk of bias.<br/><sup>b</sup>Downgraded one level due to imprecision (wide confidence interval and based on one study with few participants). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy compared with waitlist</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Specialised CBT‐based physiotherapy programme compared with wait list for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> inpatient </p> <p><b>Intervention:</b> specialised CBT‐based physiotherapy programme </p> <p><b>Comparison:</b> wait list </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait list</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Specialised CBT‐based physiotherapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> <p>As measured by FIM (higher is better)</p> <p>Range: 18–126</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean level of functioning in the control group was 80.9</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 9.20 higher</b> </p> <p>(6.06 higher to 12.34 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Specialised CBT‐based physiotherapy may slightly improve level of functioning at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CBT:</b> cognitive behavioural therapy; <b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>FIM</b> : Functional Independence Measure Motor; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded one level due to imprecision (based on one study with few patients). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy intervention compared with treatment as usual</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Specialised CBT‐based physiotherapy‐led intervention compared with TAU for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings: </b>outpatients at day hospital </p> <p><b>Intervention:</b> specialised CBT‐based physiotherapy‐led intervention </p> <p><b>Comparison:</b> TAU </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TAU</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Specialised CBT‐based physiotherapy‐led intervention</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> <p>As assessed by WSAS scale (lower is better)</p> <p>Range: 0–40</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean level of functioning in the control group was 26.9</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 7.10 lower</b> </p> <p>(11.40 lower to 2.80 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Specialised CBT‐based physiotherapy intervention may slightly improve level of functioning at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CBT:</b> cognitive behavioural therapy; <b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>TAU:</b> treatment as usual; <b>WSAS:</b> Work and Social Adjustment Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (wide confidence interval and based on one study with few patients). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Brief psychotherapeutic intervention compared with standard care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Brief psychotherapeutic intervention compared with standard care for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> brief psychotherapeutic intervention </p> <p><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Brief psychotherapeutic intervention</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>As assessed by SDQ‐20 (lower is better)</p> <p>Range: 20–100</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.12</b> (0.01 to 2.00) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>19<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Brief psychotherapeutic intervention may have no effect on physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>400 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b><br/>(396 less to 400 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>As assessed by SF‐36 (lower is better)</p> <p>Range: 0–100</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the control group was 50.56</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 6.99 lower</b> </p> <p>(28.09 lower to 14.11 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief psychotherapeutic intervention may have little effect on quality of life after end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>RR:</b> Risk Ratio; <b>SDQ‐20:</b> somatoform dissociation questionnaire; <b>SF‐36:</b> 36‐item Short Form. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (Wide confidence intervals and based on one study with few patients). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0010"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Cognitive behavioural therapy plus adjunctive physical activity compared with cognitive behavioural therapy alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CBT + APA compared with CBT alone for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> CBT + APA </p> <p><b>Comparison:</b> CBT </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CBT</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CBT + APA</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs (overall physical impact)</b> </p> <p>As measured by PMDRS, total score (lower is better)</p> <p>Range: 0–128</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 33.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 5.60 higher</b> </p> <p>(15.48 lower to 26.68 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBT + APA may have no effect on physical signs at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>APA:</b> adjunctive physical activity; <b>CBT:</b> cognitive behavioural therapy; <b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>PMDRS:</b> Psychogenic Movement Disorders Rating Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two level due to imprecision (wide confidence interval, based on one study with few participants). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0011"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Hypnosis compared with diazepam</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Hypnosis compared with diazepam for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings: </b>emergency unit </p> <p><b>Intervention:</b> hypnosis </p> <p><b>Comparison:</b> diazepam </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Diazepam</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Hypnosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Number with symptom freedom</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.69</b> (0.39 to 1.24) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>40<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypnosis may have no effect on physical signs at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>650 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>448 per 1000</b><br/>(397 less to 156 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (Wide confidence interval and based on one study with few patients). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD005331-tbl-0012"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Psychotherapy preceded by motivational interviewing compared with psychotherapy alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Psychotherapy preceded by motivational interviewing compared with psychotherapy alone for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatient </p> <p><b>Intervention:</b> psychotherapy preceded by motivational interviewing </p> <p><b>Comparison:</b> psychotherapy alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Psychotherapy</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Psychotherapy preceded by motivational interviewing</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Decrease in seizure frequency</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 34.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 41.40 higher</b> </p> <p>(4.92 higher to 77.88 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychotherapy preceded by motivational interviewing may have little effect on physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>As measured by QOLIE10 (lower is better)</p> <p>Range: 10–50</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the control group was 1.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 5.40 higher</b> </p> <p>(0.26 higher to 10.54 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychotherapy preceded by motivational interviewing may have little effect on quality of life at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> Confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>QOLIE10:</b> quality of life in epilepsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two level due to imprecision (wide confidence interval, based on one study with few participants). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD005331-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD005331-sec-0009"></div> <p>Conversion and dissociative disorders have been described in psychology and medicine in a scientific context since Freud, Charcot and Janet (<a href="./references#CD005331-bbs2-0199" title="CharcotJM , BabińskiJ , BernardJ . Oeuvres Complètes de J. M. Charcot: Leçons sur les Maladies du Système Nerveux. Paris: Bureaux du Progrès Médical, 1887.">Charcot 1887</a>; <a href="./references#CD005331-bbs2-0218" title="FreudS . The aetiology of hysteria, Standard Edition Vol. 3. Freud, S. (1920), Beyond the pleasure principle, Standard Edition1896;18:7-64.">Freud 1896</a>; <a href="./references#CD005331-bbs2-0233" title="JanetP . The Major Symptoms of Hysteria. New York (NY): Macmillan. Reprint of 1920 edition (1965), 1907.">Janet 1907</a>). These early pioneers proposed some of the first theories of both cause and effective treatment. </p> <p>In the following, we have described the current definitions of these conditions, given a brief overview of the range of different psychosocial interventions that are now used, as well as linked these to the different theories regarding how an intervention might work. </p> <section id="CD005331-sec-0010"> <h3 class="title" id="CD005331-sec-0010">Description of the condition</h3> <p>In this review, we include both dissociative disorders and conversion disorders as defined in the <i>Diagnostic and Statistical Manual of Mental Disorders 5th Edition</i> (DSM‐5) (<a href="./references#CD005331-bbs2-0185" title="American Psychiatric Association. DSM 5. Washington (DC): American Psychiatric Association, 2013.">APA 2013</a>), and the <i>International Classification of Diseases, Tenth Revision</i> (ICD‐10) (<a href="./references#CD005331-bbs2-0279" title="World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization, 1993.">WHO 1993</a>). In ICD‐10, conversion disorders are included in the category of dissociative disorders (<a href="./references#CD005331-bbs2-0279" title="World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization, 1993.">WHO 1993</a>), whereas DSM‐5 defines the conditions separately (<a href="./references#CD005331-bbs2-0185" title="American Psychiatric Association. DSM 5. Washington (DC): American Psychiatric Association, 2013.">APA 2013</a>). </p> <p>Dissociation is a collapse of usually integrated functions such as awareness, memory, orientation, or sensory and motor function in response to, or by reactivating, a severe emotional stress or trauma, whereas examples of  conversion disorders (in the DSM‐5 definition) are psychogenic non‐epileptic seizures (PNES), paralysis, gait disturbances, anaesthesia, tremor, dystonia (involuntarily muscle contractions, causing repetitive or twisting movements), functional blindness or aphonia (loss of voice due to disturbance of the vocal organs). </p> <p>DSM‐5 (<a href="./references#CD005331-bbs2-0185" title="American Psychiatric Association. DSM 5. Washington (DC): American Psychiatric Association, 2013.">APA 2013</a>) defines conversion disorder as:  </p> <p> <ul id="CD005331-list-0001"> <li> <p>one or more symptoms of altered voluntary motor or sensory function;</p> </li> <li> <p>clinical findings that show evidence of incompatibility between the symptoms and recognised neurological or medical conditions; </p> </li> <li> <p>symptoms or deficit that are not better explained by another medical or mental disorder;</p> </li> <li> <p>symptoms or deficit that cause clinically significant distress or impairment in social, occupational or other important areas of functioning or warrants medical evaluation. </p> </li> </ul> </p> <p>In DSM‐5, the dissociative disorders are placed independently and separated from the conversion section and next to, but not as part of, the trauma‐ and stressor‐related disorders, reflecting the close relationship between these diagnostic classes. Dissociative disorders in DSM‐5 include dissociative identity disorder (disruption of identity characterised by two or more distinct personality states), depersonalisation/derealisation disorder (experiences of unreality or detachment from one's mind or self or detachment from one's surroundings) and dissociative amnesia (inability to recall autobiographical information). It may sometimes involve travel or confused wandering away from one's life (dissociative fugue). </p> <p>Common for these conditions is that a psychological stressor or trauma is often present, but is not a requirement to establish the diagnosis. </p> <p>The epidemiology of conversion disorder is complicated by case definition, case ascertainment and identifying a suitable study population, but community surveys suggest a minimum prevalence of 50 per 100,000. <a href="./references#CD005331-bbs2-0210" title="DeveciA , TaskinO , DincG , YilmazH , DemetMM , Erbay-DundarP , et al. Prevalence of pseudoneurologic conversion disorder in an urban community in Manisa, Turkey. Social Psychiatry and Psychiatric Epidemiology2007;42(11):857-64.">Deveci 2007</a> found the prevalence in a city population to be 5.6% and <a href="./references#CD005331-bbs2-0272" title="StoneJ , CarsonA , DuncanR , ColemanR , RobertsR , WarlowC , et al. Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?Brain2009;132(Pt 10):2878-88.">Stone 2009</a> found conversion symptoms for 18%, among people referred to neurological outpatient clinics in the UK. There is no good evidence to suggest that conversion disorder is becoming less common or that it is more often found in low‐income countries. Conversion symptoms can occur in both men and women although all case series show a predominance of women (<a href="./references#CD005331-bbs2-0180" title="AkagiH , HouseAO . The epidemiology of hysteria: vanishingly rare or just vanishing?Psychological Medicine2002;32:191-4.">Akagi 2002</a>).  Several studies have pointed out that childhood trauma, specifically physical or sexual abuse, emotional or physical neglect, and a greater number of stressful life events and traumatic episodes characterise conversion disorders (<a href="./references#CD005331-bbs2-0242" title="KranickS , EkanayakeV , MartinezV , AmeliR , HallettM , VoonV . Psychopathology and psychogenic movement disorders. Movement Disorders2011;26(10):15.">Kranick 2011</a>; <a href="./references#CD005331-bbs2-0261" title="RoelofsK , KeijsersGP , HoogduinKA , NäringGW , MoeneFC . Childhood abuse in patients with conversion disorder. American Journal of Psychiatry2002;159(11):1908-13.">Roelofs 2002</a>; <a href="./references#CD005331-bbs2-0265" title="SarV , IslamS , OzturkE . Childhood emotional abuse and dissociation in patients with conversion symptoms. Psychiatry and Clinical Neurosciences2009;63(5):670-7.">Sar 2009</a>). <a href="./references#CD005331-bbs2-0266" title="ScevolaL , TeitelbaumJ , OddoS , CenturionE , LoidlCF , KochenS , et al. Psychiatric disorders in patients with psychogenic nonepileptic seizures and drug-resistant epilepsy: a study of an Argentine population. Epilepsy and Behavior2013;29(1):155-60.">Scevola 2013</a> found trauma history in 49% of people with PNES and sexual abuse is particularly prevalent in this group, present in 30% (<a href="./references#CD005331-bbs2-0270" title="StoneJ , SharpeM , BinzerM . Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics. Psychosomatics2004;45(6):492-9.">Stone 2004</a>) to 45% (<a href="./references#CD005331-bbs2-0267" title="SelkirkM , DuncanR , OtoM , PelosiA . Clinical differences between patients with nonepileptic seizures who report antecedent sexual abuse and those who do not. Epilepsia2008;49(8):1446-50.">Selkirk 2008</a>) of people with PNES. </p> <p>With regard to dissociative disorders, Johnson surveyed a population of 658 people in New York and found a one‐year prevalence of dissociative disorders of 9.1% (conversion disorders not included) (<a href="./references#CD005331-bbs2-0235" title="JohnsonJG , CohenP , KasenS , BrookJS . Dissociative disorders among adults in the community, impaired functioning, and axis I and II comorbidity. Journal of Psychiatric Research2006;40(2):131-40.">Johnson 2006</a>). A different study likewise found a prevalence of dissociative disorders of 10% (<a href="./references#CD005331-bbs2-0263" title="RossCA . Epidemiology of multiple personality disorder and dissociation. Psychiatric Clinics of North America1991;14:503-17.">Ross 1991</a>). </p> <p>In some clinical terminology, the concept of dissociation may be used synonymously with psychogenic dissociation (e.g. amnesia, fugue, stupor, trance or dissociative personality disorder), whereas the concept of conversion may be described clinically as somatoform dissociation. We included both somatoform dissociation (conversion) and psychoform dissociation in this review. </p> <p>The prognosis for people with conversion disorder is poorly studied, but results from several studies suggest the prospects for immediate recovery are good but a significant number of people will relapse. Factors associated with quick recovery are an acute onset and prompt treatment (<a href="./references#CD005331-bbs2-0262" title="RonM . The prognosis of hysteria/somatization disorder. In: Contemporary Approaches to the Study of Hysteria. Oxford (UK): Oxford University Press, 2001.">Ron 2001</a>). Prognosis may also be influenced by symptom pattern and some studies suggest that non‐epileptic attacks and people presenting with tremor or amnesia have a poorer prognostic outcome than those with hysterical blindness, aphonia and motor disorders (<a href="./references#CD005331-bbs2-0275" title="TooneBK . Disorders of hysterical conversion. In: BassC , editors(s). Somatization: Physical Symptoms and Psychological Illness. Oxford (UK): Blackwell Scientific Publications, 1990.">Toone 1990</a>). Trauma in childhood seems to have an impact on the seriousness of the development and progress of conversion disorder (<a href="./references#CD005331-bbs2-0267" title="SelkirkM , DuncanR , OtoM , PelosiA . Clinical differences between patients with nonepileptic seizures who report antecedent sexual abuse and those who do not. Epilepsia2008;49(8):1446-50.">Selkirk 2008</a>; <a href="./references#CD005331-bbs2-0270" title="StoneJ , SharpeM , BinzerM . Motor conversion symptoms and pseudoseizures: a comparison of clinical characteristics. Psychosomatics2004;45(6):492-9.">Stone 2004</a>). </p> </section> <section id="CD005331-sec-0011"> <h3 class="title" id="CD005331-sec-0011">Description of the intervention</h3> <p>Psychosocial interventions include all psychological interventions specified in the UK Department of Health review of psychological therapies (<a href="./references#CD005331-bbs2-0208" title="Department of Health. Treatment Choice in Psychological Therapies and Counselling. Evidence based clinical practice guidelines. London (UK): Department of Health, 2001.">Department of Health 2001</a>), social interventions such as social skills training and befriending and packages of interventions that have a psychosocial focus. </p> <p>Many psychosocial interventions have been developed for conversion and dissociative disorders. Most have been developed over decades based on observations and theory formation in the early years of psychiatry and psychology by pioneers such as Charcot, Freud and Janet (<a href="./references#CD005331-bbs2-0199" title="CharcotJM , BabińskiJ , BernardJ . Oeuvres Complètes de J. M. Charcot: Leçons sur les Maladies du Système Nerveux. Paris: Bureaux du Progrès Médical, 1887.">Charcot 1887</a>; <a href="./references#CD005331-bbs2-0218" title="FreudS . The aetiology of hysteria, Standard Edition Vol. 3. Freud, S. (1920), Beyond the pleasure principle, Standard Edition1896;18:7-64.">Freud 1896</a>; <a href="./references#CD005331-bbs2-0233" title="JanetP . The Major Symptoms of Hysteria. New York (NY): Macmillan. Reprint of 1920 edition (1965), 1907.">Janet 1907</a>), and later as part of behavioural or cognitive approaches. </p> <p>Some of the most common psychosocial interventions include the following.</p> <p> <ul id="CD005331-list-0002"> <li> <p><i>Behavioural therapy</i> consists of graded exposure to the body sensations or to situations perceived as threatening in order to reduce the patient’s apprehensive reaction towards them. If trauma is a part of the condition, it may be practised as 'prolonged exposure' (<a href="./references#CD005331-bbs2-0254" title="MyersL , Vaidya-MathurU , LancmanM . Prolonged exposure therapy for the treatment of patients diagnosed with psychogenic non-epileptic seizures (PNES) and post-traumatic stress disorder (PTSD). Epilepsy Behaviour2017;66:86-92.">Myers 2017</a>), or be combined with other forms of therapy. </p> </li> <li> <p><i>Cognitive behavioural therapy (CBT)</i> is a structured, present‐oriented psychotherapy directed towards solving current problems and teaching the patients skills to modify unhelpful thinking and behaviour. One important part of CBT is helping clients change their unhelpful thinking and behaviour, which leads to enduring improvement in their mood and functioning. </p> </li> <li> <p><i>Psychoeducation</i> is connected to CBT and concerns teaching patients about their condition, thereby empowering them to take an active part in the management of the condition and the recovery from it (<a href="./references#CD005331-bbs2-0203" title="ColomF . Keeping therapies simple: psychoeducation in the prevention of relapse in affective disorders. British Journal of Psychiatry2011;198(5):338-40. [DOI: doi.org/10.1192/bjp.bp.110.090209]">Colom 2011</a>; <a href="./references#CD005331-bbs2-0281" title="ZhaoS , SampsonS , XiaJ , JayaramMB . Psychoeducation (brief) for people with serious mental illness. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD010823.pub2]">Zhao 2015</a>).  </p> </li> <li> <p><i>Hypnosis</i> is a therapeutic technique in which clinicians make suggestions to people who have undergone a procedure designed to relax them and focus their minds. Hypnosis strengthens the ability to handle emotional stress and it often forms part of a treatment package, for example, together with CBT or eye movement desensitisation reprocessing (EMDR) (<a href="./references#CD005331-bbs2-0215" title="FineCG . Cognitive behavioral hypnotherapy for dissociative disorders. American Journal of Clinical Hypnotherapy2012;54(4):331-52.">Fine 2012</a>; <a href="./references#CD005331-bbs2-0214" title="FineCG , BerkowitzAS . The wreathing protocol: the imbrication of hypnosis and EMDR in the treatment of dissociative identity disorder and other dissociative responses. Eye Movement Desensitization Reprocessing. American Journal of Clinical Hypnotherapy2001;43(3-4):275-90.">Fine 2001</a>). </p> </li> <li> <p><i>Psychodynamic and</i> <i>psychoanalytic therapies</i> consist of a set of psychological therapies, where psychological symptoms can be seen as manifestations of intrapsychic or unconscious conflicts. These therapies use different therapeutic strategies to reveal, interpret and resolve such conflicts. In the field of dissociation or conversion, early life events and trauma experience may be an important part of the therapy.  </p> </li> <li> <p><i>Specialised physiotherapy</i> contains elements of CBT and aims to retrain motor or sensory function by redirecting attention and addressing unhelpful illness beliefs and behaviours. The patient's problems are considered in a broad biopsychosocial framework where symptom‐predisposing, precipitating and perpetuating factors can be addressed within a multidisciplinary environment (<a href="./references#CD005331-bbs2-0109" title="NielsenG . Chapter 45 – physical treatment of functional neurologic disorders. In: HallettM , StoneJ , CarsonA , editors(s). Handbook of Clinical Neurology. Vol. 139. London: Elsevier, 2016:555-69. ">Nielsen 2016</a>). </p> </li> <li> <p><i>Paradoxical intention therapy</i> is where the therapist encourages the patient to engage in the unwanted behaviour, promoting the worsening of the symptoms rather than their removal. </p> </li> <li> <p><i>Models of dissociation and trauma treatment</i>. In phase‐oriented treatments, patients are working from establishing safety and stability, for example, symptom reduction, emphasised emotion regulation and impulse control (Stage 1), to focus on maintaining stability while exploring trauma narratives and resolving trauma‐related emotions (Stage 2) and finally to emphasise integration and living without reliance on dissociation (Stage 3) (<a href="./references#CD005331-bbs2-0211" title="DorahyMJ , BrandBL , SarV , KrugerC , StavropoulosP , Martinez-TaboasA , et al. Dissociative identity disorder: an empirical overview. Australian and New Zealand Journal of Psychiatry2014;48(5):402-17.">Dorahy 2014</a>; <a href="./references#CD005331-bbs2-0276" title="van derHartO . The use of imagery in phase 1 treatment of clients with complex dissociative disorders. European Journal of Psychotraumatology2012;3:ArtID 8458.">van der Hart 2012</a>). </p> </li> <li> <p><i>Eye movement desensitisation reprocessing (EMDR)</i> is a structured therapy that encourages the patient to briefly focus on the trauma memory while simultaneously experiencing bilateral stimulation (eye movements), which is associated with a reduction in the vividness and emotion associated with the trauma memories. It is a treatment divided into phases where desensitisation in relation to a trauma is essential. </p> </li> </ul> </p> <p>Psychosocial interventions can be delivered individually or in group formats, sometimes following a very structured manual, at others adapting the intervention to the individual or group in question. </p> </section> <section id="CD005331-sec-0012"> <h3 class="title" id="CD005331-sec-0012">How the intervention might work</h3> <p>Because most theories about the origin of conversion and dissociative disorders are concerned with underlying psychological stressors or trauma, the common hypothesis is that offering treatments that work with and address this in patients' lives might produce a positive treatment effect and a reduction in symptoms. </p> <p>The basis for how the different methods and procedures in different treatment approaches to conversion and dissociative disorder are usually associated with a specific theoretical grounding, which often present divergent views on aetiology as well as on what they regard as active mediators in treatment. In general, however, for most models, the mechanism of action of therapy is the integration of dissociated parts of the personality or therapeutic work with maladaptive thoughts towards more adaptive and appropriate thoughts. For example, in therapy, one can work on integration of dissociated elements of the self (psychodynamic) or to weaken maladaptive schemas and construct new, more adaptive schemas (in cognitive therapy a schema is an organised pattern of thought and behaviour or a mental structure of preconceived ideas representing some aspect of the world). </p> <p>It must be pointed out that not just the method but also the relationship and the therapeutic alliance between the patient and the therapist are main factors for a satisfactory outcome of a therapy course (<a href="./references#CD005331-bbs2-0229" title="HorvathAO , SymondsDB . Relation between working alliance and outcome in psychotherapy: a meta-analysis. Journal of Counseling Psychology1991;38(2):139-49.">Horvath 1991</a>; <a href="./references#CD005331-bbs2-0245" title="MartinDJ , GarskeJP , DavisMK . Relation of the therapeutic alliance with outcome and other variables: a meta-analytic review. Journal of Consult Clinical Psychology2000;68(3):438-50.">Martin 2000</a>). </p> <section id="CD005331-sec-0013"> <h4 class="title">Cognitive behavioural approaches</h4> <p>These are based on Aaron Beck's personality model, which suggests that the personality is composed of different <i>modes</i> that are collections of <i>schemas</i> responsible for coding cognitive, affective, behavioural and physiological information and for generating response. A mode with associated schemas is activated only when a particular schema for orientation, related to a particular situation or feeling, triggers it. Based on this theory, <a href="./references#CD005331-bbs2-0239" title="KennedyF , KennerleyH , PearsonD , editor(s). Cognitive Behavioural Approaches to the Understanding and Treatment of Dissociation. New York (NY): Routledge, 2013.">Kennedy 2013</a> has developed a model for dissociation. </p> <p>At <i>level 1</i>, scary stimuli can result in dissociation of the schema for orientation, which results in incorrect integration of incoming information. The level involves 'detachment', that is, a change of consciousness that is a result of the fight/flight/freeze response, which results in depersonalisation or derealisation or 'compartmentalisation' (i.e. where trauma‐related information is partially stored without integration into the normal memory system and thus is inaccessible). However, when situations occur that are similar to the trauma, trauma‐related information can be activated with severe anxiety and discomfort, as in flashbacks in post‐traumatic stress disorder (PTSD). The therapy works by breaking this 'compartmentalisation' and establishing reintegration. </p> <p><i>Level 2</i> describes dissociative compartmentalisation that can occur within the single mode between the various schemas for coding cognitive, affective, behavioural and physiological information. A mode associated with a traumatic experience or an inter/intrapsychic issue can activate a dissociative process between the individual schemas. An effective schema that is unacceptable to consciousness (e.g. one unbearable feeling related to a traumatic event) can be isolated and kept out of consciousness, or a schema of behaviour can be dissociated so that the person experiences losing a physical skill in connection with a trauma or retrauma (PNES, sensory loss, paralysis or gait disturbance), which also falls within the concept of compartmentalisation. </p> <p><i>Level 3</i> describes dissociation between different modes in Beck's personality model. Generally, integrated modes representing the well‐integrated personality may be subject to dissociation upon severe stress or trauma. An example is the dissociative identity disorder or the disintegration occurring in borderline personality disorder. Based on this model, an adapted traditional cognitive treatment plan can be prepared, taking into account the dissociation level, in order to establish reintegration within schemas and modes. </p> <p><a href="./references#CD005331-bbs2-0197" title="BrownRJ . Dissociation and somatoform disorders. In: KennedyF , KennerleyH , PearsonD , editors(s). Cognitive Behavioural Approaches to the Understanding and Treatment of Dissociation. New York (NY): Routledge, 2013.">Brown 2013</a> has introduced <i>The Integrative Cognitive Model</i>, which is based on the individual's way of storing information in memory. During a dissociative process, the patient activates a primary attentional system and the most active hypothesis for an event (e.g. a misinterpretation of a symptom) combined with the corresponding sensory data creates a counterproductive working model or primary representation. This 'rogue' representation is the starting point in the case formulation that is the basis of the treatment plan. In the course of the treatment, a 'socialisation' takes place, which refers to some form of emotional neutralisation in relation to the patient's notions of the condition. Brown emphasises that not all dissociative reactions are the result of traumatic painful memories, but when it is the case, he recommends follow‐up treatment with trauma‐focused cognitive (<a href="./references#CD005331-bbs2-0213" title="EhlersA , ClarkDM . A cognitive model of posttraumatic stress disorder. Behaviour Research and Therapy2000;38(4):319-45.">Ehlers 2000</a>) or metacognitive therapy (<a href="./references#CD005331-bbs2-0278" title="WellsA , SembiS . Metacognitive therapy for PTSD: a core treatment manual. Cognitive and Behavioral Practice2004;11(4):365-77.">Wells 2004</a>). </p> </section> <section id="CD005331-sec-0014"> <h4 class="title">The structural dissociation and trauma approach</h4> <p>The two Dutch psychologists, Ellert Nijenhuis and Onno van der Hart, are the most prominent in the theory formation and research on dissociation and trauma (<a href="./references#CD005331-bbs2-0256" title="Nijenhuis EllertRS , den Boer JohanA . Psychobiology of Traumatization and Trauma-related Structural Dissociation of the Personality. I: Dell PF, O'Neil JA [red]. Dissociation and the Dissociative Disorders: DSM-V and Beyond. New York (NY): Routledge/Taylor &amp; Francis Group, 2009.">Nijenhuis 2009</a>; <a href="./references#CD005331-bbs2-0257" title="NijenhuisE , van derHartO , SteeleK . Trauma-related structural dissociation of the personality. Activitas Nervosa Superior2010;52(1):2010.">Nijenhuis 2010</a>; <a href="./references#CD005331-bbs2-0268" title="SteeleK , van derHartO , NijenhuisE . The theory of trauma-related structural dissociation of the personality. In: Dissociation and the Dissociative Disorders: DSM-V and Beyond. Abingdon (UK): Routledge/Taylor &amp; Francis Group, 2009:239-58.">Steele 2009</a>). Based on <a href="./references#CD005331-bbs2-0233" title="JanetP . The Major Symptoms of Hysteria. New York (NY): Macmillan. Reprint of 1920 edition (1965), 1907.">Janet 1907</a>, they define structural dissociation as a lack of personality integration, manifested by the existence of two or more inadequately integrated and dissociated parts of the personality. Traumatic dissociation leads to fragmentation in the individual's personality (i.e. of the entire dynamic, biopsychosocial system), which constitutes the mental and behavioural conditions of the person. They emphasise that this is fundamentally different from that mentioned in the cognitive model above regarding changes in perception and memory. </p> <p>Regarding symptom formation, Nijenhuis and van der Hart distinguish between psychoform and somatoform consciousness and identity (e.g. amnesia, fugue, flashbacks and dissociative identity disorder), while they consider somatoform dissociation as the proper term for conversion, more specifically neurological conditions and other conditions involving the body. </p> <p>The model is based on Janet's phase‐divided treatment. In <i>phase 1</i> , one strives to provide reassurance and the ability to experience bodily reactions; in <i>phase 2</i> , one looks at the integration of the different parts of the personality by working with phobias for traumatic memories and for anxious attachment; and in <i>phase 3</i>, one works with personality reintegration, phobias for ordinary life, change and intimacy (<a href="./references#CD005331-bbs2-0276" title="van derHartO . The use of imagery in phase 1 treatment of clients with complex dissociative disorders. European Journal of Psychotraumatology2012;3:ArtID 8458.">van der Hart 2012</a>). </p> </section> <section id="CD005331-sec-0015"> <h4 class="title">The psychodynamic approach</h4> <p>There exist only a few guidelines and general recommendations on conducting psychoanalytic and psychodynamic psychotherapy for dissociative and conversion disorders. Some authors describe a broader perspective (<a href="./references#CD005331-bbs2-0237" title="Kalogjera-SackellaresD . Psychodynamics and Psychotherapy of Pseudoseizures. Norwalk (CT): Crown House Publishing Limited, 2004.">Kalogjera‐Sackellares 2004</a>; <a href="./references#CD005331-bbs2-0238" title="KaplanMJ . A psychodynamic perspective on treatment of patients with conversion and other somatoform disorders. Psychodynamic Psychiatry2014;42(4):593-615.">Kaplan 2014</a>), while <a href="./references#CD005331-bbs2-0247" title="MatthewsJA , ChuJA . Psychodynamic therapy for patients with early childhood trauma. In: Trauma and Memory: Clinical and Legal Controversies. New York (NY): Oxford University Press, 1997:316-343.">Matthews 1997</a> propose a psychodynamic psychotherapy for people who have experienced severe childhood trauma. <a href="./references#CD005331-bbs2-0231" title="HowellE . Understanding and Treating Dissociative Identity Disorder. New York (NK): Routledge, 2011.">Howell 2011</a> discusses the identification and diagnosis of dissociative identity disorder and outlines a phase‐oriented treatment plan, which includes facilitating a therapeutic relationship, emphasising the multiplicity of transferences (the patient redirects feelings or desires for another person to an entirely different person, frequently the therapist), countertransferences (redirection of a therapist's feelings towards a patient) and the potential enactments of this transference and countertransference. </p> <p>The comprehensive guidelines for treating dissociative identity disorder in adults proposes a phase‐oriented treatment (<a href="./references#CD005331-bbs2-0201" title="ChuJA , DellPF , Van der HartO , CardeñaE , BarachPM , SomerE , et al. International society for the study of trauma and dissociation. Guidelines for treating dissociative identity disorder in adults, third revision. Journal of Trauma and Dissociation2011;12:115-87.">Chu 2011</a>). In <i>phase 1</i> , safety, stabilisation and symptom reduction are established; <i>phase 2</i> involves confronting, working through and integrating traumatic memories; and in <i>phase 3</i> the objectives are identity integration and rehabilitation. The guideline is referring to individual psychodynamic‐oriented psychotherapy as the most common, often incorporating other techniques as CBT techniques, hypnosis or EMDR. </p> <p>Significant contributions from contemporary psychoanalysis to the theory and treatment of dissociative disorders concerns attachment and relational theory (<a href="./references#CD005331-bbs2-0195" title="BradfieldB . The dissociation of lived experience: a relational psychoanalytic analysis of the intergenerational transmission of trauma. International Journal of Psychoanalytic Self Psychology2011;6:531-50.">Bradfield 2011</a>; <a href="./references#CD005331-bbs2-0196" title="BrombergPM . Multiple self-states, the relational mind and dissociation: a psychoanalytic perspective. In: Dissociation and the Dissociative Disorders: DSM-V and Beyond. Abingdon (UK): Routledge/Taylor &amp; Francis Group, 2009:637-52.">Bromberg 2009</a>; <a href="./references#CD005331-bbs2-0230" title="HowellEF . The Dissociative Mind. London (UK): The Analytic Press, 2005.">Howell 2005</a>). </p> <p><i>Dynamic interpersonal therapy for functional somatic disorders</i> is a mentalisation‐based approach (<a href="./references#CD005331-bbs2-0191" title="BatemanA , FonagyP . Mentalization-based treatment. Psychoanalytic Inquiry2013;33(6):595-613.">Bateman 2013</a>), which entails a focus on restoring the capacity for stress regulation by fostering the use of more adaptive attachment strategies in response to stress, and recovery of the capacity for (embodied) mentalising (<a href="./references#CD005331-bbs2-0244" title="LuytenP , Van HoudenhoveB , LemmaA , TargetM , FonagyP . Vulnerability for functional somatic disorders: a contemporary psychodynamic approach. Journal of Psychotherapy Integration2013;23(3):250.">Luyten 2013</a>). <i>Mentalisation</i> is the ability to understand the mental state, of oneself or others, that underlies overt behaviour. Dynamic interpersonal therapy consists of three phases. The <i>first phase</i> focuses on the treatment alliance and the collaborative formulation of a treatment (i.e. formulation of a shared and acceptable illness theory that recognises the complexity of the disorder through consensus). <i>The second phase</i> consists of the working through of interpersonal affective focus (how the patient perceives others in relation to a self‐perception, and the affect that links these two experiences) and consolidation of treatment gains. This is used as a guide to explore the typical interpersonal patterns with the aim to foster patients' capacities to reflect on the bodily self, others and the self‐in‐relation‐to‐others. <i>The final phase</i> focuses on the aims to transfer what one has 'learned' during treatment to the everyday context of the patient to prevent relapses and to foster autonomy and resilience long‐term. </p> </section> <section id="CD005331-sec-0016"> <h4 class="title">The contextual approach</h4> <p>This treatment model, described by <a href="./references#CD005331-bbs2-0219" title="GoldSN , SeibelSL . Treating dissociation: a contextual approach. In: Dissociation and the Dissociative Disorders: DSM-V and Beyond. Abingdon (UK): Routledge/Taylor &amp; Francis Group, 2009:625-636.">Gold 2009</a>, is not based on a specific theory but involves elements from both cognitive and psychodynamic methods, based on practical clinical experience and empirical evidence. Attachment theory, though, with a specific focus on disorganised attachment and dissociation, has particular theoretical and practical significance in this model (<a href="./references#CD005331-bbs2-0189" title="BarachPM . Multiple personality disorder as an attachment disorder. Dissociation: Progress in the Dissociative Disorders1991;4(3):117-23.">Barach 1991</a>; <a href="./references#CD005331-bbs2-0243" title="LiottiG . A model of dissociation based on attachment theory and research. Journal of Trauma &amp; Dissociation2006;7:55-73.">Liotti 2006</a>; <a href="./references#CD005331-bbs2-0280" title="WilliamsB , OspinaJP , JalilianhasanpourR , FricchioneGL , PerezDL . Fearful attachment linked to childhood abuse, alexithymia, and depression in motor functional neurological disorders. Journal of Neuropsychiatry and Clinical Neurosciences2019;31(1):65-9. [PMID: 30376786]">Williams 2019</a>), and the overall approach of the therapy is based on the observation of the absence of reliable attachment resources for these patients. Disorganised attachment is an insecure attachment style, hypothesised to be an outcome of childhood abuse and trauma, and closely related to the development of dissociation. Focus on therapeutic relationship and treatment alliance are also considered essential. The primary objective of the treatment is to improve adaptive functioning, to focus on problems that find expression in the present and teaching the patient skills that can be applied to difficulties as they arise. The treatment strategy is based on the fact that these patients may have difficulty with affect management, and identifying the presence, intensity and type of affect resulting in an associated inappropriate and incomprehensible behaviour. </p> <p>Affective arousal is so intense that cognitive processing does not sufficiently contribute to behavioural regulation and a result is that the patient experiences the dissociative episode as 'not me' and may feel shame. The intervention concerns fostering capacity for emotional de‐escalation and increasing the cognitive capacities for recognising the presence of affect. Another aspect is to reduce the propensity of chronic high arousal. <a href="./references#CD005331-bbs2-0220" title="GoldS . Not Trauma Alone: Therapy for Child Abuse Survivors in Family and Social Context. Abingdon (UK): Routledge, 2013.">Gold 2013</a> recommends training with a log sheet, relaxation techniques and a 'grounding' programme. He states that trauma exposure is inappropriate for these patients. </p> </section> <section id="CD005331-sec-0017"> <h4 class="title">The neurobiological approach</h4> <p>Neuroimaging techniques have contributed to the understanding of the basic mechanisms of conversion and dissociative disorders and on some points, pathophysiological equivalents exist for the psychological theories mentioned above and have reinforced their treatment strategies (<a href="./references#CD005331-bbs2-0186" title="AybekS , NicholsonTR , ZelayaF , O'DalyOG , CraigTJ , DavidAS , et al. Neural correlates of recall of life events in conversion disorder. JAMA Psychiatry2014;71(1):52-60.">Aybek 2014</a>; <a href="./references#CD005331-bbs2-0258" title="PerezDL , DworetzkyBA , DickersonBC , LeungL , CohnR , BasletG , et al. An integrative neurocircuit perspective on psychogenic nonepileptic seizures and functional movement disorders: neural functional unawareness. Clinical EEG and Neuroscience2015;46(1):4-15.">Perez 2015</a>; <a href="./references#CD005331-bbs2-0259" title="PerezDL , MatinN , BarskyA , Costumero-RamosV , MakaretzSJ , YoungSS , et al. Cingulo-insular structural alterations associated with psychogenic symptoms, childhood abuse and PTSD in functional neurological disorders. Journal of Neurology and Neurosurgical Psychiatry2017;88(6):491-7.">Perez 2017</a>). </p> </section> <section id="CD005331-sec-0018"> <h4 class="title">Psychoeducation</h4> <p>Psychoeducation concerns teaching patients about their condition. It is connected to CBT in that it is focused on the present and works with empowering patients to engage with their illness in more informed and helpful ways, the theory being that the more informed patients are, the better equipped they will be in dealing with their condition and with working on recovering from it. </p> <p>Psychoeducation can be performed in many ways, both formally and informally, and can last from one session to more elaborate programmes over longer periods (<a href="./references#CD005331-bbs2-0203" title="ColomF . Keeping therapies simple: psychoeducation in the prevention of relapse in affective disorders. British Journal of Psychiatry2011;198(5):338-40. [DOI: doi.org/10.1192/bjp.bp.110.090209]">Colom 2011</a>; <a href="./references#CD005331-bbs2-0281" title="ZhaoS , SampsonS , XiaJ , JayaramMB . Psychoeducation (brief) for people with serious mental illness. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD010823.pub2]">Zhao 2015</a>).  </p> </section> </section> <section id="CD005331-sec-0019"> <h3 class="title" id="CD005331-sec-0019">Why it is important to do this review</h3> <p>It is apparent that conversion and dissociative disorders cause clinically significant suffering and that developing effective interventions is important. The main purpose of this review is to update the knowledge about treating conversion and dissociative disorders. This is important for people with conversion and dissociative disorder to understand the evidence supporting the treatments offered to them and to help clinicians prescribe effective treatments. </p> <section id="CD005331-sec-0020"> <h4 class="title">Previous reviews on this theme  </h4> <p>The review is an update of the Cochrane Review "Psychosocial interventions for conversion disorder", published in 2005 (<a href="./references#CD005331-bbs2-0264" title="RuddyR , HouseA . Psychosocial interventions for conversion disorder. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD005331]">Ruddy 2005</a>). This study included conversion disorder motor and sensory symptoms or impairment, that cannot be explained by a neurological cause (conversion disorder in <i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i> (DSM‐IV)), and all dissociative states in DSM‐IV and ICD‐10. The review included all randomised controlled trials (RCT) that compared psychosocial interventions for conversion disorder with standard care (SC) or other interventions (biological or psychosocial). Only three studies (119 participants) met the inclusion criteria. One study was concerned with paradoxical injunction therapy and the other two studied the value of hypnosis. All studies were of poor methodological quality and it was, therefore, difficult to place much value on the results. The authors concluded that the use of psychosocial interventions for conversion disorder required more research and it was not possible to draw any conclusions about their potential benefits or harms from the included studies. </p> <p>The latest Cochrane Review that deals with conditions broadly within the field of conversion disorders is "Psychological and behavioural treatments for adults with non‐epileptic attack disorder" (<a href="./references#CD005331-bbs2-0246" title="MartlewJ , BakerGA , GoodfellowL , BoddeN , AldenkampA . Behavioural treatments for non-epileptic attack disorder. Cochrane Database of Systematic Reviews2007, Issue 1. [DOI: 10.1002/14651858.CD006370]">Martlew 2007</a>; <a href="./references#CD005331-bbs2-0092" title="MartlewJ , PulmanJ , MarsonAG . Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD006370.pub2]">Martlew 2014</a>). In the 2014 update, 12 studies met the inclusion criteria (four RCTs and eight non‐controlled studies). Overall, three examined CBT, two investigated hypnosis, one assessed paradoxical intention and one had a mixed intervention design. They classified two included studies at low risk of bias, one at unclear and nine at high risk of bias. For quality of the evidence (GRADE), six studies were of very low, two were of low and three were of moderate quality. However, most included studies reported improved outcomes for the intervention under investigation. The authors concluded that there is little reliable evidence to support the use of any treatment, including CBT, in the treatment of non‐epileptic seizures. </p> <p>Since the last Cochrane Review in 2014 (<a href="./references#CD005331-bbs2-0092" title="MartlewJ , PulmanJ , MarsonAG . Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD006370.pub2]">Martlew 2014</a>), one meta‐analysis on PNES has been published. <a href="./references#CD005331-bbs2-0038" title="CarlsonP , NicholsonPK . Psychological interventions for psychogenic non-epileptic seizures: a meta-analysis. Seizure2017;45:142-50. [DOI: dx.doi.org/10.1016/j.seizure.2016.12.007]">Carlson 2017</a> synthesised data from 13 studies, of which 2/13 studies used an RCT design. Studies were included if they evaluated the effectiveness of at least one psychological intervention undertaken to lessen the frequency of PNES and using seizure frequency as an outcome measure. They found a moderate to high level of heterogeneity (I<sup>2</sup> = 58% to 78%) and in general serious bias regarding incomplete data, primary and secondary outcome measures, intervention application and duration. The findings highlight the potential for psychological interventions as a favourable alternative to the lack of treatment options offered to people with PNES, but brought no new evidence to the field. </p> <p>Another meta‐analysis from 2014 dealt with the effectiveness of psychotherapy for severe somatoform disorder (<a href="./references#CD005331-bbs2-0078" title="KoelenJA , HoutveenJH , AbbassA , LuytenP , Eurelings-BontekoeEH , Van Broeckhuysen-KlothSA , et al. Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis. British Journal of Psychiatry2014;204(1):12-9. ">Koelen 2014</a>). The authors included prospective studies. The patients had a diagnosis of somatoform disorder, primarily severe conversion and somatisation (diagnosis of hypochondriasis and body dysmorphic disorder was excluded) and received psychotherapy in secondary or tertiary care. The review included 10 randomised and six non‐randomised studies. Study quality was moderately poor (ranging from very poor to very good), measured using the Psychotherapy Quality Rating Scale (<a href="./references#CD005331-bbs2-0241" title="KocsisJH , GerberAJ , MilrodB , RooseSP , BarberJ , ThaseME , et al. A new scale for assessing the quality of randomized clinical trials of psychotherapy. Comprehensive Psychiatry2010;51(3):319-24.">Kocsis 2010</a>), and heterogeneity was high. The effect size for physical symptoms was large, for psychological symptoms moderate to large and for functional impairment moderate, but effect sizes were generally lower than those typically found for other mental disorders. Post‐hoc analysis indicated that psychodynamic interventions were more effective in improving functioning than cognitive interventions, although not in improving symptoms and there was no difference in the effectiveness of group versus individual therapy was found. </p> <p>With regard to physiotherapy for conversion disorder, one systematic review by <a href="./references#CD005331-bbs2-0108" title="NielsenG , StoneJ , EdwardsMJ . Physiotherapy for functional (psychogenic) motor symptoms: a systematic review. Journal of Psychosomatic Research2013;75(2):93-102. ">Nielsen 2013</a> identified 29 studies evaluating the effect of physical treatment of adults. No RCTs and only one controlled study was described. The Nielsen review does not define one primary outcome, it only defines that they look at the same range of outcomes as used in the individual studies, and that these showed encouraging results with improvement in 60% to 70% of patients. Combining motor relearning with behavioural therapy was the most common approach. They concluded that the evidence to guide physiotherapy treatment for conversion disorder was of low quality. Likewise, there was limited and poor‐quality evidence for the efficacy of physiotherapy management of child and adolescents with conversion disorder (<a href="./references#CD005331-bbs2-0216" title="FitzGeraldTL , SouthbyAK , HainesTP , HoughJP , SkinnerEH . Is physiotherapy effective in the management of child and adolescent conversion disorder? A systematic review. Journal of Paediatrics and Child Health2015;51(2):159-67.">FitzGerald 2015</a>). </p> <p>Finally, <a href="./references#CD005331-bbs2-0032" title="BrandBL , ClassenCC , McNarySW , ZaveriP . A review of dissociative disorders treatment studies. Journal of Nervous &amp; Mental Disease2009;197(9):646-54. [DOI: dx.doi.org/10.1097/NMD.0b013e3181b3afaa]">Brand 2009</a> reviewed 20 empirical reports of treatment for dissociative disorders, mainly dissociative identity disorder. </p> <p>Collectively, these reports suggest that treatment for dissociative disorders is associated with decreased symptoms of dissociation, depression, PTSD, distress and suicidality. Effect sizes, based on pre/post measures, were in the medium to large range across studies. However, there were significant methodological limitations illustrating a serious lack of well‐designed studies in the treatment of dissociative disorders. The authors proposed good arguments for using case studies instead of RCTs when treating people with severe psychopathology, high comorbidity and the need for long‐term treatment. </p> </section> <section id="CD005331-sec-0021"> <h4 class="title">Conclusion</h4> <p>To conclude, several reviews and meta‐analyses have been published since the 2005 version of this Cochrane Review. However, none have consistently examined the same diagnostic spectrum (i.e. both conversion and dissociative disorders). In addition, we are following the revised and expanded <i>Cochrane Handbook for Systematic Reviews of Interventions</i> and are updating the methods from the first review (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). </p> </section> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD005331-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD005331-sec-0022"></div> <p>To assess the beneficial and harmful effects of psychosocial interventions of conversion and dissociative disorders in adults. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD005331-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD005331-sec-0023"></div> <section id="CD005331-sec-0024"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD005331-sec-0025"> <h4 class="title">Types of studies</h4> <p>We included all RCTs that met our inclusion criteria. We included studies irrespective of language, publication type and publication status.  </p> </section> <section id="CD005331-sec-0026"> <h4 class="title">Types of participants</h4> <p>Participants were adults aged 18 to 80 years, of any gender and nationality. Participants fulfilled the criteria for having a conversion or dissociative disorder according to the DSM‐IV (<a href="./references#CD005331-bbs2-0184" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington (DC): American Psychiatric Association, 1994.">APA 1994</a>), DSM‐5 (<a href="./references#CD005331-bbs2-0185" title="American Psychiatric Association. DSM 5. Washington (DC): American Psychiatric Association, 2013.">APA 2013</a>), or ICD‐10 (<a href="./references#CD005331-bbs2-0279" title="World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization, 1993.">WHO 1993</a>) criteria.  As some studies may have been conducted prior to DSM‐IV or ICD‐10, we included all studies where a large majority (80% or greater) of participants fulfilled current diagnostic criteria or any earlier diagnostic equivalent. We consider the use of conversion and dissociative disorders to cover the diagnostic criteria equivalent to ICD‐10 F.44 codes (F44.0 Dissociative amnesia, F44.1 Dissociative fugue, F44.2 Dissociative stupor, F44.3 Trance and possession disorders, F44.4 Dissociative motor disorders, F44.5 Dissociative convulsions, F44.6 Dissociative anaesthesia and sensory loss, F44.7 Mixed dissociative [conversion] disorders, F44.8 Other dissociative [conversion] disorders, F44.9 Dissociative [conversion] disorder, unspecified) and in the DSM system the DSM‐IV codes 300.11 Conversion disorder, 300.12 Dissociative amnesia, 300.13 Dissociative fugue, 300.14 Dissociative identity disorder, 300.6 Depersonalisation disorder and 300.15 Dissociative disorder not otherwise specified.<br/>Studies with participants with any length of illness were included, as well as studies with participants being treated in any intervention setting, as long as the diagnostic criteria were fulfilled. </p> <p>If the search identified studies where comorbidity occurred, we planned to comment on this and the participants included if they had conversion or dissociative disorder according to the DSM‐IV (<a href="./references#CD005331-bbs2-0184" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington (DC): American Psychiatric Association, 1994.">APA 1994</a>), DSM‐5 (<a href="./references#CD005331-bbs2-0185" title="American Psychiatric Association. DSM 5. Washington (DC): American Psychiatric Association, 2013.">APA 2013</a>), or ICD‐10 (<a href="./references#CD005331-bbs2-0279" title="World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization, 1993.">WHO 1993</a>) criteria. </p> </section> <section id="CD005331-sec-0027"> <h4 class="title">Types of interventions</h4> <p>We included RCTs that compared a psychosocial (including psychotherapeutic) intervention for conversion or dissociative disorder with another intervention (pharmacological or psychosocial, or mixed) or with SC or wait list controls.  </p> <section id="CD005331-sec-0028"> <h5 class="title">Experimental interventions</h5> <section id="CD005331-sec-0029"> <h6 class="title">Psychosocial interventions</h6> <p>Our understanding of psychosocial interventions follows the traditional use of this term in medical health, to cover interventions of either a psychological nature, a social nature, or both. Often what makes an intervention psychosocial is the theoretical framework it places itself within, giving a particular approach to how that intervention is regarded. Psychosocial interventions are described in much more detail in the <a href="#CD005331-sec-0011">Description of the intervention</a> section, and include the following. </p> <p> <ul id="CD005331-list-0003"> <li> <p><i>Behavioural therapy</i> </p> </li> <li> <p><i>Cognitive behavioural therapy (CBT)</i> </p> </li> <li> <p><i>Psychoeducation</i> </p> </li> <li> <p><i>Hypnosis</i> </p> </li> <li> <p><i>Psychodynamic and</i> <i>psychoanalytic therapies</i> </p> </li> <li> <p><i>Specialised physiotherapy</i> <i>based on cognitive behavioural therapy (CBT)</i> </p> </li> <li> <p><i>Paradoxical intention therapy</i> </p> </li> <li> <p><i>Models of dissociation and trauma treatment</i> </p> </li> <li> <p><i>Eye movement desensitisation reprocessing (EMDR)</i> </p> </li> </ul> </p> </section> </section> <section id="CD005331-sec-0030"> <h5 class="title">Controls </h5> <p>Controls could be SC, wait list controls, pharmaceutical interventions or another psychosocial intervention. </p> <p> <ul id="CD005331-list-0004"> <li> <p>Pharmacological interventions: any pharmaceutical medication officially recognised by US or European law. </p> </li> <li> <p>SC: standard medical care (SMC) or treatment as usual (TAU) is the care that a person would normally receive had they not been included in the research study. What this contains varies greatly in different settings and we describe this with the studies. </p> </li> <li> <p>Wait list controls: wait list controls are those patients referred to the same intervention, but who have not yet received it due to the allocation in the study. They are usually free to pursue other interventions outside of the study, but will not receive any controlled intervention while waiting. They will receive the same intervention as the active group, only delayed in time.      </p> </li> </ul> </p> </section> <section id="CD005331-sec-0031"> <h5 class="title">Comparisons </h5> <p>If possible, we compared the effects of any similar interventions with controls on both primary and secondary outcomes. By 'similar', we mean interventions that broadly speaking fall under the same category of psychosocial interventions listed above, namely the same forms of psychotherapy, interventions consisting of psychoeducation or comparable other psychosocial training. As the field of psychosocial interventions contains a variety of different approaches, the actual decision of what to group into comparisons is based on clinical judgement. </p> </section> </section> <section id="CD005331-sec-0032"> <h4 class="title">Types of outcome measures</h4> <p>If a study had more than one measure on the same outcome, only data from one measure for each outcome were included in the analysis. When several measures on the same outcome appeared in a study, we discussed this within the review author team and choose one measure based on which measure was most widely used and which we deemed most clinically relevant. </p> <section id="CD005331-sec-0033"> <h5 class="title">Time points</h5> <p>Studies were included that measured the effects at end of treatment as the main time point, and if available, follow‐up effects, which were then divided into shorter term (up to and including five months after end of treatment) and longer term (from six months after end of treatment).  </p> </section> <section id="CD005331-sec-0034"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD005331-list-0005"> <li> <p>Reduction in physical signs.</p> </li> </ul> </p> <p>This would be expected to be seen in the improvement of physical functioning or in reduction of conversion experiences such as seizures or other discrete conversion episodes.   </p> <p>There are no golden standards in scales for this outcome, but possible ways could be using scales measuring physical functioning such as the physical function dimension of 36‐item Short‐Form (SF‐36) (<a href="./references#CD005331-bbs2-0234" title="JenkinsonC , LayteR , WrightL , CoulterA . The UK SF-36: an Analysis and Interpretation Manual. Oxford (UK): Health Services Research Unit, 1996.">Jenkinson 1996</a>), or by the Somatoform Dissociation Questionnaire (SDQ‐5 and SDQ‐20) (<a href="./references#CD005331-bbs2-0255" title="NijenhuisER , vanSpinhovenP , vanDyckR , derHart VanO , vanVanderlindenJ . The development and psychometric characteristics of the Somatoform Dissociation Questionnaire (SDQ-20). Journal of Nervous and Mental Disease1996;184(11):688-94.">Nijenhuis 1996</a>). It could also be by counting number of seizures daily or weekly, or by using binary outcomes such as improvement or no improvement. </p> </section> <section id="CD005331-sec-0035"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD005331-list-0006"> <li> <p>Level of functioning: this is a new addition to this updated version of the review and has been added as a secondary outcome because level of functioning is often one of the main ways of assessing a patient's ability to participate in life despite any illness or incapacity. This could be measured using the Global Assessment of Functioning (GAF) scale (<a href="./references#CD005331-bbs2-0184" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington (DC): American Psychiatric Association, 1994.">APA 1994</a>), the Work and Social Adjustment Scale (WSAS) (<a href="./references#CD005331-bbs2-0252" title="MundtJC . The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry2002;180(5):461-4.">Mundt 2002</a>), or similar. </p> </li> <li> <p>Quality of life: this was part of the secondary outcomes in the original review, and is still very relevant in current research. This can be measured using the full version of the SF‐36 (<a href="./references#CD005331-bbs2-0234" title="JenkinsonC , LayteR , WrightL , CoulterA . The UK SF-36: an Analysis and Interpretation Manual. Oxford (UK): Health Services Research Unit, 1996.">Jenkinson 1996</a>), Quality of Life in Epilepsy‐31 (QOLIE31) (<a href="./references#CD005331-bbs2-0205" title="CramerJA , PerrineK , DevinskyO , Bryant-ComstockL , MeadorK , HermannB . Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia1998;39(1):81-8.">Cramer 1998</a>), or similar. </p> </li> <li> <p>Mental state: this secondary outcome was also used in the original review, though, in this update, we decided to divide it into anxiety and depression where possible, to get a more accurate picture of patients' experiences, resulting in three secondary outcomes: mental state, anxiety and depression. The general component of mental state can be measured using instruments such as the Symptom Check List 90 (SCL‐90) (<a href="./references#CD005331-bbs2-0209" title="DerogatisLR , ClearyPA . Confirmation of the dimensional structure of the SCL-90: a study in construct validation. Journal of Clinical Psychology1977;33(4):981-9.">Derogatis 1977</a>), or the mental component of the 12‐‐item Short Form (SF‐12)/SF‐36 (<a href="./references#CD005331-bbs2-0234" title="JenkinsonC , LayteR , WrightL , CoulterA . The UK SF-36: an Analysis and Interpretation Manual. Oxford (UK): Health Services Research Unit, 1996.">Jenkinson 1996</a>). Anxiety could be measured using instruments such as Becks Anxiety Index (BAI) (<a href="./references#CD005331-bbs2-0192" title="BeckAT , EpsteinN , BrownG , SteerRA . An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology1988;56(6):893-7.">Beck 1988</a>), or the anxiety subscale of the Hospital Anxiety and Depression Scale (HADS) (<a href="./references#CD005331-bbs2-0282" title="ZigmondAS , SnaithRP . The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica1983;67(6):361-70.">Zigmond 1983</a>). Depression could be measured using instruments such as Becks Depression Index version II (BDI‐II) (<a href="./references#CD005331-bbs2-0193" title="BeckAT , SteerRA , BallR , RanieriWF . Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. Journal of Personality Assessment1996;67(3):588-97.">Beck 1996</a>), Hamilton Depression Rating Scale (HDRS) (<a href="./references#CD005331-bbs2-0225" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry1960;23(1):56.">Hamilton 1960</a>), or by the depression subscale from the HADS (<a href="./references#CD005331-bbs2-0282" title="ZigmondAS , SnaithRP . The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica1983;67(6):361-70.">Zigmond 1983</a>).  </p> </li> <li> <p>Dropout rate/leaving the study early: this would often be measured by numbers or percentage.</p> </li> <li> <p>Use of health service resources: often measured in how many subsequent visits a patient has to hospital/accident and emergency department or local general practitioner/clinician. </p> </li> <li> <p>Adverse effects: in psychotherapy, the general adverse effects are described by <a href="./references#CD005331-bbs2-0190" title="BarlowDH . Negative effects from psychological treatments: a perspective. American Psychologist2010;65(1):13-20.">Barlow 2010</a> and <a href="./references#CD005331-bbs2-0206" title="CrawfordMJ , ThanaL , FarquharsonL , PalmerL , HancockE , BassettP , et al. Patient experience of negative effects of psychological treatment: results of a national survey dagger. British Journal of Psychiatry2016;208(3):260-5.">Crawford 2016</a>. Examples could be the risk of psychotic decompensation or self‐injury through psychological intervention of psychologically fragile patients or that participants experience more positive attention from staff or family by being in a study (secondary gains arise), which could be maintaining the symptoms. </p> </li> </ul> </p> </section> </section> </section> <section id="CD005331-sec-0036"> <h3 class="title">Search methods for identification of studies</h3> <p>For this update, the main review author (CG) in co‐operation with an Information Specialist of the Cochrane Common Mental Disorder Group and an Academic Research Librarian of the Research Unit in Region Zealand, revised the search strategies in line with current Cochrane Common Mental Disorder Group practices (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). </p> <section id="CD005331-sec-0037"> <h4 class="title">Electronic searches</h4> <p>We searched the electronic resources listed below, using the strategy detailed in <a href="./appendices#CD005331-sec-0240">Appendix 1</a>. </p> <p> <ul id="CD005331-list-0007"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (2019, Issue 7 in the Cochrane Library). Searched on 16 July 2019. </p> </li> <li> <p>MEDLINE via Ovid (from 1946). Searched on 16 July 2019.</p> </li> <li> <p>CINAHL via EBSCO. Searched on 16 July 2019.</p> </li> <li> <p>Embase via Ovid from 1974. Searched on 16 July 2019.</p> </li> <li> <p>PsycINFO via Ovid from 1806. Searched on 16 July 2019.</p> </li> <li> <p>ERIC via EBSCO. Searched on 16 August 2019. </p> </li> <li> <p>Web of Science Core Collection (Thomson Reuters). Searched on 16 July 2019.</p> </li> </ul> </p> <p>We searched online clinical trial registers for ongoing or recently completed studies on 16 July 2019, including the ISRCTN Registry (<a href="https://www.isrctn.com/" target="_blank">www.isrctn.com/</a>), US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://ClinicalTrials.gov" target="_blank">clinicaltrials.gov</a>), the World Health Organization (WHO) International Clinical Trials Registry Platform (<a href="http://who.int/trialsearch/" target="_blank">who.int/trialsearch/</a>), and the EU Clinical Trials Register (<a href="http://www.clinicaltrialsregister.eu/" target="_blank">www.clinicaltrialsregister.eu/</a>). </p> <p>There were no limitations on languages.</p> </section> <section id="CD005331-sec-0038"> <h4 class="title">Searching other resources</h4> <p>We checked references, screened reference lists, citation searching and contacted relevant study authors to identify additional studies. </p> </section> </section> <section id="CD005331-sec-0039"> <h3 class="title" id="CD005331-sec-0039">Data collection and analysis</h3> <p>We conducted the review according to the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). In the following section, we report only the methods that we were able to use in this update. </p> <section id="CD005331-sec-0040"> <h4 class="title">Selection of studies</h4> <p>Following the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>), the main review author (CG) plus one of the other members of the author team did the initial screening of abstracts using Covidence. This was divided so the main review author (CG) read all abstracts, and three other authors (OJS, RR, US) read a third of the abstracts each. When disagreements arose about inclusion of abstracts, this was discussed between the two voting review authors. In case of no consensus, we consulted a third review author. A record of all papers rejected on the basis of their abstracts were documented in Covidence but are not included in the review. </p> <p>We retrieved the full papers of all remaining abstracts and other potentially relevant articles identified by the various search strategies (reference checking, personal communications, etc.). All papers in languages other than English were (as far as possible) translated or reviewed by someone who spoke the language. Two review authors independently reviewed all articles, following the same format as for abstracts, with the main review author (CG) reading all full texts, and three other review authors (OJS, RR, US) reading a third each. The process of full‐text screening was done using Covidence, which was also used for documenting the results of each reviewer's judgement.  </p> <p>When disagreements arose about inclusion of a full text, the two voting review authors discussed them, and, if no consensus was reached, a third author was consulted.  If there was a lack of clarity about the suitability of inclusion of a study, then we contacted the authors of the article for more information. </p> <p>Any ongoing studies were followed up by contacting the principal investigators to enquire whether any data were available that could be included in this review. </p> <p>Where studies had multiple publications, we collated the reports of the same study so that each study, rather than each report, was the unit of interest for the review, and such studies had a single identifier with multiple references </p> <p>We documented the reasons for exclusion of the full papers in the <a href="./references#CD005331-sec-0252" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD005331-sec-0041"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (CG, HC) completed the extraction of data using Covidence.</p> <p>They independently extracted data onto a data collection form. We extracted information on title, authors, year of publication, source, setting, country, participant characteristics, diagnosis, comorbidity, study design and methods, interventions, outcomes and relevant information for 'Risk of bias' assessments. We exported data to Review Manager 5 and one review author (OJS) performed data analysis (<a href="./references#CD005331-bbs2-0260" title="The Nordic Cochrane Center, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration, 2014.">Review Manager 2014</a>). We resolved differences by discussion. In cases of insufficient data, or where data in the published study reports were unclear, we contacted the study authors requesting them to clarify the missing information (see <a href="#CD005331-sec-0047">Dealing with missing data</a>). </p> <p>We completed a <a href="./references#CD005331-sec-0251" title="">Characteristics of included studies</a> table. </p> </section> <section id="CD005331-sec-0042"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>In the original version of this review, methodological quality of included studies were assessed by criteria sent out in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> current at the time; however, following the publication of the revised and expanded <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0226" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>), we updated our methods accordingly.  </p> <p>Working independently, two review authors (CG and HC) assessed the risk of bias of included studies using the tool described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0226" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> <p>We assessed the following items.</p> <p> <ul id="CD005331-list-0008"> <li> <p>Sequence generation: was the allocation sequence adequately generated?</p> </li> <li> <p>Allocation concealment: was allocation adequately concealed?</p> </li> <li> <p>Blinding of participants, personnel and outcome assessors for each main outcome or class of outcomes: was knowledge of the allocated intervention adequately prevented during the study? </p> </li> <li> <p>Incomplete outcome data for each main outcome or class of outcomes: were incomplete outcome data adequately addressed? </p> </li> <li> <p>Selective outcome reporting: were reports of the study free of suggestion of selective outcome reporting? </p> </li> <li> <p>Other sources of bias: was the study apparently free of other problems that could put it at a high risk of bias? </p> </li> </ul> </p> <p>We included quotations from the text of included studies and comments on how we assessed the risk of bias in the <a href="./references#CD005331-sec-0251" title="">Characteristics of included studies</a> table. We assigned studies to one of three categories (low risk of bias, uncertain risk of bias and high risk of bias), according to guidelines in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0226" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). We resolved disagreements by discussion. We subsequently included the risk of bias assessment in the GRADE evaluation that was used to collectively assess the certainty of the estimates based on the risk of bias, imprecision, indirection and publication bias. </p> <p>If disputes arose we achieved resolution after consulting with the third review author (OJS). </p> </section> <section id="CD005331-sec-0043"> <h4 class="title">Measures of treatment effect</h4> <p>Outcomes were assessed using continuous (e.g. changes on physical function scales); categorical measures (e.g. one of three categories on a quality of life scale, such as 'better', 'worse' or 'no change') or dichotomous measures (e.g. either returned to employment or did not return to employment). </p> <section id="CD005331-sec-0044"> <h5 class="title">Continuous data</h5> <p>We compared the mean score between the two groups to give a mean difference (MD) and presented this with 95% confidence intervals (CI). We wanted to use the overall MD, where possible, to compare the outcome measures from studies. However, because some of the included studies used different rating scales for measuring the same outcome, we needed to use the standardised mean difference (SMD) in some analyses. We considered a statistical significant SMD effect size of: 0.15 or less to have no clinically meaningful effect; 0.15 to 0.40 to have a clinical meaningful but small effect; 0.40 to 0.75 to have a moderate effect; and greater than 0.75 to have a large treatment effect (<a href="./references#CD005331-bbs2-0202" title="CohenJ . Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale (NJ): Lawrence Erlbaum Associates, Publishers, 1988.">Cohen 1988</a>; <a href="./references#CD005331-bbs2-0273" title="ThalheimerW , CookS . How to calculate effect sizes from published research articles: a simplified methodology. www.worklearning.com/2016/08/11/using-effect-sizes-and-considering-meta-analyses/ (accessed 16 July 2020).">Thalheimer 2002</a>). </p> <p>Many rating scales are available to measure outcomes in psychosocial studies. These scales vary in the quality of their validation and reliability. Therefore, if a rating scale's validation had not been published in a peer‐reviewed journal, the data were included but we noted that it was not validated. In addition, it is preferable for the rating scale to be either self‐report or completed by an independent observer or relative. We included studies that used the same rating scales to evaluate the effect on a specific outcome in the same analysis for direct comparison. </p> <p>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the problems of applying parametric tests to non‐parametric data, we applied the following standards to all data before inclusion: 1. standard deviations and means had to be reported in the paper or be obtainable from the authors, 2. when a scale started from a finite number (such as zero), the standard deviation, when multiplied by two must have been less than the mean (otherwise the mean was unlikely to be an appropriate measure of the centre of the distribution) (<a href="./references#CD005331-bbs2-0181" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313:1200.">Altman 1996</a>). If data were non‐parametric, then we reported this in the text but did not used them in the meta‐analysis. </p> </section> <section id="CD005331-sec-0045"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous outcomes, we calculated the risk ratio (RR) with its associated 95% CI was estimated. </p> </section> </section> <section id="CD005331-sec-0046"> <h4 class="title">Unit of analysis issues</h4> <p>We planned to include data from randomised cross‐over studies up to the point of first cross‐over (first period only) (<a href="./references#CD005331-bbs2-0207" title="CurtinF , ElbourneD , AltmanDG . Meta-analysis combining parallel and cross-over clinical trials. III: the issue of carry-over. Statistics in Medicine2002;21(15):2161-73.">Curtin 2002</a>). We planned to include cluster randomised studies; however, we found none. If we find cluster‐randomised studies for updates of this review, they will be eligible for inclusion. We will anticipate that investigators have presented their results for cluster RCTs after appropriately checking for clustering effects (robust standard errors or hierarchical linear models). If it is unclear whether a cluster‐randomised trial has used appropriate checks for clustering, we will contact the investigators for further information. Where appropriate checks are not used, we will request and re‐analyse individual participant data using multilevel models that check for clustering. Following this, we will analyse effect sizes and standard errors in Review Manager 5 (<a href="./references#CD005331-bbs2-0260" title="The Nordic Cochrane Center, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration, 2014.">Review Manager 2014</a>), using the generic inverse method (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). </p> </section> <section id="CD005331-sec-0047"> <h4 class="title">Dealing with missing data</h4> <p>We conducted analyses 'as reported' for continuous outcomes. We attempted to retrieve any missing data from the study authors. We contacted the authors of three studies with unclear or missing data and requested the necessary data. If data remained unavailable, we tried to estimate the missing data using the available information (e.g. if the standard deviation (SD) was missing, we estimated it from the standard error, if reported). When we were unable to obtain missing data, we conducted analyses using available (incomplete) data. </p> </section> <section id="CD005331-sec-0048"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical heterogeneity by examining variability in the participants, interventions and outcomes described in each study. We assessed methodological heterogeneity by inspecting variability in the design of the studies and statistical heterogeneity by assessing the difference in the studies' intervention effects. We assessed heterogeneity between studies by visual inspection of the forest plot for overlapping CIs, using the Chi<sup>2</sup> test for homogeneity with a significance level of α (alpha) = 0.10, and the I<sup>2</sup> statistic for quantifying inconsistency (estimating the percentage of variation in effect estimates due to heterogeneity rather than sampling error). We judged I<sup>2</sup> values of 0% to 40% to indicate little heterogeneity; 30% to 60%, moderate heterogeneity; 50% to 90%, substantial heterogeneity; and 75% to 100%, considerable heterogeneity. For values including overlapping judgements, the degree of heterogeneity was considered as an interval (e.g. with a heterogeneity of 55% being considered as moderate to substantial heterogeneity) (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). </p> </section> <section id="CD005331-sec-0049"> <h4 class="title">Assessment of reporting biases</h4> <p>We handled different forms of reporting bias, especially publication bias and outcome reporting bias, according to the recommendations of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>; Section 10.1). If more than 10 studies had been included in a given meta‐analysis, we had planned to draw funnel plots to give a visual assessment on whether effects were associated with the size of the study (<a href="./references#CD005331-bbs2-0212" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34. [DOI: 10.1136/bmj.315.7109.629] [PMC2127453] [PMID: 9310563]">Egger 1997</a>). Due to the small number of eligible trials (i.e. fewer than 10 studies for each comparisons), this was not possible. </p> </section> <section id="CD005331-sec-0050"> <h4 class="title">Data synthesis</h4> <p>We included and analysed studies undertaken in any configuration or setting; for instance, in groups, hospitals, people's homes and clinics. We summarised data in a meta‐analysis when they were available. If clinical heterogeneity was not excessive (e.g. there was similarity in participants' characteristics), we performed statistical analysis in Review Manager 5 (<a href="./references#CD005331-bbs2-0260" title="The Nordic Cochrane Center, The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration, 2014.">Review Manager 2014</a>), according to recommendations in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>; Section 9.4.1). We synthesised data using final values and the inverse variance method in the meta‐analyses. We generally used the fixed‐effect model because most of the analyses included only one study. When more than one study was included, we used the random‐effects model. A random‐effects model has the assumption that apparent differences between study effects are random, but the estimated difference follows a normal distribution. This method gives more weight to small studies, whereas the fixed‐effect model gives more weight to large studies (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a><i>;</i> Section 9.5.4). </p> </section> <section id="CD005331-sec-0051"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to conduct subgroup analyses for:</p> <p> <ul id="CD005331-list-0009"> <li> <p>different symptoms groups;</p> </li> <li> <p>group versus individual therapy;</p> </li> <li> <p>manual‐driven versus non‐manual‐driven therapies.</p> </li> </ul> </p> <p>We planned to conduct these specific analyses to investigate if treatment effects vary between symptoms groups. We also wished to determine if treatment effects are influenced by how the therapy is provided (group versus individual therapy) or if therapies are based on a manual or not, or both. </p> </section> <section id="CD005331-sec-0052"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analyses for:</p> <p> <ul id="CD005331-list-0010"> <li> <p>attrition rate: more than 50% attrition compared with less than 50% attrition;</p> </li> <li> <p>use of intention to treat analyses: the studies using intention to treat analyses compared with the studies not using intention‐to‐treat analyses; </p> </li> <li> <p>differences between cluster and non‐cluster randomised studies;</p> </li> <li> <p>differences between self‐reported and observer‐reported outcomes.</p> </li> </ul> </p> </section> <section id="CD005331-sec-0053"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We constructed 12 'Summary of findings' tables for the comparisons. As the field of psychosocial interventions contains a variety of different approaches we were only able to predefine that, when possible, we would group studies together based on clinical judgement as to which interventions were most alike and create the actual comparisons after identification of the included studies. For the studies identified in this version of the review, the team agreed on the following comparisons: </p> <p> <ul id="CD005331-list-0011"> <li> <p>inpatient paradoxical intention therapy versus outpatient diazepam;</p> </li> <li> <p>inpatient treatment programme plus hypnosis versus inpatient treatment programme;</p> </li> <li> <p>outpatient hypnosis versus wait list;</p> </li> <li> <p>behavioural therapy plus routine clinical care versus routine clinical care;</p> </li> <li> <p>CBT versus SMC;</p> </li> <li> <p>psychoeducational follow‐up programmes versus TAU;</p> </li> <li> <p>specialised CBT‐based physiotherapy inpatient programme versus wait list;</p> </li> <li> <p>specialised CBT‐based physiotherapy outpatient intervention versus TAU;</p> </li> <li> <p>brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus SC; </p> </li> <li> <p>CBT plus APA versus CBT alone;</p> </li> <li> <p>hypnosis versus diazepam;</p> </li> <li> <p>psychotherapy preceded by motivational interviewing compared with psychotherapy alone.</p> </li> </ul> </p> <p>We included the primary outcome <i>reduction in physical signs</i>  and the secondary outcomes <i>level of functioning</i> and <i>quality of life</i> assessed at the relevant time points. </p> <p>We used the GRADE approach to assess the certainty of the evidence associated with each of these outcomes (<a href="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003328.pub3/references#CD003328-bbs2-0074" target="_blank">Guyatt 2008</a>). The GRADE approach appraises the certainty of a body of evidence based on the extent to which one can be confident that an estimate of effect or association reflects the item being assessed. Considerations are due to: within‐study risk of bias, directness of evidence, heterogeneity of the data, precision of effect estimates and risk of publication bias (<a href="./references#CD005331-bbs2-0182" title="AndrewsJ , GuyattG , OxmanAD , AldersonP , DahmP , Falck-YtterY , et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. Journal of Clinical Epidemiology2013;66(7):719-25. [DOI: 10.1016/j.jclinepi.2012.03.013] [PMID: 23312392]">Andrews 2013a</a>; <a href="./references#CD005331-bbs2-0183" title="AndrewsJC , SchünemannHJ , OxmanAD , PottieK , MeerpohlJJ , CoelloPA , et al. GRADE guidelines: 15. Going from evidence to recommendation – determinants of a recommendation's direction and strength. Journal of Clinical Epidemiology2013;66(7):726-35. [DOI: 10.1016/j.jclinepi.2013.02.003] [PMID: 23570745]">Andrews 2013b</a>; <a href="./references#CD005331-bbs2-0188" title="BalshemH , HelfandM , SchünemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401-6. [DOI: 10.1016/j.jclinepi.2010.07.015] [PMID: 21208779]">Balshem 2011</a>; <a href="./references#CD005331-bbs2-0198" title="BrunettiM , ShemiltI , PregnoS , ValeL , OxmanAD , LordJ , et al. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. Journal of Clinical Epidemiology2013;66(2):140-50. [DOI: 10.1016/j.jclinepi.2012.04.012] [PMID: 22863410]">Brunetti 2013</a>; <a href="./references#CD005331-bbs2-0223" title="GuyattGH , OxmanAD , SchünemannHJ , TugwellP , KnottnerusA . GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology2011;64(4):380-2. [DOI: 10.1016/j.jclinepi.2010.09.011] [PMID: 21185693]">Guyatt 2011</a>; <a href="./references#CD005331-bbs2-0253" title="MustafaRA , SantessoN , BrozekJ , AklEA , WalterSD , NormanG , et al. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. Journal of Clinical Epidemiology2013;66(7):736-42. [DOI: 10.1016/j.jclinepi.2013.02.004] [PMID: 23623694]">Mustafa 2013</a>). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD005331-sec-0054" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD005331-sec-0054"></div> <section id="CD005331-sec-0055"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD005331-sec-0251" title="">Characteristics of included studies</a>; <a href="./references#CD005331-sec-0252" title="">Characteristics of excluded studies</a>; and <a href="./references#CD005331-sec-0253" title="">Characteristics of ongoing studies</a> tables for detailed information on the individual studies and <a href="#CD005331-fig-0001">Figure 1</a> for an overview of the search process. </p> <div class="figure" id="CD005331-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="PRISMA flow diagram." data-id="CD005331-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>PRISMA flow diagram.</p> </div> </div> </div> <section id="CD005331-sec-0056"> <h4 class="title">Results of the search</h4> <p>The electronic searches resulted in 3171 references, some of which were duplicates and thus removed. This left 3048 texts to be screened in Covidence, of which 2860 were judged irrelevant on the basis of their abstracts. In the process of obtaining full texts on the relevant studies, we identified one more relevant study that was not found by the electronic search and added it to the full texts in Covidence, giving a total of 168 full‐text papers that were then read and assessed for eligibility. </p> <p>For planned and ongoing studies, we contacted the relevant authors and requested possible results and timeframes (see <a href="./references#CD005331-sec-0253" title="">Characteristics of ongoing studies</a> table for details). None of these had any results ready to share and we designated seven studies as ongoing at this stage. </p> <p>In a few otherwise relevant studies it was unclear whether the data could be extracted, in which case, we contacted the authors, all of whom responded and some supplied us with missing data and missing information about methodology (<a href="./references#CD005331-bbs2-0200" title="Chen DK [pers comm]. Question about data for Cochrane article. Email to: Ganslev CA 17 October 2018.">Chen 2018</a>; <a href="./references#CD005331-bbs2-0274" title="Thompson N [pers comm]. Question about research data on PNES study. Email to: Ganslev CA 19 October 2018.">Thompson 2018</a>; <a href="./references#CD005331-bbs2-0277" title="Vermeulen M [pers comm]. Question about research data for Cochrane review. Email to: Ganslev CA 25 October 2018.">Vermeulen 2018</a>). For the <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a> study, our question was with regard to the patient population, which the authors (<a href="./references#CD005331-bbs2-0277" title="Vermeulen M [pers comm]. Question about research data for Cochrane review. Email to: Ganslev CA 25 October 2018.">Vermeulen 2018</a>) confirmed fulfilled the criteria to be included in the review. For two other studies, our queries were with regard to the outcome data. This was not available for the <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a> study, but <a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a> did present data on secondary outcomes. All three studies were then included. </p> <p>We excluded 147 papers after reading the full texts and contacting the authors (see <a href="./references#CD005331-sec-0252" title="">Characteristics of excluded studies</a> table). </p> <p>This resulted in 21 full texts being included, seven of which were duplicates of the same study, thus the total number of studies included in the analysis was 17 (14 new, and three studies from the original review; see <a href="./references#CD005331-sec-0251" title="">Characteristics of included studies</a> table for details). </p> <p>A flowchart diagram of this process can be found in <a href="#CD005331-fig-0001">Figure 1</a>.  </p> </section> <section id="CD005331-sec-0057"> <h4 class="title">Included studies</h4> <p>Seventeen studies met the inclusion criteria: <a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>; <a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>. Each study is described in detail in the <a href="./references#CD005331-sec-0251" title="">Characteristics of included studies</a> table.  </p> <p>One cross‐over study was included in the review (<a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>). We used the data from the first period of this study as recommended by <a href="./references#CD005331-bbs2-0207" title="CurtinF , ElbourneD , AltmanDG . Meta-analysis combining parallel and cross-over clinical trials. III: the issue of carry-over. Statistics in Medicine2002;21(15):2161-73.">Curtin 2002</a>. </p> <section id="CD005331-sec-0058"> <h5 class="title">Design</h5> <p>All the 17 studies were RCTs, 16 with parallel‐group designs, and one with a cross‐over design (<a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>).  </p> </section> <section id="CD005331-sec-0059"> <h5 class="title">Sample sizes</h5> <p>The 17 studies included 894 participants. The studies varied in sizes between 16 participants and 195 participants. </p> </section> <section id="CD005331-sec-0060"> <h5 class="title">Setting</h5> <p>The studies took place in a variety of settings. Four were conducted in psychiatric inpatient settings (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>); three in psychiatric outpatient settings (<a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>); two in neurology departments, one in day‐patient settings (<a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>) and one in a general outpatient setting (<a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>); one was in a veteran medical centre with outpatients (<a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>); one in an emergency unit (<a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>); one was in a hospital rehabilitation clinic with inpatients (<a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>); one with outpatients in three different academic hospital settings (<a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>); three originated in an epilepsy unit, two of those mainly taking place at the hospital (<a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>) or in local clinics (<a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>), and one mainly by telephone (<a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>); and one study gave no information on the setting (<a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>). </p> </section> <section id="CD005331-sec-0061"> <h5 class="title">Country</h5> <p>The studies took place in nine countries, with a single study in each of Iran, Italy, Norway, Switzerland and Turkey; two studies from each of Pakistan and the UK, three studies taking place in The Netherlands and four in the USA. Thus, the locations spanned a wide range of countries given the small number of studies included. </p> </section> <section id="CD005331-sec-0062"> <h5 class="title">Participants</h5> <p>Participants were all adults aged 18–80 years with a confirmed diagnosis of conversion disorder or dissociative disorder. In one study, there were doubts about whether this was the case (<a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>), but by contacting the author, it was confirmed that the majority of participants did have conversion disorder (<a href="./references#CD005331-bbs2-0277" title="Vermeulen M [pers comm]. Question about research data for Cochrane review. Email to: Ganslev CA 25 October 2018.">Vermeulen 2018</a>). The duration of symptoms varied from a few hours in one study (<a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>) to several months or years in most other studies. The total number of participants was 894 with 673 women (75%) and 221 men (25%), giving a female:male ratio of 3:1. </p> </section> <section id="CD005331-sec-0063"> <h5 class="title">Interventions</h5> <p>The interventions were varied and included CBT (<a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>), hypnosis (<a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>), a psychoeducative focus (<a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>), physical rehabilitation within a cognitive behavioural framework (<a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>); psychodynamic therapy (<a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>); paradoxical intervention (<a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>); behavioural therapy (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>); and motivational interviewing given prior to the therapy (<a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>). </p> </section> <section id="CD005331-sec-0064"> <h5 class="title">Controls</h5> <p>Elleven studies received TAU or SMC as controls (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>; <a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>), two studies had wait list controls (<a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>), while two studies had psychopharmaceutical interventions as controls (<a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>). </p> <p>One study had four interventions and no control, only one of which was clearly a psychosocial intervention and one clearly a pharmaceutical intervention, thus for the purpose of using the data in this review, we chose the psychosocial as active intervention and the pharmaceutical as control (<a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>). </p> <p>In one study the reported control group was not part of the original randomisation for the study and data for that group thus not eligible for inclusion here (<a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>). As that study had two intervention arms where the participants were randomised correctly, we decided to extract data from those instead, using the least invasive intervention as control. </p> <p>One study had a design where similar interventions were given to both the active and control groups, but with the active group having additional components compared with the controls (<a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>). </p> <p>None of the studies had any restrictions on, or documentation of, whether their control groups received other interventions outside of the study. </p> </section> <section id="CD005331-sec-0065"> <h5 class="title">Duration of study</h5> <p>The duration of studies varied between a few hours (<a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>) and more than four months (<a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>). Interventions for inpatients or day patients tended to be relatively short, lasting five‐days to one week in hospital, some with additional follow‐up afterwards. Interventions given to outpatients of psychoeducative nature tended to have few actual contacts spread out over some months, while therapeutic interventions delivered for outpatients tended to require regular weekly or bi‐weekly visits to an outpatient clinic over 12 weeks. </p> </section> <section id="CD005331-sec-0066"> <h5 class="title">Outcomes</h5> <p>The studies were primarily clinical, with one feasibility study (<a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>), which had relevant outcome measures for use of this review.  </p> </section> <section id="CD005331-sec-0067"> <h5 class="title">Rating scales and measurements</h5> <p>Studies used the following scales and measures.</p> <section id="CD005331-sec-0068"> <h6 class="title">Primary outcomes</h6> <p>For the primary outcome of a reduction in physical signs, several studies used patients seizure diaries as the main measurement, where patients, relatives or staff noted the number of daily or weekly seizures (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>; <a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>). This would then be used to judge change either as a change in numbers, or percentage when. One study devised its own scale (<a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>). </p> <p>One study measured the primary outcome by looking at the number of participants without conversive attacks in the last two weeks (<a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>).   </p> <p>Two studies used a video rating scale developed by the authors, to judge the severity of symptoms (<a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>). </p> <p>Some studies used different standardised scales to measure reduction in physical signs (<a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>). In those studies, the following scales was used: </p> <p> <ul id="CD005331-list-0012"> <li> <p>physical component of the SF‐36 (<a href="./references#CD005331-bbs2-0234" title="JenkinsonC , LayteR , WrightL , CoulterA . The UK SF-36: an Analysis and Interpretation Manual. Oxford (UK): Health Services Research Unit, 1996.">Jenkinson 1996</a>); </p> </li> <li> <p>SDQ‐20 (<a href="./references#CD005331-bbs2-0255" title="NijenhuisER , vanSpinhovenP , vanDyckR , derHart VanO , vanVanderlindenJ . The development and psychometric characteristics of the Somatoform Dissociation Questionnaire (SDQ-20). Journal of Nervous and Mental Disease1996;184(11):688-94.">Nijenhuis 1996</a>); </p> </li> <li> <p>Psychogenic Movement Disorder Scale (PMDRS) total score (<a href="./references#CD005331-bbs2-0228" title="HinsonVK , CuboE , ComellaCL , GoetzCG , LeurgansS . Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Movement Disorders2005;20(12):1592-7.">Hinson 2005</a>); </p> </li> <li> <p>Clinical Global Impression (CGI) (<a href="./references#CD005331-bbs2-0222" title="GuyW , National Institute of Mental Health (US), Psychopharmacology Research Branch, Early Clinical Drug Evaluation Program. ECDEU Assessment Manual for Psychopharmacology. Rockville (MD): U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976.">Guy 1976</a>). </p> </li> </ul> </p> <p>Finally, three studies did not report on our primary outcome (<a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>). </p> </section> <section id="CD005331-sec-0069"> <h6 class="title">Secondary outcomes</h6> <p>Studies used the following scales.</p> <p>Level of functioning:</p> <p> <ul id="CD005331-list-0013"> <li> <p>GAF (<a href="./references#CD005331-bbs2-0184" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition. Washington (DC): American Psychiatric Association, 1994.">APA 1994</a>; <a href="./references#CD005331-bbs2-0236" title="JonesSH , ThornicroftG , CoffeyM , DunnG . A brief mental health outcome scale: reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry1995;166(5):654-9.">Jones 1995</a>); </p> </li> <li> <p>Functional Independence Measure (FIM) (<a href="./references#CD005331-bbs2-0248" title="McDowellI , NewellC . Measuring Health, a Guide to Rating Scales and Questionnaires. New York (NY): Oxford University Press, 1996.">McDowell 1996</a>); </p> </li> <li> <p>WSAS (<a href="./references#CD005331-bbs2-0252" title="MundtJC . The Work and Social Adjustment Scale: a simple measure of impairment in functioning. British Journal of Psychiatry2002;180(5):461-4.">Mundt 2002</a>). </p> </li> </ul> </p> <p>Quality of life:</p> <p> <ul id="CD005331-list-0014"> <li> <p>full version SF‐36 (<a href="./references#CD005331-bbs2-0234" title="JenkinsonC , LayteR , WrightL , CoulterA . The UK SF-36: an Analysis and Interpretation Manual. Oxford (UK): Health Services Research Unit, 1996.">Jenkinson 1996</a>); </p> </li> <li> <p>QOLIE31 (<a href="./references#CD005331-bbs2-0205" title="CramerJA , PerrineK , DevinskyO , Bryant-ComstockL , MeadorK , HermannB . Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia1998;39(1):81-8.">Cramer 1998</a>); </p> </li> <li> <p>Quality of Life in Epilepsy 10 (QOLIE10‐P) (<a href="./references#CD005331-bbs2-0204" title="CramerJA , PerrineK , DevinskyO , MeadorK . A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia1996;37(6):577-82.">Cramer 1996</a>). </p> </li> </ul> </p> <p>General mental state:</p> <p> <ul id="CD005331-list-0015"> <li> <p>SCL‐90 (<a href="./references#CD005331-bbs2-0209" title="DerogatisLR , ClearyPA . Confirmation of the dimensional structure of the SCL-90: a study in construct validation. Journal of Clinical Psychology1977;33(4):981-9.">Derogatis 1977</a>); </p> </li> <li> <p>SF‐36 or SF‐12 Mental Component) (<a href="./references#CD005331-bbs2-0234" title="JenkinsonC , LayteR , WrightL , CoulterA . The UK SF-36: an Analysis and Interpretation Manual. Oxford (UK): Health Services Research Unit, 1996.">Jenkinson 1996</a>). </p> </li> </ul> </p> <p>Depression:</p> <p> <ul id="CD005331-list-0016"> <li> <p>HADS – Depression Component (<a href="./references#CD005331-bbs2-0282" title="ZigmondAS , SnaithRP . The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica1983;67(6):361-70.">Zigmond 1983</a>); </p> </li> <li> <p>HRSD (<a href="./references#CD005331-bbs2-0225" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry1960;23(1):56.">Hamilton 1960</a>); </p> </li> <li> <p>BDI‐II (<a href="./references#CD005331-bbs2-0193" title="BeckAT , SteerRA , BallR , RanieriWF . Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. Journal of Personality Assessment1996;67(3):588-97.">Beck 1996</a>). </p> </li> </ul> </p> <p>Anxiety:</p> <p> <ul id="CD005331-list-0017"> <li> <p>BAI (<a href="./references#CD005331-bbs2-0192" title="BeckAT , EpsteinN , BrownG , SteerRA . An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology1988;56(6):893-7.">Beck 1988</a>); </p> </li> <li> <p>Hamilton Rating Scale for Anxiety (HRSA) (<a href="./references#CD005331-bbs2-0224" title="HamiltonMC . The assessment of anxiety states by rating. British Journal of Medical Psychology1959;32:50-5.">Hamilton 1959</a>); </p> </li> <li> <p>Hospital Anxiety and Depression Scale – Anxiety Component (<a href="./references#CD005331-bbs2-0282" title="ZigmondAS , SnaithRP . The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica1983;67(6):361-70.">Zigmond 1983</a>). </p> </li> </ul> </p> <p>Use of health service resources:</p> <p> <ul id="CD005331-list-0018"> <li> <p>Client Service Receipt Inventory (adjusted);</p> </li> <li> <p>number of general practitioner consultations (<a href="./references#CD005331-bbs2-0194" title="BeechamJ , KnappM . Costing psychiatric interventions. In: Measuring Mental Health Needs. Bideford (UK): Gaskell, 2001:200-24.">Beecham 2019</a>). </p> </li> </ul> </p> </section> </section> </section> <section id="CD005331-sec-0070"> <h4 class="title">Excluded studies</h4> <p>We excluded 147 full‐text articles for the following reasons: 37 studies had a wrong study design, 35 studies had no control group, 23 studies had a wrong population and seven studies had a wrong intervention. Eight texts were overview articles, 33 were reviews,  three were letters to the Editor and one was a book chapter. </p> <p>We provided references for all the excluded full texts together with the reasons in the <a href="./references#CD005331-sec-0252" title="">Characteristics of excluded studies</a> table with excluded studies.  </p> <section id="CD005331-sec-0071"> <h5 class="title">Studies awaiting assessment</h5> <p>There are no studies awaiting assessment.</p> </section> <section id="CD005331-sec-0072"> <h5 class="title">Ongoing studies</h5> <p>We found seven ongoing studies. Some had very clear and updated information on the study in the ClinicalTrials Register, in which case we have given that information below, while other studies gave less clear information and were  explored via personal communication with the principal investigators, in order to obtain all available data. The following projects are all RCTs, either in preliminary phases, still performing data collection, have not yet made their data available or have not yet published their results. </p> <p> <ul id="CD005331-list-0019"> <li> <p>Professor Laura <a href="./references#CD005331-bbs2-0221" title="Goldstein [pers comm]. Question about research on dissociative seizures. Email to: Ganslev CA 8 August 2018.">Goldstein 2018</a> is heading a large research project in the UK (CODES), which has been described in various articles (<a href="./references#CD005331-bbs2-0171" title="GoldsteinLH , ChalderT , CarsonAJ , LandauS , McCroneP , MedfordN , et al. Cognitive behavioural therapy vs. standardised medical care for adults with dissociative non-epileptic seizures (codes): progress in a randomised controlled trial. Epilepsia2016;57(Suppl 2):28-9. [DOI: [DOI: 10.1111/epi.13609]]">Goldstein 2016</a>; <a href="./references#CD005331-bbs2-0172" title="GoldsteinLH , ChalderT , CarsonAJ , LandauS , McCroneP , MedfordN , MurrayJ , et al. Cognitive behavioural therapy vs standardised medical care for adults with dissociative non-epileptic seizures (codes): update on a pragmatic randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(8):e26. [DOI: 10.1136/jnnp-2017-BNPA.56]">Goldstein 2017</a>; <a href="./references#CD005331-bbs2-0179" title="RobinsonEJ , GoldsteinLH , McCroneP , PerdueI , ChalderT , MellersJD , et al. Cognitive behavioural therapy versus standardised medical care for adults with dissociative non-epileptic seizures (CODES): statistical and economic analysis plan for a randomised controlled trial. Trials2017;18(1):258. ">Robinson 2017</a>). Their data and publication is not yet ready (<a href="./references#CD005331-bbs2-0221" title="Goldstein [pers comm]. Question about research on dissociative seizures. Email to: Ganslev CA 8 August 2018.">Goldstein 2018</a>), but is likely to be relevant for future updates of this review. </p> </li> <li> <p><a href="./references#CD005331-bbs2-0250" title="Bækkelund [pers comm]. Spørgsmål om forskning – stabilizing group treatment of complex trauma. Email to: Ganslev CA 5 September 2018.">Modum Bad 2018</a>, a treatment institution in Norway specialising in trauma, is also undertaking a research project in this area (NCT02450617b), with data collection hopefully being completed in 2019 according to the principal investigator Harald Baekkelund (<a href="./references#CD005331-bbs2-0250" title="Bækkelund [pers comm]. Spørgsmål om forskning – stabilizing group treatment of complex trauma. Email to: Ganslev CA 5 September 2018.">Modum Bad 2018</a>). </p> </li> <li> <p>Dr <a href="./references#CD005331-bbs2-0217" title="Fobian A [pers comm]. Question about research trial. Email to: Ganslev CA 16 August 2018.">Fobian 2018</a> is principal investigator on a project "Treatment outcomes of CBT for PNES" (<a href="./references#CD005331-bbs2-0178" title="NCT02801136. Treatment outcomes of CBT for PNES. clinicaltrials.gov/ct2/show/NCT02801136 (first received 15 June 2016). ">NCT02801136</a>), which is due to publish results soon according to the author (<a href="./references#CD005331-bbs2-0217" title="Fobian A [pers comm]. Question about research trial. Email to: Ganslev CA 16 August 2018.">Fobian 2018</a>). </p> </li> <li> <p>Dr Meinlschmidt has conducted a study on "Treatment of globus sensations with psychotherapy (<a href="./references#CD005331-bbs2-0174" title="NCT01590992. Treatment of globus sensations with psychotherapy. clinicaltrials.gov/ct2/show/NCT01590992 (first received 3 May 2012). ">NCT01590992</a>), but according to the author no results are available yet (<a href="./references#CD005331-bbs2-0249" title="Meinlschmidt [pers comm]. Question about research trial. Email to: CA Ganslev 4 September 2018.">Meinlschmidt 2018</a>). </p> </li> <li> <p>Another study, "The role of the temporo‐parietal junction in functional neurological disorders. A study with mindfulness‐based stress reduction therapy" had received ethical approval and was due to start late 2018  according to the principal investigator Professor <a href="./references#CD005331-bbs2-0187" title="Aybek S [pers comm]. Question about research trial – results. Email to: Ganslev CA 14 August 2018.">Aybek 2018</a> (<a href="./references#CD005331-bbs2-0187" title="Aybek S [pers comm]. Question about research trial – results. Email to: Ganslev CA 14 August 2018.">Aybek 2018</a>; <a href="./references#CD005331-bbs2-0168" title="DRKS00012997. The role of the temporo-parietal junction in functional neurological disorders. a study with mindfulness-based stress reduction therapy. www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00012997 (first received 8 September 2017). ">DRKS00012997</a>). </p> </li> <li> <p>Dr Kim D Bullock is leading a study on "Embodied virtual reality therapy for functional neurological symptom/conversion disorder', which is currently recruiting participants and expects to be complete by January 2022 (<a href="./references#CD005331-bbs2-0177" title="NCT02764476. Embodied virtual reality therapy for functional neurological symptom/conversion disorder. clinicaltrials.gov/ct2/show/NCT02764476 (first received 6 May 2016). ">NCT02764476</a>). </p> </li> <li> <p>Dr Anna Philine Senf‐Beckenbach is heading a study named "Evaluation of the effect of a psychotherapy program with body movement focus for patients with dissociative seizures." (<a href="./references#CD005331-bbs2-0169" title="DRKS00014251. Evaluation of the effect of a psychotherapy program with body movement focus for patients with dissociative seizures. www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&amp;TRIAL_ID=DRKS00014251 (first received 6 April 2018). ">DRKS00014251</a>).  </p> </li> </ul> </p> </section> </section> </section> <section id="CD005331-sec-0073"> <h3 class="title">Risk of bias in included studies</h3> <p>We assessed the risk of bias of each included study using the Cochrane 'Risk of bias' tool (<a href="./references#CD005331-bbs2-0226" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). A summary of our assessment is displayed in <a href="#CD005331-fig-0002">Figure 2</a> and <a href="#CD005331-fig-0003">Figure 3</a> and the details of the assessment of each study can be found in the <a href="./references#CD005331-sec-0251" title="">Characteristics of included studies</a> table. We assessed most studies to be studies with an overall high risk of bias. </p> <div class="figure" id="CD005331-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005331-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD005331-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005331-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD005331-sec-0074"> <h4 class="title">Allocation</h4> <section id="CD005331-sec-0075"> <h5 class="title">Random sequence generation</h5> <p>We considered random sequence generation at low risk of bias in 13 studies (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>; <a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>), at high risk in one study (<a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>), and at unclear risk of bias in three studies (<a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>). </p> </section> <section id="CD005331-sec-0076"> <h5 class="title">Allocation concealment</h5> <p>We considered allocation concealment at low risk of bias in five studies (<a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>), and at unclear risk of bias in 12 studies (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>). </p> </section> </section> <section id="CD005331-sec-0077"> <h4 class="title">Blinding</h4> <p>We considered the method of blinding of participants and personal unclear in nine studies (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>), and at high risk of bias in eight studies (<a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>; <a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>). </p> <p>We considered the method of blinding of outcome assessment at low risk of bias in five studies (<a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>), and unclear in eight studies (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>). In four studies there was a high risk of bias regarding blinding of outcome assessment (<a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>). </p> </section> <section id="CD005331-sec-0078"> <h4 class="title">Incomplete outcome data</h4> <p>Eight studies displayed low risk of bias in regards to incomplete data (<a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>), and six studies displayed high risk of bias (<a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>; <a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>). In three studies, there was lack of information and we could not assess whether the method used to handle missing data was likely to bias the effect estimate (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>).  </p> </section> <section id="CD005331-sec-0079"> <h4 class="title">Selective reporting</h4> <p>Five studies displayed low risk of bias with regard to selective reporting (<a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>; <a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>), and five studies displayed high risk of bias (<a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>). In seven studies, it was unclear whether authors reported all predefined outcomes (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>). </p> </section> <section id="CD005331-sec-0080"> <h4 class="title">Other potential sources of bias</h4> <p>In 15 studies there were no other sources of bias (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>; <a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>; <a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>; <a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>; <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>; <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>; <a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>; <a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>; <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>; <a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>). One study measured the primary outcome using a self‐developed scale that was not properly validated (<a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>) and this was assessed to likely bias the effect estimate. In one study, it was unclear whether there was any other sources of bias (<a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>). </p> <section id="CD005331-sec-0081"> <h5 class="title">Subgroup analysis</h5> <p>We did not perform any subgroup or sensitivity analyses due to lack of data</p> </section> <section id="CD005331-sec-0082"> <h5 class="title">Sensitivity analysis</h5> <p>We did not perform any sensitivity analyses due to lack of data</p> </section> </section> </section> <section id="CD005331-sec-0083"> <h3 class="title" id="CD005331-sec-0083">Effects of interventions</h3> <p>See: <a href="./full#CD005331-tbl-0001"><b>Summary of findings 1</b> Paradoxical intention therapy compared with diazepam</a>; <a href="./full#CD005331-tbl-0002"><b>Summary of findings 2</b> Hypnosis plus treatment as usual compared with treatment as usual</a>; <a href="./full#CD005331-tbl-0003"><b>Summary of findings 3</b> Hypnosis compared with wait list</a>; <a href="./full#CD005331-tbl-0004"><b>Summary of findings 4</b> Behavioural therapy plus treatment as usual compared with treatment as usual</a>; <a href="./full#CD005331-tbl-0005"><b>Summary of findings 5</b> Cognitive behavioural therapy as compared with standard medical care</a>; <a href="./full#CD005331-tbl-0006"><b>Summary of findings 6</b> Psychoeducational follow‐up programme compared with treatment as usual</a>; <a href="./full#CD005331-tbl-0007"><b>Summary of findings 7</b> Specialised cognitive behavioural therapy‐based physiotherapy compared with waitlist</a>; <a href="./full#CD005331-tbl-0008"><b>Summary of findings 8</b> Specialised cognitive behavioural therapy‐based physiotherapy intervention compared with treatment as usual</a>; <a href="./full#CD005331-tbl-0009"><b>Summary of findings 9</b> Brief psychotherapeutic intervention compared with standard care</a>; <a href="./full#CD005331-tbl-0010"><b>Summary of findings 10</b> Cognitive behavioural therapy plus adjunctive physical activity compared with cognitive behavioural therapy alone</a>; <a href="./full#CD005331-tbl-0011"><b>Summary of findings 11</b> Hypnosis compared with diazepam</a>; <a href="./full#CD005331-tbl-0012"><b>Summary of findings 12</b> Psychotherapy preceded by motivational interviewing compared with psychotherapy alone</a> </p> <p>We present the results for each of the primary and secondary outcomes connected to the 12 comparisons below. Most are presented as MDs because there was only one study; where there is more than one study and the outcomes were reported on different scales, we present the standardised mean difference (SMD). We considered a statistical significant SMD effect size of: 0.15 or less to have no clinically meaningful effect; 0.15 to 0.40 to have a clinical meaningful but small effect; 0.40 to 0.75 to have a moderate effect; and greater than 0.75 to have a large treatment effect (<a href="./references#CD005331-bbs2-0202" title="CohenJ . Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale (NJ): Lawrence Erlbaum Associates, Publishers, 1988.">Cohen 1988</a>; <a href="./references#CD005331-bbs2-0273" title="ThalheimerW , CookS . How to calculate effect sizes from published research articles: a simplified methodology. www.worklearning.com/2016/08/11/using-effect-sizes-and-considering-meta-analyses/ (accessed 16 July 2020).">Thalheimer 2002</a>). </p> <p>We contacted the authors of three studies with unclear or missing data and requested the necessary information. All three replied, which led to one study being included but with no data available (<a href="./references#CD005331-bbs2-0016" title="ThompsonN , ConnellyL , PeltzerJ , NowackWJ , HameraE , HunterEE . Psychogenic nonepileptic seizures: a pilot study of a brief educational intervention. Perspectives in Psychiatric Care2013;49(2):78-83. [DOI: 10.1111/j.1744-6163.2012.00353.x]">Thompson 2013</a>), one study included in the final analysis on basis of secondary outcomes as no data were available on primary outcomes (<a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>), and one study included in the final analysis as it was clarified that the population consisted of people with conversion and dissociative disorders (<a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>). </p> <p>We considered most studies at high risk of bias due to systematic errors. However, we used all eligible studies in the meta‐analyses, as it is recommend in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to do so when all the studies are assigned the same risk of bias. We took into account our 'Risk of bias' assessment when considering the quality of the evidence using the GRADE approach, to ensure that judgements about risk of bias and other factors affecting the certainty of the evidence are taken into account when interpreting the results of the review (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>; Section 8.8.3.1). </p> <section id="CD005331-sec-0084"> <h4 class="title">Comparison 1: inpatient paradoxical intention therapy compared with outpatient diazepam</h4> <p>One study compared inpatient paradoxical intention therapy with outpatient diazepam (<a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>). </p> <section id="CD005331-sec-0085"> <h5 class="title">1.1 Reduction in physical signs</h5> <p>Inpatient paradoxical intention therapy did not reduce conversive symptoms, measured by number of participants without conversive attacks in the last week, compared with outpatient diazepam et end of treatment (RR 1.44, 95% CI 0.91 to 2.28; 1 study, 30 participants; P = 0.12) (<a href="./references#CD005331-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD005331-sec-0086"> <h5 class="title">1.2 Level of functioning</h5> <p>The study did not measure level of functioning.</p> </section> <section id="CD005331-sec-0087"> <h5 class="title">1.3 Quality of life</h5> <p>The study did not measure quality of life.</p> </section> <section id="CD005331-sec-0088"> <h5 class="title">1.4 Mental state</h5> <section id="CD005331-sec-0089"> <h6 class="title">1.4.1 Anxiety</h6> <p>Inpatient paradoxical intention therapy might reduce anxiety symptoms at end of treatment, measured by HADS, compared with outpatient diazepam at end of treatment (MD –3.73, 95% CI –6.96 to –0.50; 1 study, 30 participants; P = 0.02) (<a href="./references#CD005331-fig-0005" title="">Analysis 1.2</a>). </p> </section> </section> <section id="CD005331-sec-0090"> <h5 class="title">1.5 Dropout rate</h5> <p>In <a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>, no participants left the study before the end from either group. </p> </section> <section id="CD005331-sec-0091"> <h5 class="title">1.6 Use of health service resources</h5> <p>The study did not measure use of health service resources.</p> </section> <section id="CD005331-sec-0092"> <h5 class="title">1.7 Adverse effects</h5> <p>The study did not measure adverse effects.</p> </section> </section> <section id="CD005331-sec-0093"> <h4 class="title">Comparison <i>2</i>: inpatient treatment programme plus hypnosis compared with inpatient treatment programme </h4> <p>One study compared inpatient treatment programme plus hypnosis with inpatient treatment programme (<a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>). </p> <section id="CD005331-sec-0094"> <h5 class="title">2.1 Reduction in physical signs</h5> <p>Inpatient treatment programme plus hypnosis did not reduce severity of impairment, measured using a video rating scale, compared with inpatient treatment programme at the end of treatment (MD –0.49, 95% CI –1.28 to 0.30; 1 study, 45 participants; P = 0.23) or at follow‐up (MD 0.13, 95% CI –0.55 to 0.81; 1 study, 45 participants; P = 0.71) (<a href="./references#CD005331-fig-0007" title="">Analysis 2.1</a>). </p> </section> <section id="CD005331-sec-0095"> <h5 class="title">2.2 Level of functioning</h5> <p>The study did not measure level of functioning.</p> </section> <section id="CD005331-sec-0096"> <h5 class="title">2.3 Quality of life</h5> <p>The study did not measure quality of life.</p> </section> <section id="CD005331-sec-0097"> <h5 class="title">2.4 Mental state</h5> <p>Inpatient treatment programme plus hypnosis did not reduce symptoms of mental state, measured using SCL‐90, compared with inpatient treatment programme at the end of treatment (MD 1.42 95% CI –36.02 to 38.86; 1 study, 45 participants; P = 0.94) or at follow‐up (MD –5.97, 95% CI –44.22 to 32.28; 1 study, 45 participants; P = 0.76) (<a href="./references#CD005331-fig-0008" title="">Analysis 2.2</a>). </p> </section> <section id="CD005331-sec-0098"> <h5 class="title">2.5 Dropout rate</h5> <p>In <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>, 2/26 participants left the treatment programme and hypnosis group compared with 2/23 of the participants in the treatment programme and individual sessions group before the end of treatment (RR 0.88, 95% CI 0.14 to 5.79; 1 study, 49 participants; P = 0.90) (<a href="./references#CD005331-fig-0009" title="">Analysis 2.3</a>). </p> </section> <section id="CD005331-sec-0099"> <h5 class="title">2.6 Use of health service resources</h5> <p>The study did not measure use of health service resources.</p> </section> <section id="CD005331-sec-0100"> <h5 class="title">2.7 Adverse effects</h5> <p>The study did not measure adverse effects.</p> </section> </section> <section id="CD005331-sec-0101"> <h4 class="title">Comparison 3: outpatient hypnosis compared with wait list</h4> <p>One study compared outpatient hypnosis with wait list (<a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>). </p> <section id="CD005331-sec-0102"> <h5 class="title">3.1 Reduction in physical signs</h5> <section id="CD005331-sec-0103"> <h6 class="title">3.1.1 Severity of impairment</h6> <p>Outpatient hypnosis might reduce severity of impairment, measured using a video rating scale, compared with wait list at the end of treatment (MD 2.10, 95% CI 1.34 to 2.86; 1 study, 49 participants; P &lt; 0.00001) (<a href="./references#CD005331-fig-0010" title="">Analysis 3.1</a>). </p> </section> </section> <section id="CD005331-sec-0104"> <h5 class="title">3.2 Level of functioning</h5> <p>The study did not measure level of functioning.</p> </section> <section id="CD005331-sec-0105"> <h5 class="title">3.3 Quality of life</h5> <p>The study did not measure quality of life.</p> </section> <section id="CD005331-sec-0106"> <h5 class="title">3.4 Mental state</h5> <p>The study did not measure mental state.</p> </section> <section id="CD005331-sec-0107"> <h5 class="title">3.5 Dropout rate</h5> <p>Outpatient hypnosis did not reduce dropout compared with wait list at end of treatment (RR 4.17, 95% CI 0.50 to 34.66; 1 study, 49 participants; P = 0.19) (<a href="./references#CD005331-fig-0011" title="">Analysis 3.2</a>). </p> </section> <section id="CD005331-sec-0108"> <h5 class="title">3.6 Use of health service resources</h5> <p>The study did not measure use of health service resources.</p> </section> <section id="CD005331-sec-0109"> <h5 class="title">3.7 Adverse effects</h5> <p>No study measured adverse effects.</p> </section> </section> <section id="CD005331-sec-0110"> <h4 class="title">Comparison 4: behavioural therapy plus routine clinical care compared with routine clinical care </h4> <p>Two studies compared behavioural therapy plus routine clinical care with routine clinical care (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>). </p> <section id="CD005331-sec-0111"> <h5 class="title">4.1 Reduction in physical signs</h5> <section id="CD005331-sec-0112"> <h6 class="title">4.1.1 Number of weekly seizures</h6> <p>Behavioural therapy plus routine clinical care might reduce the number of weekly seizures at the end of treatment, measured using participant's seizure diaries, compared with routine clinical care alone at end of treatment (MD –21.40, 95% CI –27.88 to –14.92; 1 study, 18 participants; P &lt; 0.00001) (<a href="./references#CD005331-fig-0012" title="">Analysis 4.1</a>). </p> </section> <section id="CD005331-sec-0113"> <h6 class="title">4.1.2 Symptom severity</h6> <p>Behavioural therapy plus routine clinical care might reduce symptom severity at the end of treatment, measured using the CGI scale, compared with routine clinical care alone at end of treatment (MD –2.90 95% CI –3.41 to –2.39; 1 study, 90 participants; P &lt; 0.00001) (<a href="./references#CD005331-fig-0013" title="">Analysis 4.2</a>). </p> </section> </section> <section id="CD005331-sec-0114"> <h5 class="title">4.2 Level of functioning</h5> <p>Neither study measured level of functioning.</p> </section> <section id="CD005331-sec-0115"> <h5 class="title">4.3 Quality of life</h5> <p>Neither study measured quality of life.</p> </section> <section id="CD005331-sec-0116"> <h5 class="title">4.4 Mental state</h5> <section id="CD005331-sec-0117"> <h6 class="title">4.4.1 Anxiety</h6> <p>Behavioural therapy plus routine clinical care might reduce symptoms of anxiety at the end of treatment, measured using Hamilton Anxiety Scale, compared with routine clinical care alone at end of treatment (MD –5.47, 95% CI –7.08 to –3.86; 2 studies, 108 participants; P &lt; 0.00001) (<a href="./references#CD005331-fig-0014" title="">Analysis 4.3</a>). </p> </section> <section id="CD005331-sec-0118"> <h6 class="title">4.4.2 Depression</h6> <p>Behavioural therapy plus routine clinical might reduce symptoms of depression at follow‐up, measured using Hamilton Depression Scale, compared with routine clinical care alone at follow‐up (MD –4.99, 95% CI –6.36 to –3.62; 2 studies, 108 participants; P &lt; 0.00001) (<a href="./references#CD005331-fig-0015" title="">Analysis 4.4</a>). </p> </section> </section> <section id="CD005331-sec-0119"> <h5 class="title">4.5 Dropout rate</h5> <p>Behavioural therapy plus routine clinical care was associated with fewer dropouts compared with routine clinical care alone at end of treatment (RR 0.24, 95% CI 0.06 to 0.90; 2 studies, 118 participants; P = 0.04) (<a href="./references#CD005331-fig-0016" title="">Analysis 4.5</a>). </p> </section> <section id="CD005331-sec-0120"> <h5 class="title">4.6 Use of health service resources</h5> <p>Neither study measure used of health service resources.</p> </section> <section id="CD005331-sec-0121"> <h5 class="title">4.7 Adverse effects</h5> <p>Neither study measured adverse effects.</p> </section> </section> <section id="CD005331-sec-0122"> <h4 class="title">Comparison 5: cognitive behavioural therapy compared with standard medical care</h4> <p>Two studies compared CBT with SMC (<a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>; <a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>). </p> <section id="CD005331-sec-0123"> <h5 class="title">5.1 Reduction in physical signs</h5> <section id="CD005331-sec-0124"> <h6 class="title">5.1.1 Monthly seizure frequency (reduction in %)</h6> <p>CBT did not reduce monthly seizure frequency, measured using participants' seizure diaries, compared with SMC at end of treatment (RR 1.56, 95% CI 0.39 to 6.19; 1 study, 16 participants; P = 0.53) (<a href="./references#CD005331-fig-0017" title="">Analysis 5.1</a>). </p> </section> <section id="CD005331-sec-0125"> <h6 class="title">5.1.2 Monthly seizure frequency (median interquartile range)</h6> <p>CBT did not reduce monthly seizure frequency, measured using participants' seizure diaries, compared with SMC at end of treatment (MD –4.75, 95% CI –18.73 to 9.23; 1 study, 61 participants; P = 0.51) or at follow‐up (MD –3.50, 95% CI –12.69 to 5.69; 1 study, 59 participants; P = 0.46) (<a href="./references#CD005331-fig-0018" title="">Analysis 5.2</a>). </p> </section> <section id="CD005331-sec-0126"> <h6 class="title">5.1.3 Seizure freedom</h6> <p>CBT did not reduce seizure freedom, measured using participants' seizure diaries, compared with SMC at end of treatment (RR 2.33, 95% CI 0.30 to 17.88; 1 study, 16 participants; P = 0.41) (<a href="./references#CD005331-fig-0019" title="">Analysis 5.3</a>). </p> </section> </section> <section id="CD005331-sec-0127"> <h5 class="title">5.2 Level of functioning</h5> <p>CBT did not increase level of functioning compared with SMC at end of treatment (SMD 0.44, 95% CI –1.69 to 2.57; 2 studies, 74 participants; P = 0.69) or at follow‐up (SMD –0.63, 95% CI –1.18 to –0.08; 1 study, 53 participants; P = 0.03) (<a href="./references#CD005331-fig-0020" title="">Analysis 5.4</a>). </p> </section> <section id="CD005331-sec-0128"> <h5 class="title">5.3 Quality of life</h5> <p>CBT did not increase quality of life, measured using QOLIE31, compared with SMC at end of treatment (MD 11.20, 95% CI –7.98 to 30.38; 1 study, 16 participants; P = 0.25) (<a href="./references#CD005331-fig-0021" title="">Analysis 5.5</a>). </p> </section> <section id="CD005331-sec-0129"> <h5 class="title">5.4 Mental state</h5> <section id="CD005331-sec-0130"> <h6 class="title">5.4.1 Anxiety</h6> <p>CBT did not reduce symptoms of anxiety compared with SMC at end of treatment (SMD –0.31, 95% CI –0.78 to 0.15; 2 studies, 74 participants; P = 0.18) or at follow‐up (SMD –0.31, 95% CI –0.85 to 0.23; 1 study, 53 participants; P = 0.25) (<a href="./references#CD005331-fig-0022" title="">Analysis 5.6</a>). </p> </section> <section id="CD005331-sec-0131"> <h6 class="title">5.4.2 Depression</h6> <p>CBT did not reduce symptoms of depression compared with SMC at end of treatment (SMD –0.25, 95% CI –0.71 to 0.21; 2 studies, 74 participants; P = 0.28) or at follow‐up (SMD –0.32, 95% CI –0.86 to 0.23; 1 study, 53 participants; P = 0.25) (<a href="./references#CD005331-fig-0023" title="">Analysis 5.7</a>). </p> </section> <section id="CD005331-sec-0132"> <h6 class="title">5.4.3 Symptoms of general mental state</h6> <p>CBT might reduce negative mental state symptoms, measured using SCL‐90, compared with SMC at end of treatment (MD –70.60, 95% CI –121.59 to –19.61; 1 study, 16 participants; P = 0.007) (<a href="./references#CD005331-fig-0024" title="">Analysis 5.8</a>). </p> </section> </section> <section id="CD005331-sec-0133"> <h5 class="title">5.5 Dropout rate</h5> <p>CBT did not decrease dropout compared with SMC at end of treatment (RR 0.37, 95% CI 0.02 to 8.01; 2 studies, 83 participants; P = 0.52) or at follow‐up (RR 1.41, 95% 0.25 to 7.87; 1 study, 64 participants; P = 0.70) (<a href="./references#CD005331-fig-0025" title="">Analysis 5.9</a>). </p> </section> <section id="CD005331-sec-0134"> <h5 class="title">5.6 Use of health service resources</h5> <p>CBT did not decrease primary health service use, measured using numbers of general practitioner consultations, compared with SMC at follow‐up (MD –1.00, 95% CI –3.32 to 1.32; 1 study, 46 participants; P = 0.40) (<a href="./references#CD005331-fig-0026" title="">Analysis 5.10</a>). </p> </section> <section id="CD005331-sec-0135"> <h5 class="title">5.7 Adverse effects</h5> <p>Neither study measured adverse effects.</p> </section> </section> <section id="CD005331-sec-0136"> <h4 class="title">Comparison 6: psychoeducational follow‐up programmes compared with treatment as usual</h4> <p>Two studies compared psychoeducational follow‐up programmes with TAU (<a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>; <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a>). </p> <section id="CD005331-sec-0137"> <h5 class="title">6.1 Reduction in physical signs</h5> <section id="CD005331-sec-0138"> <h6 class="title">6.1.1 Seizure frequency</h6> <p>Psychoeducational follow‐up programmes might reduce seizure frequency, measured using a self‐developed scale, compared with TAU at follow‐up (MD –0.80, 95% CI –1.44 to –0.16; 1 study, 27 participants; P = 0.01) (<a href="./references#CD005331-fig-0027" title="">Analysis 6.1</a>). </p> </section> <section id="CD005331-sec-0139"> <h6 class="title">6.1.2 Physical symptoms load</h6> <p>Psychoeducational follow‐up programmes did not reduce physical symptoms load, measured using SSF‐36 Physical Component scale, compared with TAU at follow‐up (MD –0.26, 95% CI –3.76 to 3.24; 1 study, 186 participants; P = 0.88) (<a href="./references#CD005331-fig-0028" title="">Analysis 6.2</a>). </p> </section> </section> <section id="CD005331-sec-0140"> <h5 class="title">6.2 Level of functioning</h5> <p>Psychoeducational follow‐up programmes might improve level of functioning, measured using WSAS, compared with TAU at end of treatment (MD –7.12, 95% CI –12.47 to –1.77; 1 study, 43 participants; P = 0.009), and at follow‐up (MD –6.11, 95% CI –11.67 to –0.55; 1 study, 43 participants; P = 0.03) (<a href="./references#CD005331-fig-0029" title="">Analysis 6.3</a>). </p> </section> <section id="CD005331-sec-0141"> <h5 class="title">6.3 Quality of life</h5> <p>Psychoeducational follow‐up programmes might improve quality of life, measured using QOLIE10‐P, compared with TAU at follow‐up (MD –9.30, 95% CI –14.06 to –4.54; 1 study, 27 participants; P = 0.0001) (<a href="./references#CD005331-fig-0030" title="">Analysis 6.4</a>). </p> </section> <section id="CD005331-sec-0142"> <h5 class="title">6.4 Mental state</h5> <section id="CD005331-sec-0143"> <h6 class="title">6.4.1 Anxiety</h6> <p>Psychoeducational follow‐up programmes did not reduce anxiety symptoms, measured using HADS – Anxiety, compared with TAU at follow‐up (MD –0.47, 95% CI –1.67 to 0.73; 1 study, 192 participants; P = 0.44) (<a href="./references#CD005331-fig-0031" title="">Analysis 6.5</a>) </p> </section> <section id="CD005331-sec-0144"> <h6 class="title">6.4.2 Depression</h6> <p>Psychoeducational follow‐up programmes did not reduce depression symptoms compared with TAU at follow‐up (SMD –0.30, 95% CI –1.08 to 0.48; 2 studies, 219 participants; P = 0.45) (<a href="./references#CD005331-fig-0032" title="">Analysis 6.6</a>). </p> </section> </section> <section id="CD005331-sec-0145"> <h5 class="title">6.5 Dropout rate</h5> <p>Psychoeducational follow‐up programmes did not decrease dropout compared with TAU at end of treatment (RR 1.76, 95% CI 0.82 to 3.78; 1 study, 64 participants; P = 0.14) or at follow‐up (RR 0.54, 95% CI 0.00 to 70.37; 2 studies, 259 participants; P = 0.81) (<a href="./references#CD005331-fig-0033" title="">Analysis 6.7</a>). </p> </section> <section id="CD005331-sec-0146"> <h5 class="title">6.6 Use of health service resources</h5> <p>Psychoeducational follow‐up programmes did not decrease number of hospital visits compared with TAU at end of treatment (RR 0.18, 95% CI 0.02 to 1.43; 1 study, 64 participants; P = 0.10) (<a href="./references#CD005331-fig-0034" title="">Analysis 6.8</a>). </p> </section> <section id="CD005331-sec-0147"> <h5 class="title">6.7 Adverse effects</h5> <p>Neither study measured adverse effects.</p> </section> </section> <section id="CD005331-sec-0148"> <h4 class="title">Comparison 7: specialised cognitive behavioural therapy‐based physiotherapy inpatient programme compared with wait list </h4> <p>One study compared CBT with wait list (<a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>). </p> <section id="CD005331-sec-0149"> <h5 class="title">7.1 Reduction in physical signs</h5> <p>The study did not measure reduction in physical signs.</p> </section> <section id="CD005331-sec-0150"> <h5 class="title">7.2 Level of functioning</h5> <p>Specialised CBT‐based physiotherapy inpatient programme might improve level of functioning, measured using FIM, compared with wait list at end of treatment (MD 9.20, 95% CI 6.06 to 12.34; 1 study, 118 participants; P &lt; 0.00001 (<a href="./references#CD005331-fig-0035" title="">Analysis 7.1</a>). </p> </section> <section id="CD005331-sec-0151"> <h5 class="title">7.3 Quality of life</h5> <p>The study did not measure quality of life.</p> </section> <section id="CD005331-sec-0152"> <h5 class="title">7.4 Mental state</h5> <p>Specialised CBT‐based physiotherapy inpatient programme might improve mental state, measured using SF‐12, compared with wait list at end of treatment (MD 9.10, 95% CI 4.96 to 13.24; 1 study, 118 participants; P &lt; 0.0001) (<a href="./references#CD005331-fig-0036" title="">Analysis 7.2</a>). </p> </section> <section id="CD005331-sec-0153"> <h5 class="title">7.5 Dropout rate</h5> <p>Specialised CBT‐based physiotherapy inpatient programme did not reduce dropout compared with wait list at end of treatment (RR 0.23, 95% CI 0.03 to 1.97; 1 study, 60 participants; P = 0.18) (<a href="./references#CD005331-fig-0037" title="">Analysis 7.3</a>). </p> </section> <section id="CD005331-sec-0154"> <h5 class="title">7.6 Use of health service resources</h5> <p>The study did not measure use of health service resources.</p> </section> <section id="CD005331-sec-0155"> <h5 class="title">7.7 Adverse effects</h5> <p>The study did not measure adverse effects.</p> </section> </section> <section id="CD005331-sec-0156"> <h4 class="title">Comparison 8: specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared with treatment as usual </h4> <p>One study compared specialised CBT‐based physiotherapy outpatient intervention with TAU (<a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>). </p> <section id="CD005331-sec-0157"> <h5 class="title">8.1 Reduction in physical signs</h5> <section id="CD005331-sec-0158"> <h6 class="title">8.1.1 Physical symptom load</h6> <p>Specialised CBT‐based physiotherapy outpatient intervention might reduce physical symptom load, measured using SF‐36 – Physical Component), compared with TAU at follow‐up (MD 9.20, 95% CI 4.00 to 14.40; 1 study, 57 participants; P = 0.0005) (<a href="./references#CD005331-fig-0038" title="">Analysis 8.1</a>). </p> </section> </section> <section id="CD005331-sec-0159"> <h5 class="title">8.2 Level of functioning</h5> <p>Specialised CBT‐based physiotherapy outpatient intervention might improve level of functioning, measured using WSAS, compared with TAU at end of treatment (MD –7.10, 95% CI –11.40 to –2.80; 1 study, 54 participants; P = 0.001) or at follow‐up (MD –6.70, 95% CI –12.07 to –1.33; 1 study, 57 participants; P = 0.01) (<a href="./references#CD005331-fig-0039" title="">Analysis 8.2</a>). </p> </section> <section id="CD005331-sec-0160"> <h5 class="title">8.3 Quality of life</h5> <p>The study did not measure quality of life.</p> </section> <section id="CD005331-sec-0161"> <h5 class="title">8.4 Mental state</h5> <section id="CD005331-sec-0162"> <h6 class="title">8.4.1 Anxiety</h6> <p>Specialised CBT‐based physiotherapy outpatient intervention did not reduce symptoms of anxiety, measured using HADS, compared with TAU at end of treatment (MD –0.60, 95% CI –3.05 to 1.85; 1 study, 54 participants; P = 0.63) or at follow‐up (MD –1.00, 95% CI –3.71 to 1.71; 1 study, 57 participants; P = 0.47) (<a href="./references#CD005331-fig-0040" title="">Analysis 8.3</a>). </p> </section> <section id="CD005331-sec-0163"> <h6 class="title">8.4.2 Depression</h6> <p>Specialised CBT‐based physiotherapy outpatient intervention might reduce symptoms of depression, measured using HADS, compared with TAU at end of treatment (MD –3.60, 95% CI –7.13 to –0.07; 1 study, 54 participants; P =0.05) and at follow‐up (MD –3.20, 95% CI –5.33 to –0.87; 1 study, 57 participants; P = 0.007) (<a href="./references#CD005331-fig-0041" title="">Analysis 8.4</a>). </p> </section> </section> <section id="CD005331-sec-0164"> <h5 class="title">8.5 Dropout rate</h5> <p>Specialised CBT‐based physiotherapy outpatient intervention did not improve dropout compared with TAU at end of treatment (RR 0.20, 95% CI 0.02 to 1.61; 1 study, 60 participants; P = 0.13) or at follow‐up (RR 0.50, 95% CI 0.05 to 5.22; 1 study, 60 participants; P = 0.56) (<a href="./references#CD005331-fig-0042" title="">Analysis 8.5</a>). </p> </section> <section id="CD005331-sec-0165"> <h5 class="title">8.6 Use of health service resources</h5> <p>The study did not measure use of health service resources.</p> </section> <section id="CD005331-sec-0166"> <h5 class="title">8.7 Adverse effects</h5> <p>The study did not measure adverse effects.</p> </section> </section> <section id="CD005331-sec-0167"> <h4 class="title">Comparison 9: brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) compared with standard care </h4> <p>One study compared brief psychotherapeutic interventions with SC (<a href="./references#CD005331-bbs2-0007" title="HubschmidM , AybekS , MaccaferriGE , ChocronO , GholamrezaeeMM , RossettiAO , et al. Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. General Hospital Psychiatry2015;37(5):448-55. [DOI: 10.1016/j.genhosppsych.2015.05.007]">Hubschmid 2015</a>). </p> <section id="CD005331-sec-0168"> <h5 class="title">9.1 Reduction in physical signs</h5> <section id="CD005331-sec-0169"> <h6 class="title">9.1.1 Conversion symptoms</h6> <p>Brief psychotherapeutic interventions did not reduce conversion symptoms, measured using SDQ‐20, compared with SC at end of treatment (RR 0.12, 95% CI 0.01 to 2.00; 1 study, 19 participants; P = 0.14), at four months' follow‐up (RR 1.13, 95% CI 0.08 to 15.19; 1 study, 17 participants; P = 0.93) or at 10 months' follow‐up (RR 0.16, 95% 0.01 to 2.66; 1 study, 15 participants; P = 0.20) (<a href="./references#CD005331-fig-0043" title="">Analysis 9.1</a>). </p> </section> </section> <section id="CD005331-sec-0170"> <h5 class="title">9.2 Level of functioning</h5> <p>The study did not measure level of functioning.</p> </section> <section id="CD005331-sec-0171"> <h5 class="title">9.3 Quality of life</h5> <p>Brief psychotherapeutic interventions did not improve quality of life, measured using SF‐36 – Physical Component, compared with SC at end of treatment (MD –6.99, 95% CI –28.09 to 14.11; 1 study, 16, participants; P = 0.52), at four months' follow‐up (MD –19.53, 95% CI –43.91 to 4.85; 1 study, 16 participants; P = 0.12) or at 10 months' follow‐up (MD –11.43, 95% CI –36.16 to 13.30; 1 study, 14 participants; P = 0.37) (<a href="./references#CD005331-fig-0044" title="">Analysis 9.2</a>). </p> </section> <section id="CD005331-sec-0172"> <h5 class="title">9.4 Mental state</h5> <section id="CD005331-sec-0173"> <h6 class="title">9.4.1 Depression</h6> <p>Brief psychotherapeutic intervention did not reduce depression symptoms, measured using BDI‐II, compared with SC at end of treatment (RR 1.29, 95% CI 0.10 to 17.14; 1 study, 16 participants; P = 0.85), at four months' follow‐up (RR 3.86, 95% CI 0.50 to 29.55; 1 study, 16 participants; P = 0.19) or at 10 months' follow‐up (RR 1.00, 95% CI 0.08 to 13.02; 1 study, 14 participants; P = 1.00) (<a href="./references#CD005331-fig-0045" title="">Analysis 9.3</a>). </p> </section> </section> <section id="CD005331-sec-0174"> <h5 class="title">9.5 Dropout rate</h5> <p>Brief psychotherapeutic intervention did not reduce dropout compared with SC at end of treatment (RR 1.09, 95% CI 0.18 to 6.48; 1 study, 23 participants; P = 0.92), at four months' follow‐up (RR 1.09, 95% CI 0.28 to 4.32; 1 study, 23 participants; P = 0.90) or at 10 months' follow‐up (RR 0.82, 95% CI 0.23 to 2.87; 1 study, 23 participants; P = 0.75) (<a href="./references#CD005331-fig-0046" title="">Analysis 9.4</a>). </p> </section> <section id="CD005331-sec-0175"> <h5 class="title">9.6 Use of health service resources</h5> <p>Brief psychotherapeutic intervention did not reduce use of health service compared with SC at end of treatment (MD –0.16 95% CI –1.25 to 0.93; 1 study, 19 participants; P = 0.77) (<a href="./references#CD005331-fig-0047" title="">Analysis 9.5</a>). </p> </section> <section id="CD005331-sec-0176"> <h5 class="title">9.7 Adverse effects</h5> <p>The study did not measure adverse effects.</p> </section> </section> <section id="CD005331-sec-0177"> <h4 class="title">Comparison 10: cognitive behavioural therapy plus adjunctive physical activity compared with cognitive behavioural therapy alone </h4> <p>One study compared CBT plus APA with CBT alone (<a href="./references#CD005331-bbs2-0004" title="DallocchioC , TinazziM , BombieriF , ArnoN , ErroR . Cognitive behavioural therapy and adjunctive physical activity for functional movement disorders (conversion disorder): a pilot, single-blinded, randomized study. Psychotherapy and Psychosomatics2016;85(6):381-3. [DOI: 10.1159/000446660]ErroR , TinazziM , DallocchioC . Cognitive behavioural therapy and adjunctive physical therapy for functional movement disorders. 20th International Congress of Parkinson's Disease and Movement Disorders; 2019 Jun 19-23; Berlin, Germany . [DOI: 10.1002/mds.26688]">Dallocchio 2016</a>). </p> <section id="CD005331-sec-0178"> <h5 class="title">10.1 Reduction in physical signs</h5> <section id="CD005331-sec-0179"> <h6 class="title">10.1.1 Overall physical impacts</h6> <p>CBT plus APA did not reduce overall physical impacts, measured using PMDRS total score, compared with CBT alone at end of treatment (MD 5.60, 95% CI –15.48 to 26.68; 1 study, 21 participants; P = 0.60) (<a href="./references#CD005331-fig-0048" title="">Analysis 10.1</a>). </p> </section> </section> <section id="CD005331-sec-0180"> <h5 class="title">10.2 Level of functioning</h5> <p>The study did not measure level of functioning.</p> </section> <section id="CD005331-sec-0181"> <h5 class="title">10.3 Quality of life</h5> <p>The study did not measure quality of life.</p> </section> <section id="CD005331-sec-0182"> <h5 class="title">10.4 Mental state</h5> <section id="CD005331-sec-0183"> <h6 class="title">10.4.1 Anxiety</h6> <p>CBT plus APA did not reduce symptoms of anxiety, measured using BAI, compared with CBT alone at end of treatment (MD –3.40, 95% CI –8.01 to 1.21; 1 study, 21 participants; P = 0.15) (<a href="./references#CD005331-fig-0049" title="">Analysis 10.2</a>). </p> </section> <section id="CD005331-sec-0184"> <h6 class="title">10.4.2 Depression</h6> <p>CBT plus APA did not reduce symptoms of depression, measured using Hamilton Depression Scale, compared with CBT alone at end of treatment (MD –0.50, 95% CI –3.32 to 2.32; 1 study, 21 participants; P = 0.73) (<a href="./references#CD005331-fig-0050" title="">Analysis 10.3</a>). </p> </section> </section> <section id="CD005331-sec-0185"> <h5 class="title">10.5 Dropout rate</h5> <p>CBT plus APA did not reduce dropout compared with CBT alone at end of treatment (MD 1.87, 95% CI 0.40 to 8.65; 1 study, 29 participants; P = 0.42) (<a href="./references#CD005331-fig-0051" title="">Analysis 10.4</a>). </p> </section> <section id="CD005331-sec-0186"> <h5 class="title">10.6 Use of health service resources</h5> <p>The study did not measure use of health service resources.</p> </section> <section id="CD005331-sec-0187"> <h5 class="title">10.7 Adverse effects</h5> <p>The study did not measure adverse effects.</p> </section> </section> <section id="CD005331-sec-0188"> <h4 class="title">Comparison 11: hypnosis compared with diazepam</h4> <p>One study compared hypnosis with diazepam (<a href="./references#CD005331-bbs2-0013" title="MousaviSG , RahimiJ , AfsharH . Comparison of four different treatment options in the management of acute conversion disorder. Iranian Journal of Psychiatry and Behavioral Sciences2008;2(1):21-5. ">Mousavi 2008</a>). </p> <section id="CD005331-sec-0189"> <h5 class="title">11.1 Reduction in physical signs</h5> <section id="CD005331-sec-0190"> <h6 class="title">11.1.1 Symptom freedom</h6> <p>Hypnosis did not increase symptom freedom, measured using PMDRS Total Score, compared with diazepam at end of treatment (RR 0.69, 95% CI 0.39 to 1.24; 1 study, 40 participants; P = 0.22) (<a href="./references#CD005331-fig-0052" title="">Analysis 11.1</a>). </p> </section> </section> <section id="CD005331-sec-0191"> <h5 class="title">11.2 Level of functioning</h5> <p>The study did not measure level of functioning.</p> </section> <section id="CD005331-sec-0192"> <h5 class="title">11.3 Quality of life</h5> <p>The study did not measure quality of life.</p> </section> <section id="CD005331-sec-0193"> <h5 class="title">11.4 Mental state</h5> <p>The study did not measure mental state.</p> </section> <section id="CD005331-sec-0194"> <h5 class="title">11.5 Dropout rate</h5> <p>The study did not measure dropouts.</p> </section> <section id="CD005331-sec-0195"> <h5 class="title">11.6 Use of health service resources</h5> <p>The study did not measure use of health service resources.</p> </section> <section id="CD005331-sec-0196"> <h5 class="title">11.7 Adverse effects</h5> <p>The study did not measure adverse effects.</p> </section> </section> <section id="CD005331-sec-0197"> <h4 class="title">Comparison 12: outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone </h4> <p>One study compared psychotherapy preceded by MI with psychotherapy alone (<a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>). </p> <section id="CD005331-sec-0198"> <h5 class="title">12.1 Reduction in physical signs</h5> <section id="CD005331-sec-0199"> <h6 class="title">12.1.1 Decrease in seizure frequency</h6> <p>Psychotherapy preceded by MI might have a slight effect on physical signs, measured using participants' seizure diaries, compared with psychotherapy alone at end of treatment (MD 41.40, 95% CI 4.92 to 77.88; 1 study, 54 participants; P = 0.03) (<a href="./references#CD005331-fig-0053" title="">Analysis 12.1</a>). </p> </section> </section> <section id="CD005331-sec-0200"> <h5 class="title">12.2 Level of functioning</h5> <p>The study did not measure level of functioning.</p> </section> <section id="CD005331-sec-0201"> <h5 class="title">12.3 Quality of life</h5> <p>Psychotherapy preceded by MI might have a slight effect on quality of life compared with psychotherapy alone at end of treatment (MD 5.40, 95% CI 0.26 to 10.54; 1 study, 47 participants; P = 0.04) (<a href="./references#CD005331-fig-0055" title="">Analysis 12.3</a>). </p> </section> <section id="CD005331-sec-0202"> <h5 class="title">12.4 Mental state</h5> <p>The study did not measure mental state.</p> </section> <section id="CD005331-sec-0203"> <h5 class="title">12.5 Dropout rate</h5> <p>Psychotherapy preceded by MI did not change dropouts compared with psychotherapy alone at end of treatment (RR 1.60, 95% CI 0.29 to 8.92; 1 study, 60 participants; P = 0.59) (<a href="./references#CD005331-fig-0056" title="">Analysis 12.4</a>). </p> </section> <section id="CD005331-sec-0204"> <h5 class="title">12.6 Use of health service resources</h5> <section id="CD005331-sec-0205"> <h6 class="title">12.6.1 Change in monthly visits</h6> <p>Psychotherapy preceded by MI did not change use of health service resources compared with psychotherapy alone at end of treatment (MD –0.21, 95% CI –0.55 to 0.13; 1 study, 54 participants; P = 0.23) (<a href="./references#CD005331-fig-0054" title="">Analysis 12.2</a>). </p> </section> </section> <section id="CD005331-sec-0206"> <h5 class="title">12.7 Adverse effects</h5> <p>The study did not measure adverse effects.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD005331-sec-0207" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD005331-sec-0207"></div> <p>We conducted this systematic review to examine the effects of psychosocial interventions of conversion and dissociative disorders in adults. We considered 168 full‐text reports from which we included 17 studies published in 21 articles in this review. We used all studies with eligible data in the meta‐analyses, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). </p> <section id="CD005331-sec-0208"> <h3 class="title" id="CD005331-sec-0208">Summary of main results</h3> <p>In the following, we give a brief summary and present a short discussion on the results found for the primary and secondary outcomes of the review. As the overall GRADE analysis deemed all studies to be of low to very low quality, none of the following is to be taken as recommendations, but as indications of what might have effect, knowing very well that this would need to be replicated by studies of higher quality. </p> <section id="CD005331-sec-0209"> <h4 class="title">Primary outcomes</h4> <section id="CD005331-sec-0210"> <h5 class="title">Reduction in physical signs</h5> <p>For the primary outcome, only five comparisons showed statistically significant positive effects on reduction in physical signs. These were: </p> <p> <ul id="CD005331-list-0020"> <li> <p>hypnosis treatment for outpatients (Comparison 3);</p> </li> <li> <p>behavioural therapy plus routine clinical care for inpatients (Comparison 4);</p> </li> <li> <p>psychoeducational follow‐up programmes for outpatients (Comparison 6);</p> </li> <li> <p>specialised CBT‐based physiotherapy‐led intervention (Comparison 8);</p> </li> <li> <p>psychotherapy preceded by MI (Comparison 12).</p> </li> </ul> </p> <p>Comparison 3 consisted of one study only, which showed that hypnosis compared to wait list reduced the severity of physical impairment at the end of treatment (<a href="./references#CD005331-bbs2-0012" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. International Journal of Clinical and Experimental Hypnosis2003;51(1):29-50. [DOI: 10.1076/iceh.51.1.29.14067]">Moene 2003</a>). Interestingly, hypnosis for inpatients did not have the same effect (<a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a>), perhaps because for inpatients the hypnosis treatment was an addition to an already full treatment programme, whereas for the outpatients it was the sole treatment. It could be argued that any treatment is better than none, but we cannot know this is the case without considering adverse effects and these were not reported. </p> <p>Both studies in Comparison 4 had positive results on primary outcomes (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>). <a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a> showed a statistically significant reduction in the number of weekly seizures at end of treatment, while <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a> produced a statistically significant reduced symptom severity at end of treatment. It is noticeable that these two studies (of which <a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a> was modelled on the <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>) are the studies most alike of all our comparisons, and also the only comparison group that had a positive effect on the primary outcome in more than one study.  It would be of interest to see if similar results were obtained by new RCTs of a similar design, but with a much larger number of participants and lower risk of bias. </p> <p>In Comparison 6, the studies showed different results. <a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a> showed a statistically significant reduction in seizure frequency compared to TAU at follow‐up, while <a href="./references#CD005331-bbs2-0015" title="NTR2570. Treatment of functional neurological symptoms. www.trialregister.nl/trial/2454 (first received 19 June 2009). PleizierM , De HaanRJ , VermeulenM . Management of patients with functional neurological symptoms: a single-centre randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(5):430-6. [DOI: 10.1136/jnnp-2015-312889]">Pleizier 2017</a> showed that psychoeducational follow‐up programmes did not reduce physical symptom load compared to TAU at follow‐up. The studies used different measures (a self‐developed scale based on number of seizures versus the SF‐36 Physical Component), but it would still be expected that similar effects would show on both measures for this outcome. </p> <p>Comparison 8 only had one study, which was a five‐day outpatient specialised physiotherapy‐led intervention compared to TAU (<a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>). This was conducted as a feasibility study, inspired by the <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a> study (which was inpatient cognitive behavioural‐based physiotherapy), but as one was inpatients and the other outpatients, we decided to have the two studies in separate comparisons. </p> <p>In Comparison 7, <a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a> found no statistically significant effects on this outcome, while Comparison 8 found a reduction in physical signs at four months' follow‐up. It would be interesting if the authors of <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a> decided to conduct a new and more comprehensive RCT, and see if the indication of effect found here could be affirmed. </p> <p>Comparison 12 consisted of only one study, which showed that intervention led to a decrease in seizure frequency at end of treatment (<a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>). This study was conducted to investigate whether adherence to treatment would be higher if psychotherapy was preceded by MI immediately after diagnosis. Both groups thus received psychotherapy, but as the active group attended more sessions (i.e. adherence was better), it could be argued as to what might actually be the active mediator in the intervention. Perhaps a new study that compared the effect of the same number of actually received psychotherapy sessions in each arm might give some information on the extent MI or psychotherapy is the active mediator. </p> </section> </section> <section id="CD005331-sec-0211"> <h4 class="title">Secondary outcomes</h4> <p>The overall findings of the analysis do point towards statistically significant treatment effects of psychosocial interventions on some of the secondary outcomes. </p> <section id="CD005331-sec-0212"> <h5 class="title">Level of functioning</h5> <p>Three different comparisons showed an effect on level of functioning. Comparison 5 showed that CBT increased level of functioning compared to SMC at follow‐up (<a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>), while both Comparison 6 (psychoeducational follow‐up programmes versus TAU) (<a href="./references#CD005331-bbs2-0003" title="ChenDK , MaheshwariA , FranksR , TrolleyGC , RobinsonJS , HrachovyRA . Brief group psychoeducation for psychogenic nonepileptic seizures: a neurologist-initiated program in an epilepsy center. Epilepsia2014;55(1):156-6. [DOI: 10.1111/epi.12481]MaheshwariA , TrolleyG , FranksR , ChenDK . An abbreviated support group therapy for psychogenic nonepileptic events: a neurologist-initiated program in an epilepsy center. Epilepsy Currents2013;1:133-4. [DOI: 10.5698/1535-7511-13.s1.1]">Chen 2014</a>), and Comparison 8 (specialised CBT‐based physiotherapy led intervention compared to TAU) (<a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>), showed improved level of functioning both at end of treatment and follow‐up. </p> </section> <section id="CD005331-sec-0213"> <h5 class="title">Quality of life</h5> <p>Comparison 6 found effects on improved quality of life at follow‐up (<a href="./references#CD005331-bbs2-0005" title="Drane Dl, LaRocheSM , GaneshGA , TeagardenD , LoringDW . A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2016;54:34-9. [DOI: 10.1016/j.yebeh.2015.10.026]GaneshG , DraneD , LoringD , TeagardenD , KressK , LarocheSM . Treatment strategies for psychogenic nonepileptic seizures: a pilot study. Epilepsy Currents2013;13:135-6. [DOI: 10.5698/1535-7511-13.s1.1]">Drane 2016</a>), and comparison 12 found improved quality of life at end of treatment (<a href="./references#CD005331-bbs2-0017" title="NCT02598076. Motivational interviewing to enhance adherence of patients with psychogenic non-epileptic seizures. clinicaltrials.gov/ct2/show/NCT02598076 (first received 5 November 2015). TolchinB , BasletG , SuzukiJ , MartinoS , BlumenfeldH , HirschLJ , et al. Randomized controlled trial of motivational interviewing for psychogenic nonepileptic seizures. Epilepsia2019;60(5):986-95. [DOI: 10.1111/epi.14728]">Tolchin 2019</a>). </p> </section> <section id="CD005331-sec-0214"> <h5 class="title">Mental state, anxiety and depression</h5> <p>Two comparisons showed effects on general mental state. Comparison 5 found that CBT compared to SMC reduced symptoms of general mental state at end of treatment (<a href="./references#CD005331-bbs2-0010" title="Baird Gl, Harlow Ll, MachanJT , LaFranceWC . Cluster reduction in patients in a pilot treatment trial for psychogenic nonepileptic seizures. Epilepsy &amp; Behavior2017;73:273-9. [DOI: 10.1016/j.yebeh.2017.04.015]LaFrance WC Jr, Frank WebbA , BlumAS , KeitnerGI , BarryJ , SzaflarskiJ . Multi-center treatment trial pilot for psychogenic nonepileptic seizures. Epilepsy Currents2013;1:99. [DOI: 10.5698/1535-7511-13.s1.1]LaFranceWC , Baird Gl, BarryJJ , BlumAS , FrankWA , KeitnerGI , et al. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry2014;71(9):997-1005. [DOI: 10.1001/jamapsychiatry.2014.817]NCT00835627. Treatment trial for psychogenic nonepileptic seizures (NEST-T_1). clinicaltrials.gov/ct2/show/NCT00835627 (first received 3 February 2009). ">LaFrance 2014</a>), while Comparison 7 showed that specialised CBT‐based physiotherapy in an inpatient programme improved mental state compared to wait list at end of treatment (<a href="./references#CD005331-bbs2-0008" title="JordbruAA , SmedstadLM , KlungsøyrO , MartinsenEW . Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up. Journal of Rehabilitation Medicine2014;46(2):181-7. [DOI: 10.2340/16501977-1246]">Jordbru 2014</a>).  </p> <p>Two different comparisons showed effects on anxiety. Comparison 1 showed that inpatient paradoxical intention therapy reduced anxiety symptoms at end of treatment compared to outpatient diazepam (<a href="./references#CD005331-bbs2-0002" title="AtaogluA , OzcetinA , IcmeliC , OzbulutO . Paradoxical therapy in conversion reaction. Journal of Korean Medical Science2003;18(4):581-4. [DOI: 10.3346/jkms.2003.18.4.581]">Ataoglu 2003</a>), while Comparison 4 (behavioural therapy plus routine clinical care compared to routine clinical care alone) likewise found effects in reduction in symptoms of anxiety at end of treatment (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>). Comparison 4 also found effects on reduction in symptoms of depression at follow‐up. </p> </section> <section id="CD005331-sec-0215"> <h5 class="title">Dropout rate</h5> <p>Only Comparison 4 showed statistical significant reduction in dropout at end of treatment (<a href="./references#CD005331-bbs2-0001" title="AamirS , HamayonS , SultanS . Behavior therapy in dissociative convulsion disorder. Journal of Depression &amp; Anxiety2012;1(1):100-3. [DOI: 10.4172/2167-1044.1000103]">Aamir 2012</a>; <a href="./references#CD005331-bbs2-0009" title="KhattakT , FarooqS , JanB . Behavior therapy in dissociative convulsions disorder. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP2006;16(5):359-63. [PMID: PMID: 16756783]">Khattak 2006</a>). </p> </section> <section id="CD005331-sec-0216"> <h5 class="title">Use of health service resources</h5> <p>We found no statistically significant results for use of health services resources.</p> </section> <section id="CD005331-sec-0217"> <h5 class="title">Adverse effects</h5> <p>We found no statistically significant results for adverse effects.</p> </section> </section> </section> <section id="CD005331-sec-0218"> <h3 class="title" id="CD005331-sec-0218">Overall completeness and applicability of evidence</h3> <p>The review contains a mixture of strengths and issues in terms of overall completeness and applicability of evidence. </p> <section id="CD005331-sec-0219"> <h4 class="title">Issues concerning the overall completeness and applicability of the evidence</h4> <p>The review highlights some major issues concerning the overall completeness and applicability of the evidence of the benefits and harms of psychosocial interventions on people diagnosed with conversion or dissociative disorders compared with SC; wait‐list controls; or with another intervention, either pharmaceutical/biological or a different psychosocial intervention. </p> <p>The impact of the applicability of findings related to the duration of studies, choice of interventions and comparators, diagnostic criteria, issues related to the ratings scales and lack of data of adverse effects. </p> <section id="CD005331-sec-0220"> <h5 class="title">Duration of studies</h5> <p>The duration of studies was very short, ranging from a few hours to four months. The mean duration of studies was 9.5 weeks (range two hours to 20 weeks). Due to lack of data it was not possible to investigate the long‐term benefits of psychological interventions for conversion and dissociative disorders. Overall, the evidence on long‐term effects on psychosocial interventions for people with conversion and dissociative disorders is lacking, and it is possible that the small, possibly beneficial effects found in this review might be diminished over the time. </p> </section> <section id="CD005331-sec-0221"> <h5 class="title">Interventions and comparators</h5> <p>The studies in this review compared one type of psychosocial intervention with either another intervention (either pharmacological or psychosocial, or mixed) or with SC/SMC or wait list controls. </p> <p>We had hoped to have combined those comparators in meta‐analyses; however, this was not possible due to variations in the interventions. </p> </section> <section id="CD005331-sec-0222"> <h5 class="title">Lack of validated scales</h5> <p>The field of research on conversion disorder, dissociative disorder and related conditions has no clear guidance about the best way to measure the efficacy of treatments. There seem to be a variety of views on this, from researchers developing their own instruments (e.g. <a href="./references#CD005331-bbs2-0011" title="MoeneFC , SpinhovenP , HoogduinKA , DyckR . A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychotherapy and Psychosomatics2002;71(2):66-76. [DOI: 10.1159/000049348]">Moene 2002</a> has created VMCR), some studies using scales that are not widely used (e.g. <a href="./references#CD005331-bbs2-0014" title="NCT02275000. Feasibility study of physiotherapy for functional motor symptoms. clinicaltrials.gov/ct2/show/NCT02275000 (first received 27 October 2014). NielsenG , BuszewiczM , StevensonF , HunterR , HoltK , DudziecM , et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. Journal of Neurology, Neurosurgery, and Psychiatry2017;88(6):484-90. [DOI: 10.1136/jnnp-2016-314408]">Nielsen 2017</a>, which used PMDRS), while others prefer to simply ask their participants to note the number of seizures in a day, week or month (e.g. <a href="./references#CD005331-bbs2-0006" title="GoldsteinLH , ChalderT , ChigwedereC , KhondokerMR , MoriartyJ , TooneBK , et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology2010;74(24):1986-94. [DOI: 10.1212/WNL.0b013e3181e39658]GoldsteinLH , ChalderT , ChigwedereC , MoriartyJ , TooneBK , MellersJD . A randomised controlled trial of CBT and standard medical care in patients with dissociative (non-epileptic) seizures. Epilepsia2009;11:221-2. NCT00688727. Cognitive behavioural therapy in dissociative seizures. clinicaltrials.gov/ct2/show/NCT00688727 (first received 3 June 2008). NCT02325544. Comparing different treatments in reducing dissociative seizure occurrence (CODES). clinicaltrials.gov/ct2/show/NCT02325544 (first received 25 December 2014). ">Goldstein 2010</a>). Some authors also mentioned that the nature of these disorders makes it difficult to decide on which aspect to focus, be it physical ability or quality of life. </p> <p>This lack of common measures and lack of commonly used validated scales means it becomes almost impossible to compare the effects of different treatments. The findings of this review highlight the wide variety of different scales used to measure the primary outcome across the studies. </p> </section> <section id="CD005331-sec-0223"> <h5 class="title">Lack of adverse effects</h5> <p>The studies did not describe adverse effects. As it is unusual for any treatment, psychosocial, medical or otherwise, to have no adverse effects, we would expect some of the studies in the review to have observed adverse effects, even if these are not reported. </p> </section> <section id="CD005331-sec-0224"> <h5 class="title">Lack of participant involvement</h5> <p>None of the studies included report on whether they involved participants in deciding which outcomes to focus on. This would be a major improvement for future studies, to investigate which outcomes are most important to patients and include those. For this update of the review, we amended the secondary outcomes from the original review to be more in line with the interest of patients, but direct patient involvement could also be improved further in future updates. </p> </section> </section> <section id="CD005331-sec-0225"> <h4 class="title">Strengths in the overall completeness and applicability of the evidence</h4> <section id="CD005331-sec-0226"> <h5 class="title">Countries and settings</h5> <p>One strength of the review was that the studies were from a wide range of countries and settings, which included low‐, medium‐ and high‐income economies, showing how widespread this condition is, as well as the interest in the psychosocial treatment of it. </p> </section> <section id="CD005331-sec-0227"> <h5 class="title">Diagnostic criteria</h5> <p>A different strength of the review was that it concerned a diagnostic area usually very consistent in identifying the conditions in it, with only 4% of patients being misdiagnosed (<a href="./references#CD005331-bbs2-0271" title='StoneJ , SmythR , CarsonA , LewisS , PrescottR , WarlowC , et al. Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ2005;331(7523):989.'>Stone 2005</a>). Furthermore, in a follow‐up study of <a href="./references#CD005331-bbs2-0272" title="StoneJ , CarsonA , DuncanR , ColemanR , RobertsR , WarlowC , et al. Symptoms 'unexplained by organic disease' in 1144 new neurology out-patients: how often does the diagnosis change at follow-up?Brain2009;132(Pt 10):2878-88.">Stone 2009</a>, only 0.4% had acquired an organic disease diagnosis that was unexpected at initial assessment. These percentages are very low compared with other conditions, both psychiatric and somatic ones. </p> <p>This means clinicians and policy makers can rest assured that whatever the findings of the review (or future versions of it), it will be applicable to conditions diagnosed in this way.  </p> </section> </section> </section> <section id="CD005331-sec-0228"> <h3 class="title" id="CD005331-sec-0228">Quality of the evidence</h3> <p>As assessed by GRADE, the overall quality of the evidence ranged from low to very low. We assessed most of studies to have high risk of bias, which may cause systematic errors, that is overestimation of benefits and underestimation of harms (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>). The certainty of the evidence was downgraded as a consequence of potential risk of bias, as many of the studies had unclear or inadequate allocation concealment, making them prone to selection bias. Due to the nature of psychological interventions, maintaining an adequate level of blinding of both personal and participants is often difficult. Despite this, it should be noted that most studies included in this review still managed a considerable level of blinding. </p> <p>Our results were based on 17 studies with a limited number of participants (894). Due to the heterogeneous reporting of outcomes, it was not possible to combine results into a collective analysis to investigate for common effects across studies. Therefore, the results are based on individual studies with only few participants included. This led to imprecision and inconsistency of the estimates, ultimately resulting in further downgrading of the evidence. We were unable to perform funnel plot or any other analyses to assess whether there was risk of publication bias. </p> <p>These important methodological limitations have reduced the reliability and robustness of the results in this review. Currently, there is insufficient evidence to draw any conclusions on the effect of any form of psychosocial intervention of conversion and dissociative disorders in adults. Further research may change the estimates of the treatment effect, but such studies ought to be conducted without risk of systematic errors (bias), random errors (play of chance) and design errors (<a href="./references#CD005331-bbs2-0240" title="KeusF , WetterslevJ , GluudC , vanLaarhovenCJ . Evidence at a glance: error matrix approach for overviewing available evidence. BMC Medical Research Methodology2010;10:90. [DOI: 10.1186/1471-2288-10-90]">Keus 2010</a>).  Overall, we found consistency between conclusions in the previous (<a href="./references#CD005331-bbs2-0264" title="RuddyR , HouseA . Psychosocial interventions for conversion disorder. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD005331]">Ruddy 2005</a>) and the current review. </p> <p>To advance this field, there is a need for high‐quality RCTs with large numbers of participants, that include similar reporting of core outcomes related to this disorder. </p> </section> <section id="CD005331-sec-0229"> <h3 class="title" id="CD005331-sec-0229">Potential biases in the review process</h3> <p>We conducted extensive searches of relevant databases. Two review authors independently selected studies for inclusion and extracted data. Disagreements were resolved by discussion with team members. We assessed risk of bias in all studies according to the recommendations provided in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0226" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> <section id="CD005331-sec-0230"> <h4 class="title">Data collection as risk of bias</h4> <p>To our knowledge we did not introduce any bias in the data collection process, as we used a comprehensive search strategy and made all available attempts to retrieve any missing data. </p> <p>We do not know whether there could be any publication bias, in that it is possible that studies have been conducted but not been published, which would have been of interest to this review. </p> </section> <section id="CD005331-sec-0231"> <h4 class="title">Deciding on rating scales</h4> <p>As many studies used several scales measuring our predefined outcomes, we made a choice for each study about which one to include. This was based on what the review author team deemed most relevant and of best quality, with reference to those scales highlighted in our <a href="#CD005331-sec-0023">Methods</a> section. As the selection process was subjective and not a guideline‐based decision process, this could have introduced bias. We would assume that the various instruments assessing similar aspects would provide similar results if the instruments had been of similar quality. However, this is not necessarily the case as many self‐created and unvalidated rating scales were used. </p> <p>Most of the 12 comparators had data on our primary outcome: 'Reduction in physical signs', although this was measured in many different ways. There were also data on many of our predefined secondary outcomes, most of them measuring important outcomes for these people. We had six secondary outcomes, which in fact was eight because we decided to divide the mental health outcome into anxiety and depression where possible. This high number of outcomes was chosen due to the clinical importance of these outcomes. However, we are aware that this might be problematic as it increases the likelihood of finding a statistical significant result just by chance (<a href="./references#CD005331-bbs2-0232" title="JakobsenJC , WetterslevJ , WinkelP , LangeT , GluudC . Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Medical Research Methodology2014;14:120. [DOI: 10.1186/1471-2288-14-120]">Jakobsen 2014</a>). </p> </section> <section id="CD005331-sec-0232"> <h4 class="title">Subjective judgements as risk of bias</h4> <p>It is inevitable that there will be certain aspects in the many steps of the process which may have or will have had subjective judgements involved. </p> <p>For this review, there are a few areas we would like to address.</p> <p>First, the risk of bias assessment itself will have had some subjective discussion behind the final decisions. Whether to be very strict on a judgement may or may not be clouded by the review authors' backgrounds and daily routines. In the case of this review, the main author is also a clinician, thus has a knowledge of what is possible and desirable in everyday clinical practice. The other review author working on risk of bias has a different background, one of extensive research, and we deliberately chose this combination to minimise the effects of any particular perspective. We followed the guidance of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD005331-bbs2-0227" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.">Higgins 2019</a>), and discussed any discrepancies and found consensus on all items. Hence, we do not judge that our processes would have introduced bias, but want to point out that this could be <i>perceived</i> if one is not aware of the knowledge and experience each review author brings to the process. </p> <p>Second, in choosing which studies to group to create the possibility for comparisons, a risk of bias is also possible. As there are no guidelines on which comparisons to make, the choice presented in this review was based on our clinical judgement, discussed at length among the review author team to provide some coherence in comparing studies, while also ensuring fair and relevant groupings of studies. This should not have affected judgements about overall risk of bias, as the studies were chosen independently of any results, and the comparisons are made on the primary and secondary outcomes as predefined by this review, rather than by the individual studies. However, it is worth noting that such a decision will most likely depend on the clinical experience of the review authors, when studies are as diverse as the ones included here. </p> <p>In conclusion, we judge that the review author team and the processes followed will not have introduced bias in the production of this review, but wanted to mention these areas for future updates and other teams to be aware of. </p> </section> </section> <section id="CD005331-sec-0233"> <h3 class="title" id="CD005331-sec-0233">Agreements and disagreements with other studies or reviews</h3> <p>To our knowledge, this update of the previous Cochrane Review from <a href="./references#CD005331-bbs2-0264" title="RuddyR , HouseA . Psychosocial interventions for conversion disorder. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD005331]">Ruddy 2005</a> is the most extensive and comprehensive systematic review of RCTs of psychosocial interventions for conversion and dissociative disorders. The 2005 review identified 260 references and only three RCTs (119 participants) met the inclusion criteria. In the current review, we identified 3045 relevant research papers and included 17 RCTs (894 participants). </p> <p>The review authors' conclusions in the 2005 study was that "<i>If psychosocial interventions are available for people with conversion disorder then at present they should be viewed as experimental with slight evidence in favour of help rather than harm</i> " and "<i>It is unclear what effects these interventions and other psychosocial interventions have on social functioning, interpersonal relationships, quality of life or satisfaction with care.</i>" </p> <p>It was reasonable to presume with more studies since 2005 and that there may be a better evidence base for drawing conclusions about treatment of these conditions. Unfortunately, despite there being some tentative conclusions about effectiveness in the current review, the overall findings are inconclusive because of the poor quality of the studies and because there was little opportunity to combine results from studies given a wide variety of different psychosocial interventions.  </p> <p>The results were assessed to be of very low to low quality of evidence measured by GRADE and most studies had a high risk of bias. Therefore, we likewise found no evidence of any conclusive benefits of any psychosocial intervention for conversion and dissociative disorders in adults. However, comparing the two reviews, we can see some improvement in the method and quality of studies in this area and find it encouraging to know that potentially high‐quality studies will appear soon (see 'Ongoing studies' and <a href="./references#CD005331-sec-0253" title="">Characteristics of ongoing studies</a> table). </p> <p>Several other reviews and meta‐analyses have been published since the previous version of our review. However, none of them have consistently examined the same diagnostic spectrum (i.e. both conversion and dissociation). Our results confirm the findings of <a href="./references#CD005331-bbs2-0092" title="MartlewJ , PulmanJ , MarsonAG . Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD006370.pub2]">Martlew 2014</a> who concluded that there is little reliable evidence to support the use of any specific treatment for non‐epileptic seizures. They used the same methods as us, but found only four RCTs, which we included in our review. </p> <p>In a review of <a href="./references#CD005331-bbs2-0038" title="CarlsonP , NicholsonPK . Psychological interventions for psychogenic non-epileptic seizures: a meta-analysis. Seizure2017;45:142-50. [DOI: dx.doi.org/10.1016/j.seizure.2016.12.007]">Carlson 2017</a> the results of the analyses indicated that psychological interventions for non‐epileptic seizures may lead to greater rates of seizure reduction and seizure freedom compared to those who do not receive psychotherapy. When compared with the existing evidence, the results of the meta‐analyses indicated that psychological interventions may yield greater rates of seizure reduction (82%) and seizure freedom (47%) compared with those who do not receive psychotherapy (14% to 23%). However, they found there was a high risk of bias and a there was no proper analysis of the quality of evidence. They only found two RCTs, both are included in our review. </p> <p>Some non‐randomised studies found a medium‐ to large‐effect size of psychotherapy and physical treatment for a range of psychological symptoms, physical symptoms and functional impairment (<a href="./references#CD005331-bbs2-0032" title="BrandBL , ClassenCC , McNarySW , ZaveriP . A review of dissociative disorders treatment studies. Journal of Nervous &amp; Mental Disease2009;197(9):646-54. [DOI: dx.doi.org/10.1097/NMD.0b013e3181b3afaa]">Brand 2009</a>; <a href="./references#CD005331-bbs2-0078" title="KoelenJA , HoutveenJH , AbbassA , LuytenP , Eurelings-BontekoeEH , Van Broeckhuysen-KlothSA , et al. Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis. British Journal of Psychiatry2014;204(1):12-9. ">Koelen 2014</a>; <a href="./references#CD005331-bbs2-0108" title="NielsenG , StoneJ , EdwardsMJ . Physiotherapy for functional (psychogenic) motor symptoms: a systematic review. Journal of Psychosomatic Research2013;75(2):93-102. ">Nielsen 2013</a>). However, these studies had methodological limitations. </p> <p>A more detailed description of these studies can be found in the 'Previous reviews on this theme' in the <a href="#CD005331-sec-0019">Why it is important to do this review</a> section. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD005331-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-FIG-01" target="_blank"><b></b></a></p> </div><img alt="PRISMA flow diagram." data-id="CD005331-fig-0001" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>PRISMA flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD005331-fig-0002" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD005331-fig-0003" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Inpatient paradoxical intention therapy versus outpatient diazepam, Outcome 1: Reduction in physical signs: no conversion symptoms in last 2 weeks" data-id="CD005331-fig-0004" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Inpatient paradoxical intention therapy versus outpatient diazepam, Outcome 1: Reduction in physical signs: no conversion symptoms in last 2 weeks </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Inpatient paradoxical intention therapy versus outpatient diazepam, Outcome 2: Mental state – anxiety (Hamilton)" data-id="CD005331-fig-0005" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Inpatient paradoxical intention therapy versus outpatient diazepam, Outcome 2: Mental state – anxiety (Hamilton) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Inpatient paradoxical intention therapy versus outpatient diazepam, Outcome 3: Dropout rate" data-id="CD005331-fig-0006" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Inpatient paradoxical intention therapy versus outpatient diazepam, Outcome 3: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Inpatient treatment programme plus hypnosis versus inpatient treatment programme, Outcome 1: Reduction in physical signs: severity of impairment (VRMC)" data-id="CD005331-fig-0007" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Inpatient treatment programme plus hypnosis versus inpatient treatment programme, Outcome 1: Reduction in physical signs: severity of impairment (VRMC) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Inpatient treatment programme plus hypnosis versus inpatient treatment programme, Outcome 2: Mental state (SCL‐90)" data-id="CD005331-fig-0008" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Inpatient treatment programme plus hypnosis versus inpatient treatment programme, Outcome 2: Mental state (SCL‐90) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Inpatient treatment programme plus hypnosis versus inpatient treatment programme, Outcome 3: Dropout rate" data-id="CD005331-fig-0009" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Inpatient treatment programme plus hypnosis versus inpatient treatment programme, Outcome 3: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Outpatient hypnosis versus wait list, Outcome 1: Reduction in physical signs: severity of impairment (VRMC)" data-id="CD005331-fig-0010" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Outpatient hypnosis versus wait list, Outcome 1: Reduction in physical signs: severity of impairment (VRMC) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Outpatient hypnosis versus wait list, Outcome 2: Dropout rate" data-id="CD005331-fig-0011" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Outpatient hypnosis versus wait list, Outcome 2: Dropout rate</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 1: Reduction in physical signs: number of weekly fits" data-id="CD005331-fig-0012" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 1: Reduction in physical signs: number of weekly fits </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 2: Reduction in physical signs: symptom severity (Clinical Global Impression CGI)" data-id="CD005331-fig-0013" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 2: Reduction in physical signs: symptom severity (Clinical Global Impression CGI) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 3: Mental state – anxiety (HADS)" data-id="CD005331-fig-0014" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 3: Mental state – anxiety (HADS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 4: Mental state – depression (HADS)" data-id="CD005331-fig-0015" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 4: Mental state – depression (HADS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 5: Dropout rate" data-id="CD005331-fig-0016" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: Behavioural therapy plus routine clinical care versus routine clinical care, Outcome 5: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 1: Reduction in physical signs: monthly seizure frequency (reduction in %)" data-id="CD005331-fig-0017" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 1: Reduction in physical signs: monthly seizure frequency (reduction in %) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 2: Reduction in physical signs: monthly seizure frequency" data-id="CD005331-fig-0018" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 2: Reduction in physical signs: monthly seizure frequency </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 3: Reduction in physical sign: seizure freedom" data-id="CD005331-fig-0019" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 3: Reduction in physical sign: seizure freedom </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 4: Level of functioning" data-id="CD005331-fig-0020" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 4: Level of functioning </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 5: Quality of life (QOLIE31)" data-id="CD005331-fig-0021" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 5: Quality of life (QOLIE31) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 6: Mental state – anxiety" data-id="CD005331-fig-0022" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 6: Mental state – anxiety </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 7: Mental state – depression" data-id="CD005331-fig-0023" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 7: Mental state – depression </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 8: Mental state (SCL‐90)" data-id="CD005331-fig-0024" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 8: Mental state (SCL‐90) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 9: Dropout rate" data-id="CD005331-fig-0025" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 9: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-005.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 10: Use of health services (number of general practitioner consultations)" data-id="CD005331-fig-0026" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-005.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5: Cognitive behavioural therapy versus standard medical care, Outcome 10: Use of health services (number of general practitioner consultations) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-005.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 1: Reduction in physical signs: seizure frequency (self‐made scale)" data-id="CD005331-fig-0027" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 1: Reduction in physical signs: seizure frequency (self‐made scale) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 2: Reduction in physical signs: physical symptom load (SF‐36 – physical)" data-id="CD005331-fig-0028" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 2: Reduction in physical signs: physical symptom load (SF‐36 – physical) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 3: Level of functioning (WSAS)" data-id="CD005331-fig-0029" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 3: Level of functioning (WSAS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 4: Quality of life (QOLIE10‐P)" data-id="CD005331-fig-0030" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 4: Quality of life (QOLIE10‐P) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 5: Mental state – anxiety (HADS)" data-id="CD005331-fig-0031" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 5: Mental state – anxiety (HADS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 6: Mental state – depression" data-id="CD005331-fig-0032" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 6: Mental state – depression </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-006.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 7: Dropout rate" data-id="CD005331-fig-0033" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-006.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 7: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-006.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 8: Use of health services (number hospital visits)" data-id="CD005331-fig-0034" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-006.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6: Psychoeducational follow‐up programmes versus treatment as usual, Outcome 8: Use of health services (number hospital visits) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-006.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Specialised cognitive behavioural therapy‐based physiotherapy inpatient programme versus wait list, Outcome 1: Level of functioning (Functional Independence Measure Motor (FIM))" data-id="CD005331-fig-0035" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Specialised cognitive behavioural therapy‐based physiotherapy inpatient programme versus wait list, Outcome 1: Level of functioning (Functional Independence Measure Motor (FIM)) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Specialised cognitive behavioural therapy‐based physiotherapy inpatient programme versus wait list, Outcome 2: Mental state (SF‐12)" data-id="CD005331-fig-0036" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Specialised cognitive behavioural therapy‐based physiotherapy inpatient programme versus wait list, Outcome 2: Mental state (SF‐12) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Specialised cognitive behavioural therapy‐based physiotherapy inpatient programme versus wait list, Outcome 3: Dropout rate" data-id="CD005331-fig-0037" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Specialised cognitive behavioural therapy‐based physiotherapy inpatient programme versus wait list, Outcome 3: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 1: Reduction in physical signs: physical symptom load (SF‐36 – Physical Component)" data-id="CD005331-fig-0038" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 1: Reduction in physical signs: physical symptom load (SF‐36 – Physical Component) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 2: Level of functioning (WSAS)" data-id="CD005331-fig-0039" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 2: Level of functioning (WSAS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 3: Mental state – anxiety (HADS)" data-id="CD005331-fig-0040" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 3: Mental state – anxiety (HADS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-008.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 4: Mental state – depression (HADS)" data-id="CD005331-fig-0041" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-008.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 4: Mental state – depression (HADS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-008.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 5: Dropout rate" data-id="CD005331-fig-0042" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-008.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8: Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU), Outcome 5: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-008.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 1: Reduction in physical signs: conversions symptoms (SDQ20)" data-id="CD005331-fig-0043" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 1: Reduction in physical signs: conversions symptoms (SDQ20) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 2: Quality of life (SF‐36)" data-id="CD005331-fig-0044" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 2: Quality of life (SF‐36) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 3: Mental state – depression (BDI‐II)" data-id="CD005331-fig-0045" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 3: Mental state – depression (BDI‐II) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-009.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 4: Dropout rate" data-id="CD005331-fig-0046" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-009.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 4: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-009.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 5: Use of health services (emergency department visits)" data-id="CD005331-fig-0047" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-009.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9: Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care, Outcome 5: Use of health services (emergency department visits) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-009.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone, Outcome 1: Reduction in physical signs: overall physical impact (Psychogenic Movement Disorder Scale (PMDRS)" data-id="CD005331-fig-0048" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone, Outcome 1: Reduction in physical signs: overall physical impact (Psychogenic Movement Disorder Scale (PMDRS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-010.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone, Outcome 2: Mental state – anxiety (BAI)" data-id="CD005331-fig-0049" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-010.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-010.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10: Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone, Outcome 2: Mental state – anxiety (BAI) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-010.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-010.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone, Outcome 3: Mental state – depression (Hamilton)" data-id="CD005331-fig-0050" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-010.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-010.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10: Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone, Outcome 3: Mental state – depression (Hamilton) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-010.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-010.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone, Outcome 4: Dropout rate" data-id="CD005331-fig-0051" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-010.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-010.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10: Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone, Outcome 4: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-010.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-011.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Hypnosis versus diazepam, Outcome 1: Reduction in physical signs: symptom freedom" data-id="CD005331-fig-0052" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-011.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-011.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11: Hypnosis versus diazepam, Outcome 1: Reduction in physical signs: symptom freedom </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-011.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-012.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone, Outcome 1: Reduction in physical signs: decrease in seizure frequency" data-id="CD005331-fig-0053" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-012.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-012.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12: Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone, Outcome 1: Reduction in physical signs: decrease in seizure frequency </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-012.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-012.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone, Outcome 2: Changes in monthly visits" data-id="CD005331-fig-0054" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-012.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-012.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12: Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone, Outcome 2: Changes in monthly visits </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-012.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-012.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone, Outcome 3: Quality of life" data-id="CD005331-fig-0055" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-012.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-012.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12: Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone, Outcome 3: Quality of life </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-012.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD005331-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/urn:x-wiley:14651858:media:CD005331:CD005331-CMP-012.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone, Outcome 4: Dropout rate" data-id="CD005331-fig-0056" src="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-012.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_t/tCD005331-CMP-012.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12: Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone, Outcome 4: Dropout rate </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/media/CDSR/CD005331/image_n/nCD005331-CMP-012.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Paradoxical intention therapy compared with diazepam</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Paradoxical intention therapy compared with diazepam for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatient and inpatient </p> <p><b>Intervention:</b> paradoxical intention therapy </p> <p><b>Comparison:</b> diazepam over 45 days </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Diazepam</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Paradoxical intention therapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>(number of patients without any conversive attacks in last 2 weeks)</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.44</b> (0.91 to 2.28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>30<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Paradoxical intention therapy may have no effect on physical signs at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>600 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>864 per 1000</b><br/>(54 less to 768 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to imprecision (wide confidence intervals; based on one study with few patients).<br/><sup>b</sup>Downgraded one level due to high risk of bias. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Paradoxical intention therapy compared with diazepam</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Hypnosis plus treatment as usual compared with treatment as usual</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Hypnosis + treatment as usual compared with treatment as usual for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> inpatient </p> <p><b>Intervention:</b> hypnosis + TAU </p> <p><b>Comparison:</b> TAU </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TAU</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Hypnosis + TAU</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs (Severity of impairment)</b> </p> <p>Measured by the VRMC scale (higher is better)</p> <p>Range: 1–7</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 5.9</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.49 lower</b> </p> <p>(1.28 lower to 0.30 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypnosis + TAU may have no effect on physical signs at end of treatment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>TAU:</b> treatment as usual; <b>VRMC:</b> The Video Rating Scale for Motor Conversion Symptoms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (wide confidence intervals; based on 1 study with few patients). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Hypnosis plus treatment as usual compared with treatment as usual</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Hypnosis compared with wait list</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Hypnosis compared with wait list for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatient </p> <p><b>Intervention:</b> hypnosis </p> <p><b>Comparison:</b> wait list </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait list</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Hypnosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs (Severity of impairment)</b> </p> <p>Measured by the VRMC scale (higher is better)</p> <p>Range: 1–7</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 3.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.10 higher</b> </p> <p>(1.34 higher to 2.86 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypnosis may have little effect on reduction in physical signs at end of treatment</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>VRMC:</b> Video Rating Scale for Motor Conversion Symptoms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded one level due to imprecision (based on 1 study with few patients). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Hypnosis compared with wait list</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Behavioural therapy plus treatment as usual compared with treatment as usual</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Behavioural therapy + TAU compared with TAU for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> inpatient </p> <p><b>Intervention:</b> behavioural therapy + TAU </p> <p><b>Comparison:</b> TAU </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TAU</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Behavioural therapy + TAU</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Number of weekly seizures, as assessed by daily self‐reported treatment diary</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 27.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 21.40 lower</b> </p> <p>(27.88 lower to 14.92 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Very low</b><sup>a,b</sup> </p> <p>⊕⊝⊝⊝</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Behavioural therapy + TAU may have little effect on reduction in physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p><b>(symptom severity)</b> </p> <p>Measured by Clinical Global Impression scale (lower is better)</p> <p>Range: 1–7</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 4.48</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.90 lower</b> </p> <p>(3.41 lower to 2.39 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Very low</b><sup>a,b</sup> </p> <p>⊕⊝⊝⊝</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Behavioural therapy + TAU may have little effect on reduction in physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> Confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to high risk of bias.<br/><sup>b</sup>Downgraded one level due to imprecision (data based on 1 study with few participants). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Behavioural therapy plus treatment as usual compared with treatment as usual</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Cognitive behavioural therapy as compared with standard medical care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Cognitive behavioural therapy compared with standard medical care for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings: </b>outpatient </p> <p><b>Intervention:</b> cognitive behavioural therapy </p> <p><b>Comparison:</b> standard medical care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard medical care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Cognitive behavioural therapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Reduction in monthly seizure frequency as assessed by a daily self‐reported seizure diary </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.56</b> (0.39 to 6.19) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>16<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on reducing physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>286 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>446 per 1000</b><br/>(174 less to 1484 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Monthly seizure frequency as assessed by a daily self‐reported seizure diary (lower is better) </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 6.75</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD –4.75 lower</b> </p> <p>(18.73 lower to 9.23 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on reducing physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical sign</b> </p> <p>Seizure freedom as assessed by a daily self‐reported seizure diary</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 2.33</b> (0.30 to 17.88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>16<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on reducing physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>143 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b><br/>(100 less to 2414 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> <p>As measured by the GAF (range 0–100) scale and the WSAS scale (0–40) (lower is better)</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.44 higher</b> </p> <p>(1.69 lower to 2.57 higher)</p> <p>I<sup>2</sup> = 91% </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74<br/>(2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on level of functioning at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>As assessed by QOLIE31 (higher is better)</p> <p>Range: 15–97</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the control group was 9.7</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 11.20 higher</b> </p> <p>(7.98 lower to 30.38 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cognitive behavioural therapy may have little or no effect on quality of life at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>GAF</b> : global assessment of functioning; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>QOLIE31</b> : quality of life in epilepsy inventory; <b>RR:</b> Risk Ratio; <b>SMD:</b> standardised mean difference; <b>WSAS:</b> work and social adjustment scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (wide confidence intervals; 1 study with few participants).<br/><sup>c</sup>Downgraded one level due to imprecision (wide confidence intervals).<br/><sup>d</sup>Downgraded one level due to inconsistency (I<sup>2</sup> = 91%). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Cognitive behavioural therapy as compared with standard medical care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Psychoeducational follow‐up programme compared with treatment as usual</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Systematic follow‐up programme compared with TAU for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings: </b>outpatient </p> <p><b>Intervention:</b> systematic follow‐up programme </p> <p><b>Comparison:</b> TAU </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TAU</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Systematic follow‐up programme</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> <p>As assessed by WSAS scale (lower is better)</p> <p>Range: 0–40</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean level of functioning in the control group was 25.52</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 7.12 lower</b> </p> <p>(12.47 lower to 1.77 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychoeducational follow‐up programme may have little effect on level of functioning at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>TAU:</b> treatment as usual; <b>WSAS:</b> Work and Social Adjustment Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels due to high risk of bias.<br/><sup>b</sup>Downgraded one level due to imprecision (wide confidence interval and based on one study with few participants). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Psychoeducational follow‐up programme compared with treatment as usual</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy compared with waitlist</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Specialised CBT‐based physiotherapy programme compared with wait list for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> inpatient </p> <p><b>Intervention:</b> specialised CBT‐based physiotherapy programme </p> <p><b>Comparison:</b> wait list </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Wait list</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Specialised CBT‐based physiotherapy</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> <p>As measured by FIM (higher is better)</p> <p>Range: 18–126</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean level of functioning in the control group was 80.9</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 9.20 higher</b> </p> <p>(6.06 higher to 12.34 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Specialised CBT‐based physiotherapy may slightly improve level of functioning at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CBT:</b> cognitive behavioural therapy; <b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>FIM</b> : Functional Independence Measure Motor; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded one level due to imprecision (based on one study with few patients). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy compared with waitlist</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy intervention compared with treatment as usual</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Specialised CBT‐based physiotherapy‐led intervention compared with TAU for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings: </b>outpatients at day hospital </p> <p><b>Intervention:</b> specialised CBT‐based physiotherapy‐led intervention </p> <p><b>Comparison:</b> TAU </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>TAU</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Specialised CBT‐based physiotherapy‐led intervention</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> <p>As assessed by WSAS scale (lower is better)</p> <p>Range: 0–40</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean level of functioning in the control group was 26.9</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 7.10 lower</b> </p> <p>(11.40 lower to 2.80 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Specialised CBT‐based physiotherapy intervention may slightly improve level of functioning at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CBT:</b> cognitive behavioural therapy; <b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>TAU:</b> treatment as usual; <b>WSAS:</b> Work and Social Adjustment Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (wide confidence interval and based on one study with few patients). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy intervention compared with treatment as usual</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Brief psychotherapeutic intervention compared with standard care</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Brief psychotherapeutic intervention compared with standard care for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> brief psychotherapeutic intervention </p> <p><b>Comparison:</b> standard care </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Standard care</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Brief psychotherapeutic intervention</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>As assessed by SDQ‐20 (lower is better)</p> <p>Range: 20–100</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.12</b> (0.01 to 2.00) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>19<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Brief psychotherapeutic intervention may have no effect on physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>400 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b><br/>(396 less to 400 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>As assessed by SF‐36 (lower is better)</p> <p>Range: 0–100</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the control group was 50.56</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 6.99 lower</b> </p> <p>(28.09 lower to 14.11 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief psychotherapeutic intervention may have little effect on quality of life after end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>RR:</b> Risk Ratio; <b>SDQ‐20:</b> somatoform dissociation questionnaire; <b>SF‐36:</b> 36‐item Short Form. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (Wide confidence intervals and based on one study with few patients). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Brief psychotherapeutic intervention compared with standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0010"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Cognitive behavioural therapy plus adjunctive physical activity compared with cognitive behavioural therapy alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CBT + APA compared with CBT alone for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatients </p> <p><b>Intervention:</b> CBT + APA </p> <p><b>Comparison:</b> CBT </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CBT</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CBT + APA</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs (overall physical impact)</b> </p> <p>As measured by PMDRS, total score (lower is better)</p> <p>Range: 0–128</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 33.2</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 5.60 higher</b> </p> <p>(15.48 lower to 26.68 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CBT + APA may have no effect on physical signs at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>APA:</b> adjunctive physical activity; <b>CBT:</b> cognitive behavioural therapy; <b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>PMDRS:</b> Psychogenic Movement Disorders Rating Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two level due to imprecision (wide confidence interval, based on one study with few participants). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 10.</span> <span class="table-title">Cognitive behavioural therapy plus adjunctive physical activity compared with cognitive behavioural therapy alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0011"> <div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Hypnosis compared with diazepam</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Hypnosis compared with diazepam for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings: </b>emergency unit </p> <p><b>Intervention:</b> hypnosis </p> <p><b>Comparison:</b> diazepam </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Diazepam</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Hypnosis</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Number with symptom freedom</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.69</b> (0.39 to 1.24) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>40<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Hypnosis may have no effect on physical signs at end of treatment.</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>650 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>448 per 1000</b><br/>(397 less to 156 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two levels due to imprecision (Wide confidence interval and based on one study with few patients). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 11.</span> <span class="table-title">Hypnosis compared with diazepam</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD005331-tbl-0012"> <div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Psychotherapy preceded by motivational interviewing compared with psychotherapy alone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Psychotherapy preceded by motivational interviewing compared with psychotherapy alone for conversion disorder</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with conversion disorder according to DSM‐IV or ICD‐10 criteria </p> <p><b>Settings:</b> outpatient </p> <p><b>Intervention:</b> psychotherapy preceded by motivational interviewing </p> <p><b>Comparison:</b> psychotherapy alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>No of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="3" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Psychotherapy</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Psychotherapy preceded by motivational interviewing</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Reduction in physical signs</b> </p> <p>Decrease in seizure frequency</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean reduction in physical signs in the control group was 34.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 41.40 higher</b> </p> <p>(4.92 higher to 77.88 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychotherapy preceded by motivational interviewing may have little effect on physical signs at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Level of functioning</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life</b> </p> <p>As measured by QOLIE10 (lower is better)</p> <p>Range: 10–50</p> <p>End of treatment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean quality of life in the control group was 1.8</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 5.40 higher</b> </p> <p>(0.26 higher to 10.54 higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/>(1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychotherapy preceded by motivational interviewing may have little effect on quality of life at end of treatment. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse events</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No studies assessed this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> Confidence interval; <b>DSM‐IV:</b><i>Diagnostic and Statistical Manual of Mental Disorders 4th Edition</i>; <b>ICD‐10:</b><i>International Classification of Diseases, Tenth Revision</i>; <b>MD:</b> mean difference; <b>QOLIE10:</b> quality of life in epilepsy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level due to high risk of bias.<br/><sup>b</sup>Downgraded two level due to imprecision (wide confidence interval, based on one study with few participants). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 12.</span> <span class="table-title">Psychotherapy preceded by motivational interviewing compared with psychotherapy alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/full#CD005331-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Inpatient paradoxical intention therapy versus outpatient diazepam</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Reduction in physical signs: no conversion symptoms in last 2 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.91, 2.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.91, 2.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Mental state – anxiety (Hamilton) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.73 [‐6.96, ‐0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.73 [‐6.96, ‐0.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Inpatient paradoxical intention therapy versus outpatient diazepam</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Inpatient treatment programme plus hypnosis versus inpatient treatment programme</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Reduction in physical signs: severity of impairment (VRMC) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.49 [‐1.28, 0.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.55, 0.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Mental state (SCL‐90) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [‐36.02, 38.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.97 [‐44.22, 32.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.14, 5.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Inpatient treatment programme plus hypnosis versus inpatient treatment programme</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Outpatient hypnosis versus wait list</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Reduction in physical signs: severity of impairment (VRMC) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [1.34, 2.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [1.34, 2.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.17 [0.50, 34.66]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Outpatient hypnosis versus wait list</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Behavioural therapy plus routine clinical care versus routine clinical care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Reduction in physical signs: number of weekly fits <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐21.40 [‐27.88, ‐14.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐21.40 [‐27.88, ‐14.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Reduction in physical signs: symptom severity (Clinical Global Impression CGI) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.90 [‐3.41, ‐2.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.90 [‐3.41, ‐2.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Mental state – anxiety (HADS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.47 [‐7.08, ‐3.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.47 [‐7.08, ‐3.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Mental state – depression (HADS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.99 [‐6.44, ‐3.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4.1 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>108</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.99 [‐6.44, ‐3.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.5.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.06, 0.90]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Behavioural therapy plus routine clinical care versus routine clinical care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Cognitive behavioural therapy versus standard medical care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Reduction in physical signs: monthly seizure frequency (reduction in %) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.39, 6.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Reduction in physical signs: monthly seizure frequency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.75 [‐18.73, 9.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.50 [‐12.69, 5.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Reduction in physical sign: seizure freedom <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.33 [0.30, 17.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Level of functioning <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [‐1.69, 2.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.63 [‐1.18, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 Quality of life (QOLIE31) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.20 [‐7.98, 30.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>11.20 [‐7.98, 30.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.6 Mental state – anxiety <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.78, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.31 [‐0.85, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.7 Mental state – depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.25 [‐0.71, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.32 [‐0.86, 0.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.8 Mental state (SCL‐90) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐70.60 [‐121.59, ‐19.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐70.60 [‐121.59, ‐19.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.9 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.02, 8.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.25, 7.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.10 Use of health services (number of general practitioner consultations) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐3.32, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10.1 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐3.32, 1.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Cognitive behavioural therapy versus standard medical care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Psychoeducational follow‐up programmes versus treatment as usual</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Reduction in physical signs: seizure frequency (self‐made scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.44, ‐0.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐1.44, ‐0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Reduction in physical signs: physical symptom load (SF‐36 – physical) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐3.76, 3.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2.1 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>186</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐3.76, 3.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Level of functioning (WSAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.12 [‐12.47, ‐1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.11 [‐11.67, ‐0.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Quality of life (QOLIE10‐P) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.30 [‐14.06, ‐4.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4.1 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.30 [‐14.06, ‐4.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Mental state – anxiety (HADS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐1.67, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.1 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>192</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐1.67, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 Mental state – depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.08, 0.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.1 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐1.08, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.7 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.82, 3.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.00, 70.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.8 Use of health services (number hospital visits) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.18 [0.02, 1.43]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Psychoeducational follow‐up programmes versus treatment as usual</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy inpatient programme versus wait list</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Level of functioning (Functional Independence Measure Motor (FIM)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.20 [6.06, 12.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.20 [6.06, 12.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Mental state (SF‐12) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.10 [4.96, 13.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.10 [4.96, 13.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.03, 1.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy inpatient programme versus wait list</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Reduction in physical signs: physical symptom load (SF‐36 – Physical Component) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.20 [4.00, 14.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.20 [4.00, 14.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Level of functioning (WSAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.10 [‐11.40, ‐2.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.70 [‐12.07, ‐1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 Mental state – anxiety (HADS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐3.05, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐3.71, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.4 Mental state – depression (HADS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.60 [‐7.13, ‐0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.20 [‐5.53, ‐0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.5 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.02, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.05, 5.22]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Specialised cognitive behavioural therapy‐based physiotherapy outpatient intervention compared to treatment as usual (TAU)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Reduction in physical signs: conversions symptoms (SDQ20) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [0.01, 2.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.2 Follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.08, 15.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1.3 Follow‐up 10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.01, 2.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Quality of life (SF‐36) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.99 [‐28.09, 14.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.2 Follow‐up 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐19.53 [‐43.91, 4.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2.3 Follow‐up 10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐11.43 [‐36.16, 13.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 Mental state – depression (BDI‐II) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.10, 17.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3.2 Follow‐up 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.86 [0.50, 29.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3.3 Follow‐up 10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.08, 13.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.4 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.18, 6.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4.2 Follow‐up 4 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.28, 4.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4.3 Follow‐up 10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.23, 2.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.5 Use of health services (emergency department visits) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐1.25, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.5.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐1.25, 0.93]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Brief psychotherapeutic intervention (psychodynamic interpersonal treatment approach) versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 Reduction in physical signs: overall physical impact (Psychogenic Movement Disorder Scale (PMDRS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.60 [‐15.48, 26.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.60 [‐15.48, 26.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.2 Mental state – anxiety (BAI) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.40 [‐8.01, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.40 [‐8.01, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.3 Mental state – depression (Hamilton) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐3.32, 2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.50 [‐3.32, 2.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.4 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.87 [0.40, 8.65]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Cognitive behavioural therapy plus adjunctive physical activity versus cognitive behavioural therapy alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Hypnosis versus diazepam</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.1 Reduction in physical signs: symptom freedom <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.39, 1.24]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Hypnosis versus diazepam</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD005331-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.1 Reduction in physical signs: decrease in seizure frequency <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>41.40 [4.92, 77.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>41.40 [4.92, 77.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.2 Changes in monthly visits <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.55, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.55, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.3 Quality of life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.40 [0.26, 10.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.40 [0.26, 10.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.4 Dropout rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.29, 8.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4.1 End of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.29, 8.92]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Outpatient motivational interviewing and mindfulness‐based psychotherapy compared with psychotherapy alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD005331.pub3/references#CD005331-tbl-0024">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD005331.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD005331-note-0016">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD005331-note-0024">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD005331-note-0022">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD005331-note-0023">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD005331-note-0021">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD005331-note-0019">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD005331-note-0020">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD005331-note-0018">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD005331-note-0015">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD005331-note-0017">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005331\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005331\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005331\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD005331\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD005331\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=8ranHhTh&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005331.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD005331.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD005331.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD005331.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD005331.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740720190629"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005331.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740720190633"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD005331.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dfb18291e9377',t:'MTc0MDcyMDE5MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 